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Insight on mortality compression: a cause-of-death analysis of
variability in human longevity in Italy
by Andrea GAMBONI
As a result of the mortality transition, humans today live much longer
than in the past and also experience a lesser uncertainty about the even-
tual timing of their death. This lesser uncertainty is the consequence of the
compression of the age-at-death distribution: deaths are more and more
concentrated in a narrower age range as time passes by.
In this dissertation, I investigate on changes in length of life variabil-
ity in Italy. Thanks to cause-specific data from 1980 to 2013, I am able to
assess the role played by various causes of death on the observed mortal-
ity compression, trying to give an epidemiological explanation of trends in
lifespan variability and gender differences in lifespan variability. In partic-
ular, I focus my attention on two distinct aspects of this phenomenon, that
is, the changes in the distribution of deaths over a broad age range and the
changes in the distribution of deaths within the old age range.
In order to analyze the whole 1980-2013 period, cause-specific time se-
ries were reconstructed because of the changes brought by the introduc-
tion of the tenth International Classification of Diseases revision (ICD-10)
in 2003.
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1Chapter 1
Introduction
In his unfinished opera "Pensées", the French mathematician and philoso-
pher Blaise Pascal states: "The human being is only a reed, the most feeble in
nature; but this is a thinking reed [...] The human being becomes still nobler than
that which kills him, because he knows that he is dying, and the advantage that
the universe has over him. The universe, it does not have a clue." (Pascal, 1670).
Awareness of dying has accompanied human beings all over their history,
and it is exactly this awareness that, according to Pascal, makes them nobler
than anything else.
Along with being conscious of death, human beings experienced the
fear of dying. It is not surprising, thus, that speculations on the concept of
death can be found in many philosophers of any era. From a mathemat-
ical point of view, however, the first noticeable attempt in studying how
death occurs in a population has only been made in the XVIIth century by
John Graunt. Graunt, who can be probably considered as the first demog-
rapher in history, systematically collected mortality data for the London’s
population and used them to produce life tables (Graunt, 1662). From that
moment on, the mathematical study of mortality increased more and more,
and it is nowadays of fundamental importance in many disciplines such as
demography, economy, biology and medicine.
Until relatively few decades ago, humans experienced short average
lifespan, with many not living past the first year of life, and a great uncer-
tainty about the timing of deaths (Blacklow, 2007; Edwards and Tuljapurkar
2005; Fries, 1980; Myers and Manton, 1984; Oeppen and Vaupel, 2002; Vallin
and Mesle, 2001). In demography, life expectancy (i.e. the average length of
life) is the most used indicator to describe mortality condition of a popula-
tion. In my opinion, however, it is not less important monitoring also how
much the length of life varies among members of a population. Life ends for
everybody but not for everybody lasts the same amount of time, and since
time is all we have, uncertainty in the timing of death could be probably
considered as the most important inequality for humans. That is the reason
why this latter concept is the main object of this dissertation. Throughout
the dissertation, I will refer to it using different terms, but they all have
the same meaning: uncertainty in the timing of death, lifespan variability,
lifespan inequality, length of life variability, variability of the age-at-death
distribution.
From the end of the XVIIIth century to the beginning of the XIXth cen-
tury, mortality conditions started to improve noticeably in European coun-
tries. Such improvements were mainly driven by progress against infec-
tious diseases and the consequent reduction of many forms of premature
mortality, in particular infant and childhood mortality (Caselli et al., 2002;
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Country e0 (1900) e0 (2013) S10 (1900) S10 (2013)
Belgium 46.5 81.1 25.7 13.3
Denmark 51.8 80.3 23.7 12.8
Finland 41.7 80.9 31.3 13.6
France 45.0 82.0 25.6 13.9
Italy 41.8 82.7 31.1 12.3
Netherlands 48.8 81.3 25.2 12.5
Norway 53.5 81.7 23.7 12.8
Spain 41.3 82.5 30.5 12.7
Sweden 52.2 81.9 24.8 12.5
England and Wales 46.3 81.4 25.6 13.1
TABLE 1.1: Life expectancy at birth, e0, and standard devi-
ation of ages at death above age 10, S10, in ten European
countries in 1900 and 2013. Total population. Data source:
Human Mortality Database
Corsini and Viazzo, 1997). Thenceforth, mortality continued to decline and
nowadays we enjoy longer and less uncertain lifespan.
Table 1.1 gives an idea of the remarkable improvements in either length-
ening of average lifespan or decline of lifespan variability. It displays life
expectancy at birth, e0, and standard deviation of ages at death above age
10, S10, values registered in ten European countries in 1900 and 2013 for
the total population. In slightly more than a century, average lifespan has
been growing up outstandingly: in 1900, among the considered countries,
e0 was in the range of 41.8 years (Italy) and 53.5 years (Norway) while in
2013 it exceeds 80 years in all cases with the highest value of 82.7 reported
in Italy. Improvements in reducing the uncertainty in the timing of death,
here summarized by S10, are not less outstanding. From the beginning
of the XIXth century to nowadays lifespan inequality has been halved, or
more, in all countries.
So, even if we are still bound by the chains of mortality, thanks to the
progress made, the time of death has considerably been postponed and it is
much less aleatory. As a consequence of such improvements, human beings
have also changed their way of approaching death. While in the past the
death was seen as something not expected, traumatic and random, death
is nowadays seen as something related to the unavoidable consumption of
human body and the biological limits of human beings.
Starting from the 1980s, researchers have made several efforts to deepen
the knowledge of changes in lifespan variability. Currently, an open ques-
tion is whether, after decades of improvements, lifespan variability will de-
cline further or not. Some countries, especially Japan, are indeed showing
in the most recent years a slow down in the pace of decline or even con-
stant trends (Bergeron-Boucher et al., 2015; Canudas Romo, 2008; Cheung
et al., 2007; Zurieck, 2010). Answering this question is quite complicated.
As it will be shown in the Chapter devoted to the literature review, the
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main issue is that variability of the age-at-death distribution can be defined
in many ways and, therefore, many are the indicators that can be used to
measure it. As a consequence, it is difficult to give a unique answer to the
question.
Despite a growing number of studies, the topic of variability in length
of life has almost always been tackled using all-cause mortality data. Only
very recently, few studies have tried to document lifespan inequality trends
using a cause-specific approach (Horiuchi et al., 2012; Nau and Firebaugh,
2014). Thus, the knowledge on the role played by causes of death in shap-
ing the variability of the age-at-death distribution is still very poor. Us-
ing a cause-of-death perspective, this dissertation intends to fill this lack
of information and provide new epidemiological understanding about the
greater and greater certainty of our lifespans. The all-cause age-at-death
distribution, dx, can just be seen as what results summing up the various
cause-specific age-at-death distribution, dx,k. Figure 1.1 helps in visualiz-
ing such decomposition. It reports for Italian males and females in 1980
and 2013, the age-at-death distribution of diseases of the circulatory, respi-
ratory and digestive system, neoplasms, external causes and other causes of
death (i.e. the remaining causes grouped all together.) These are the single
components of the all-cause age-at-death distribution and thus, looking at
their changes permits to get new insights on the evolution of lifespan vari-
ability over the course of time. In particular, taking advantage of Italian
data on causes of death from 1980 to 2013 provided by the Italian national
institute of statistics (ISTAT), this dissertation aims to revisit lifespan vari-
ability trends in Italy in the light of information coming from cause-specific
analysis.
Before presenting my results, I provide a review of literature of all main
topics covered in the dissertation (Chapter 2) and details on the data, mea-
sures and methods used (Chapter 3). The literature review, apart from ex-
ploring the current state of scientific knowledge in lifespan variability, also
offers a revision of the demographic and epidemiological transition in Italy
and introduces the issue of harmonizing different International Classifica-
tion of Diseases (ICD). Indeed, since Italian data on causes of death have
been recorded using the ninth ICD revision (ICD-9) from 1980 to 2002 and
using the tenth revision (ICD-10) from 2003 to 2013, to get consistent re-
sults the statistical disruption introduced by the new classification must be
fixed. With regard to data and methodological issues presented in Chapter
3, I give particular attention to the reasons behind the choice of standard
deviation of ages at death above age 10, S10, and standard deviation of ages
at death above the mode, SD(M+), as indicators to monitor lifespan vari-
ability in Italy and I highlight how recent advances in sensitivity analysis
and decomposition techniques unable to explore the effects of changes in
age and cause-specific mortality rates on measures of lifespan inequality.
Chapter 4 is organized into two main sections. In the first, after having
identified and analyzed the statistical disruption in cause-specific time se-
ries introduced by the adoption of ICD-10, I present the new reconstructed
and coherent time series for 17 causes of death. The reconstruction repre-
sents the fundamental step for any further analysis reported in the disser-
tation. In fact, only having in hand the new coherent time-series, it would
be possible to study the evolution of lifespan variability in Italy from 1980
using a cause-specific perspective. The second section offers a revisitation
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FIGURE 1.1: Cause-specific age-at-death distributions. Cal-
culations are based on smoothed data.
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of mortality by cause of death in Italy in the light of reconstruction results.
The information resulting from this analysis, giving an overview of cause-
specific mortality in Italy, will be helpful, in later chapters of the thesis, to
better comprehend lifespan variability dynamics. In this sense, of particular
interest is the outcome coming from the investigation on the mortality im-
provement’s pattern which shows how mortality is not declining uniformly
either across ages or causes of death.
In Chapter 5 and Chapter 6 I tackle the main goal of my work. As men-
tioned above, variability in length of life can be defined in different ways
and according to the definition various indicators have been developed.
In Chapter 5, using S10 to measure lifespan variability, I am interested in
looking at how the shape of the age-at-death distribution is changing as a
whole. S10 perfectly fits this aim, taking into account a vast age range 1.
On the other hand, being in the longevity extension era, it is also essential
monitoring how lifespans are distributed among the old. For this reason, in
Chapter 6 lifespan variability is measured using the standard deviation of
ages at death above the mode, SD(M+), focusing the attention on the right-
hand tail of the distribution. Thus, Chapter 5 and Chapter 6 consider two
distinct features of variability in length of life, but they both have in com-
mon the cause-of-death approach. Stressing the role played by different
causes of death reveals a new understanding of trends in lifespan variabil-
ity and also offers an epidemiological explanation about the current gender
gap in favor of females.
Finally, in Chapter 7, I draw my conclusion, discussing the implications
of my results, summarizing the limitations of my study and outlining ave-
nues for further research.
1Excluding ages until 10 has some advantages as it will be shown in Chapter 3.
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Literature Review
My review of literature focuses on three main topics: 1) variability in length
of life 2) demographic transition and related epidemiological transition in
Italy 3) the issue of harmonizing different International Classification of
Diseases (ICD).
The first part of the review offers an overview about lifespan variability
which represents the primary subject of this dissertation. Particular atten-
tion will be given to: how the concept of variability in length of life has
been interpreted in demographic studies and its relationship with mortality
models; which indicators have been developed to measures lifespan vari-
ability; the implications for humans being of changing in lifespan variabil-
ity over the course of time; how the study of variability in length of life has
been related to causes of death. As specified in the introductive chapter, my
analysis of lifespan variability focuses on the Italian situation using a cause-
of-death approach. Therefore, the target of the second part of the literature
review is the demographic and epidemiological transition in Italy. Finally,
since two different ICD are involved in the data used in this dissertation,
the third part illustrates how different ways of classifying diseases over the
course of time have introduced statistical disruptions in the death’s time
series and the solutions developed to solve this problem.
2.1 Variability in length of life
Mortality transition’s majors benefits for humans being are basically two: a
longer life on average and a greater certainty about the timing of death. In
fact, life expectancy has been steadily increasing in the last two centuries
(Oeppen and Vaupel, 2002) and the present variability of age at death is
much lower than the variability of age at death before the mortality tran-
sition (Edwards and Tuljapurkar, 2005; Kannisto, 2000; Wilmoth and Hori-
uchi, 1999). As stated above, in this dissertation I intend to study the latter
benefit: less uncertainty in the timing of death.
Variations in length of life can be regarded as one of the most impor-
tant inequalities for humans. Decreasing trends in the variability of age
at death, known as mortality compression in the demographic literature,
have created a lot of interest among researchers in this field (Eakin and Wit-
ten, 1995; Fries, 1980; Myers and Manton 1984; Rothenberg et al., 1991).
Experiencing greater certainty about the eventual timing of death empow-
ered humans with a greater sense of control over their own lives. Moreover,
measurement of transformations in lifespan inequality enable governments
and policymakers to ensure sustainability of social security and health-care
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systems (Ouellette and Bourbeau, 2011). The implication of changes in cer-
tainty of timing of death are numerous and regard not only demography
but also psychology and economy as we will see later.
In developed countries, mortality compression was mainly driven by
the huge decline in death rates in infant, childhood and young adult ages
during the first part of the XXth century. In the second half, lifespan in-
equality continued to go down thanks to the considerable decline of adult-
age mortality (Edwards, 2009 ; Kannisto et al. 1994). In these last decades,
however, the decrease in lifespan variability was slower than at the begin-
ning of XXth century and a new scenario of shifting mortality (a situation of
constant variability with the age-at-death distribution shifting to the right
retaining its shape) has been hypothesized by some scholars (Boongaarts,
2005; Canudas-Romo, 2008).
2.1.1 Measures of mortality compression
Kannisto defines mortality compression as occurring when a given propor-
tion of deaths take place in a shorter age interval than before (Kannisto, 2000).
Using this definition, mortality compression can be documented examin-
ing changes in the age-at-death distribution, dx, of either period or cohort
life tables. An alternative and entirely complimentary way of examining
trends in mortality compression, it is to look at changes in the survivorship
distribution, lx, across period or cohort life tables. From this perspective,
trends in mortality compression are assessed by measuring the degree of
rectangularization of the survival curve. The survival curve, indeed, be-
comes increasingly rectangular over time as more members of the cohort
survive to older ages. These two ways of analysis are displayed in Figure
2.1 which represents the age at death distribution, dx, and the survivorship
distribution, lx, for the French population in three different points of time:
1910, 1960 and 2010. In both cases, the decline in lifespan variability over
time is evident and can be detected by a simple graphical inspection.
To precisely assess the degree of mortality compression (and/or the
rectangularization of the survival curve) several measures have been de-
veloped in the last decades. Cheung et al. have done a nice review of these
measures dividing the existing indicators into seven categories (Cheung et
al. 2005). Table 2.1 provides the classification of Cheung et al., including
also e† (life expectancy lost due to premature death) and SDM (Standard
deviation around the mode) which are not reported in the original paper.
Even if mortality compression has been broadly studied, there has not
been any agreement on how to measure it. Moreover, the results obtained
for different measures do not always show a perfect consensus on the mag-
nitude of lifespan variability decline and the timing of its emergence. In
their analysis of ten measures of mortality compression, Wilmoth and Ho-
riuchi, have pointed out that exists a high degree of correlation among these
measures but, in spite of this, the discordance in their trends is often unde-
niable (Wilmoth and Horiuchi, 1999).
Trends in four measures ( e†, H1, S10 and IQR) in Japan are shown in Fig-
ure 2.2. The measures offer different interpretation of the history of mortal-
ity compression in this country from 1954 and 2012. For example, according
1H’s values multiplied by 100 to make them comparable with other indicators.
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Classification Measure
Central longevity indicator Life expectancy ( e0)
Median age at death (Me)
Mode age at death (M)
Horizontalization indicator Degree of horizontalization (β)
Concentration and/or Verticaliza-
tion indicator
Standard deviation of ages at death
( Sx)
Standard deviation above the mode
(SD(M+))
Mean square deviation around the
modal age at death (SDM)
Standard deviation above the third
quartile
Interquartile range (IQR)
C-Family ( C10, C50, C90)
Prolate Index
Entropy Keyfitz’s (H)
Life expectancy lost due to prema-
ture death (e†)
Life expectancy at median lifespan
and third quartile
Fatest decline and/or highest pro-
portion of deaths
Degree of verticalization (θ and θ∗)
Rectangularization indicator Fixed rectangle
Moving rectangle and/or index of
rectangularity R
Person-years ratio (PR)
Person-years differential (PD)
Maximum Longevity indicator Life endurancy
Maximum lifespan (MLS)
Length of the outer tail of longevity
M + 4SDM+
Mapping indicators Percentile
Other indicators Coefficient of variation (CV)
Numerator of Keyfitz’s (N)
Gini coefficient
TABLE 2.1: Classification of existing indicators proposed to
monitor the rectangularization of the survival curve and/or
the compression of mortality. Taken from Cheung et al.
(2005). e† and SDM are not reported in the original paper.
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to H, lifespan variability in Japan is still declining, while the other three in-
dicators show a situation of shifting mortality (even a slight expansion in
the case of IQR). Also, the degree of compression varies measures by mea-
sures: in the first twenty years of the series, for instance, all indicators have
a decreasing trend but the magnitude of the decline is much more evident
for e†, H and IQR than S10. What is clear is that differences arise because
of differences in the age range covered, differences in the central indicator
used in the calculation of variability and whether or not the measurement is
attached to fixed percentiles of the death distribution (Zurieck, 2010). Thus,
each measure captures a different kind of variability and consequently each
of them highlights a different aspect of lifespan inequality. It simply doesn’t
exist a perfect indicator, it is the researcher that has to choose the indicator
that best fits his/her aims. In this dissertation I rely my analysis on two
measures: S10 and SD(M+). The first measure is used to study lifespan
variability over (almost) the entire age range, while the second focus the
attention on old-age lifespan variability that, in the era of longevity exten-
sion, has become increasingly important. The reasons for adopting these
two indicators and the methodological details will be laid out in Chapter 3.
2.1.2 What do we know of lifespan variability?
The study of mortality of mortality compression has its roots in the field of
biology (Comfort, 1979; Pearl, 1940; Upton, 1977). After these pioneering
works, it was the article published by Fries Aging, natural death and the com-
pression of morbity that has stimulated a lot of scholars to focus their atten-
tion on that topic (Fries, 1980). Fries’ theory states that premature mortality
would eventually be eradicated and so the age-at-death distribution would
then follow a normal distribution centered at age 85 years and with a stan-
dard deviation of 4 years (two third of deaths occurring between 81 to 89).
Thus, for Fries, the maximum feasible longevity is fixed and mortality will
be more and more compressed until humans reach such fixed biological
limit that will eventually result in an ideal age-at-death distribution. Fries
forecasted a maximum average age at death of 85 years by extrapolating
linear trends in life expectancy at different ages and considering the point
of intersection of these trend lines. The concept of normal life duration was
not, however, was not introduced by Fries. More than a century early, in-
deed, Lexis gave his view of the distribution of deaths as consisting of three
parts (Lexis, 1878): an high number of deaths within the first year of life
(infant mortality), deaths that occur at young ages (premature mortality)
and deaths centered around the modal age at death accounting for senes-
cent mortality (normal deaths). A graphical representation of Lexis’ view is
given in the top panel Figure 2.3.
Since Fries’ paper, a lot of researchers have obtained results disproving
his theory (Eakin and Witten, 1995; Fries, 1980; Myers and Manton 1984;
Rothenberg et al., 1991). The predicted maximum mean age at death of
85 years has been exceeded in many developed countries, especially by fe-
males, and the related variability of age-at-death is still much higher than
what Fries hypothesized. The fallacy of these two predictions is displayed
in the bottom panel of Figure 2.3, in which Fries’ deaths distribution is com-
pared to Japanese females distribution (2012) that can be regarded as the
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FIGURE 2.3: Top panel: Lexis’ distribution of deaths. Bot-
tom panel: Fries’ ideal age-at-death distribution compared
to Japanese females age-at-death distribution in 2012.
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most evoluted one. Also, the assumption that humans are reaching a bio-
logically fixed limit to lifespan has been challenged by many researchers.
Kannisto has shown that mortality rates above age 80 have been falling in
Western countries and that the pace of decline has raised in last decades
(Kannisto et al. 1994). Cheung and Robine demonstrate that the maximum
reported age at death has been increasing in Japan and that such increase is
not only the consequence of a greater number of living people which make
it more likely to observe higher age at death than in the past (Cheung and
Robine, 2007). Wilmoth and Lundstrom show that the upper tail of the age-
at-death distribution has moved steadily higher over a period of 130 years
in Sweden and over shorter periods in other developed countries (Wilmoth
and Lundstrom, 1996).
The study of mortality compression is undoubtedly much more compli-
cated than the study of life expectancy. In fact, while a decline in mortality
rates at any age acts incrementing life expectancy, the effect of mortality de-
cline on variability measures is not so straightforward and varies by age:
avoiding deaths can either increase or decrease lifespan variability. For one
of the measures presented previously, e†, Zhang and Vaupel have demon-
strated that exists an age such that avoiding deaths before that age reduces
inequality and avoiding deaths after that age increases inequality (Zhang
and Vaupel, 2009). These scenarios are illustrated in Figure 2.4. From the
top panels one can see that the effect of reducing mortality rates, mx, at
young ages is to decrease the variability of the density function, dx , as
deaths are pushed out further on the tail of the age-at-death distribution.
From the bottom panels, instead, one can see that the effect of reducing
mortality rates at old ages is to increase the variability of the density func-
tion as deaths of the right-hand tail of the age-at-death distribution are more
spread out and concentrated at later ages. Thus, the way in which the age
pattern of mortality change is of fundamental importance for the interpre-
tation of lifespan inequality.
The definition of a young-old threshold age, before which mortality
decline decreases lifespan variability and after which mortality decline in-
creases lifespan variability, has also been developed by Gillespie et al. with
regard to the variance of ages at death above age x, Vx (Gillespie et al.,
2014). Investigating on what would be the change due to a proportional
mortality reduction at an age a greater than x, the authors have found the
rate of change of Vx with respect to the force of mortality µx and defined
it as the sensitivity of Vx. An example of such sensitivity analysis and the
eventual finding of a young-old threshold age is displayed in Figure 2.5,
which shows the sensitivity of V10 for French females in 1950 and 2010.
In this time interval, the threshold age has increased by 13 years (from
63 to 76) but this shift to the right it is not the only difference between the
two curves. While in 1950 V10 was really sensitive to mortality reduction at
young ages, this is not the case in 2010, since mortality at young ages has
reached such a low level that any supplementary decrease cannot impact
strongly lifespan variability. Nowadays, it is mainly the decrease in middle-
adult mortality that has the capacity to further lower variability in age-at-
death.
Another important finding that relates the age pattern of mortality change
and the compression of deaths, specifically concerns the standard deviation
of ages at death above the mode, SD(M+), i.e. old age lifespan variability.
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FIGURE 2.4: Hypothetical effects of changes in age-specific
mortality on variability of age at death. Topleft panel: re-
duction in mx at young ages. Topright panel: decrease in
variability of age at death due to reduction in mx at young
ages. Bottomleft panel: reduction in mx at old ages. Bot-
tomright panel: increase in variability of age at death due
to reduction in mx at old ages. Initial mx and dx taken
from Denmark 1935, males population. Data source: HMD
Fitting a simple version of the logistic model with only two parameters (as
known as Kannisto model), to death rates at age 70 and 90, Thatcher et
al. have investigated on the conditions under which compression of deaths
above the mode will occur (Thatcher et al., 2010). The model is as follow:
µ(x) =
aebx
1 + aebx
(2.1)
Where µ(x) is the force of mortality at age x, a is the parameter that
indicates the level of mortality and b the parameter for the rate of increase
in mortality, i.e. the rate of aging.
The authors discovered that the modal age at death, M, depends on both
parameters, while SD(M+) depends uniquely on the parameter b:
M =
ln(b)
b
− ln(a)
b
(2.2)
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FIGURE 2.5: Sensitivity of V10 to proportional mortality
decrease. French females in 1950 and 2010. Data source:
HMD.
SD(M+) =
√√√√ ∞∑
x=M
x2(
1 + b
1 + bebx
)1/b
bebx
1 + bebx
(2.3)
Mortality compression occurs if the logit of the death rate at age 70 falls
faster than the logit of the death rate at age 90. To achieve shifting mortality,
where the modal age increases while variability of age at death above the
mode remains constant, the logits of the death rates at age 70 and 90 must
fall at the same rate so that the parameter retains the same value over time.
These two situations are displayed in Figure 2.6.
Thatcher et al. have fitted their model for six countries (England&Wales,
France, Japan, Italy, Switzerland and Sweden) for each sex separately. In all
cases, the b at the latest date was higher than the b at the earliest date, so
the predicted standard deviation above the mode SD(M+) was lower at the
later date. Thus, over the period as a whole, there had been compression
above the mode in all six countries, for both males and females (Thatcher
et al., 2010).
The conclusion of Thatcher et al., differs from one of Bongaarts that
used a 3-parameter logistic model, which add to the model of equation 2.1
the Makeham’s constant, γ, to measure background mortality (Boongaarts,
2005). Fitting the model to ages 25 to 109 Boongaarts found that the rate
of increase in mortality, measured by the parameter b, has remained nearly
constant from 1950 to 2000 and as a consequence the age-at-death distri-
bution will shift to the right retaining its shape without showing any com-
pression. The reason for the difference between these two findings lies in
the difference between the ages range for which the two model fit data well.
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FIGURE 2.6: Graphical representation of shifting mortality
(top panels) and compression of mortality (bottom panels)
above the mode, M, using the simplified version of the lo-
gistic model.
Fitting the model for a wider age range, as Bongaarts did since he used the
3-parameter version of the model, which is thought to include background
mortality, leads to an estimate of b constant over time, whereas, if the same
model is fitted only at old ages, as in the case of Thatcher at al. which
used a model appropriate for old ages, the slope parameter tend to increase
over time. After a few years, Bongaarts himself arrived at these conclusions
showing that if his model is fitted over shorter age ranges, the estimates of
b are not all the same (Boongaarts, 2009).
In the context of old age mortality compression, SD(M+) has been adopted
as a key indicator also in many other studies, especially by Cheung and
her colleagues (Cheung et al. 2005, 2008, 2009; Cheung and Robine 2007;
Robine et al. 2006; Canudas-Romo, 2010; Ouellette and Bourbeau, 2011).
These studies show that trends in SD(M+) have been very similar in devel-
oped countries with basically no important changes in this measure until
1950. After that point a decline, along with some fluctuations, has been ob-
served, meaning that compression of old-age mortality has been going on
in the last decades. The recent decline in SD(M+) is particularly intriguing
because it SD(M+) can be interpreted as the fact that the increase in human
longevity is meeting some resistance.
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The adoption of SD(M+) as a lifespan inequality measure is largely re-
lated to the increasing importance given to the modal age at death as a
longevity indicator (Canudas-Romo, 2008; Cheung and Robine, 2007; Kan-
nisto, 2001). Indeed, even if life expectancy at birth is still the most used
index to measure the lifespan of a population, since nowadays in devel-
oped countries the majority of deaths occur at old ages, focusing on life
expectancy can disregard some important information. On the contrary,
the modal age at death is determined by adult mortality only and, in many
cases, can be a better indicator in studies of senescence and longevity. More-
over, the number of life table deaths at the mode, d(M), has also an impor-
tant meaning in the contest of lifespan variability. An increase in d(M),
indeed, is related to a compression of the age-at-death distribution. To
achieve shifting mortality, the distribution has not only to shift to the right
(increase in M) but also to retain the same shape (stability of d(M)). For the
Gompertz, Logistic (3-parameter version) and Weibull model, Robine et al.
have shown as the number of deaths at the modal age at death is related to
the rate of aging parameter b, by the following relationships (Robine et al.,
2006):
d(M) = be−1+(a/b) ≈ b/e Gompertz (2.4)
d(M) =
b
[1 + (b/g)]1+g/b
≈ b/e Logistic (2.5)
d(M) =
b
M
e−b/(b+1) ≈ b/eM Weibull (2.6)
Thus b not only determines SDM+ in the Logistic model, but it also has a
relationship with d(M) in the most popular mortality models: as the rate of
aging increases, the number of deaths occurring at the modal age at death
increases too.
2.1.3 Lifespan variability among groups
Measures of lifespan inequality can largely vary, within the same country,
among different groups. Gender, socioeconomic status (SES) and race may
have an influence not only on life expectancy but also on measures of lifes-
pan variability.
Nowadays, in most of developed and not developed countries, females
are experiencing lower mortality rates than males at all ages and, conse-
quently, a higher life expectancy (Edwars and Tujapurkar, 2005). Until early
XXth century, however, males enjoyed better mortality conditions than fe-
males in childhood and early adulthood principally because of an advan-
tage in mortality related to infectious diseases. Currently, females’ higher
average lifespan in developed countries also reflects into a lower variabil-
ity of age at death. Edwards and Tuljapurkar find that S10 among females
is lower than for both sexes combined of about 1 year (Edwards and Tul-
japurkar, 2005). The extreme case is represented by France, where female
S10 is 1.5 years lower than for both sexes combined, and by Denmark where
this difference it is only of 0.5 year. These results are supported by those of
Pampel, who reports evidence of lighter smoking among French females,
heavier smoking among Danish females, and sex differentials in mortality
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that appear to reflect those behavioral differences (Pampel, 2002). Females’
lower lifespan variability is also found by using other inequality indica-
tors: the Theil’s index (Van Raalte, 2011), the C-family (Kannisto, 2000) and
SDM+ (Thatcher et al., 2010).
Also with regard to SES there is a long tradition of studies exploring
how socioeconomic differences have an impact on life expectancy. Recently,
researchers have shown that lower SES is not only associated with shorter
lifespan but also with a greater uncertainty about the timing of death (Brown
et al., 2012; Edwards and Tuljapurkar, 2005; Shkolnikov et al. 2003; Van
Raalte et al. 2011).
Using longitudinal data on individuals in the U.S. National Longitudi-
nal Mortality Study (NLMS) Edwards and Tuljapurkar have explored the
relationship between SES (measured by income and education) and the
variability of the age-at-death distribution (measured by S10). Using in-
come as a proxy of SES, individuals were sorted into two groups, those in
the first quintile of household income and the rest, while when education
is used as a proxy of SES the two groups are represented by those having a
high school diploma and those having a lower education level. The results
show that using income or education doesn’t alter the outcome which is
similar in both cases: adults in lower socioeconomic strata not only suffer
shorter life expectancy, they also endure greater variability. The gap in av-
erage lifespan between individuals in the first income quintile and those in
the top four-fifths is 5.5 years, while the difference in standard deviations
is nearly 2.5 years. Similarly, high school graduates live an average of 5
years longer than their less educated counterparts, while enjoying a stan-
dard deviation that is 2 years lower. These results for the United States are
confirmed by the research of Brown et al. (2012). Based on the Health and
Retirement Study and the National Health Interview Survey Linked Mor-
tality File they found a strong educational gradient in both longevity and
mortality compression and that mortality is more compressed within ed-
ucational groups among women than men. An important difference with
respect to the research of Edwards and Tuljapurkar is that the results re-
fer to old-age mortality compression. Indeed, the indicators used to assess
lifespan variability, in this case, are SMD+ and d(M). Similar outcomes have
been found in 10 European countries by Van Raalte et al. (2011). They used
harmonized census-based mortality data to construct life tables by sex and
educational level, identified by three groups: low (less than secondary ed-
ucation), medium (complete secondary education) and high (tertiary edu-
cation). The lifespan variability indicator, used to assess whether mortality
compression has a relationship with the education level, is S35, the standard
deviation of ages at death above age 35. Moreover, the authors also decom-
posed differences between educational groups in lifespan inequality by age
and cause of death. The results indicate, clearly, that the age-at-death distri-
bution is more spread out among the lower educated in every country, and
especially among men and in Eastern Europe. About causes of death, the
greater lifespan variability in lower educated groups was mainly driven by
conditions causing death at younger ages, such as external causes of death
and neoplasms.
Finally, a couple of studies have also documented, within the same
country, different levels of mortality compression among different racial
groups. All of them pertain the United States, where racial differential in
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life expectancy are well documented and are viewed as an important indi-
cator of socioeconomic inequality (Edwards and Tuljapurkar 2005; Go et al.
1995; Lynch et al. 2003).
Go et al. (1995) studied race specific California vital statistics data for
1970, 1980 and 1990 finding that, in each period, mortality was more com-
pressed among whites than it was among other racial groups. Lynch et al.
(2003), using U.S. vital statistics data between 1970 and 1992, analyzed dif-
ferences in lifespan inequality between whites and blacks finding a higher
level of age-at-death variability among the latter group. A result confirmed
by Edwards and Tuljapurkar (2005), in a study of U.S. vital statistics data
from the late 1960s to the early 1990s.
2.1.4 Lifespan variability and causes of death
Despite mortality compression has been widely documented, its study has
been mainly focused on all-cause mortality. With regard to the role played
by specific cause of death into the decline of variability of the age-at-death
distribution the knowledge is extremely poor. A few attempts in this sense
have been recently made using French data (Zurieck, 2010; Horiuchi et al.,
2012) and US data (Nau and Firebaugh, 2014), plus the previously men-
tioned study of Van Raalte et al. (2011) in which information on the rela-
tionship between SES, causes of death and mortality compression are com-
bined.
Zurieck has documented trends in variability of age at death, specif-
ically in S10, and causes of death from 1925 to 1999. Decomposing dif-
ferences in sex-specific S10 in the periods 1925-29, 1960-64 and 1995-99 she
analyses the contributions of differences in age and cause-specific mortality
between the sexes. During the first period, 1925-29, female S10 was higher
than male S10 by 0.79 years: female disadvantage in infectious disease and
maternal mortality at younger ages and female advantage in mortality for
all causes at older ages led to a more disperse death distribution for fe-
males relative to males. The results for the two following period, 1960-64
and 1995-99, reveal similar patterns of age and cause-specific contributions
which are in contrast to the 1925-29 period. Female’s S10 is now lower than
male’s S10 and the difference seems to have been primarily driven by fe-
male advantage in external related mortality at younger ages. Moreover,
in the 1995-99 period, the effect of female mortality advantage in neoplasm
and heart disease in the middle adult ages on the sex gap in S10 becomes
more pronounced.
Horiuchi et al., have instead analyzed effects of cause-specific death
rates on the rise of all-cause b parameter of the logistic model used by
Thatcher et al. and previously mentioned. They consider two possible
reasons for the increase of all-cause b. First, if it is difficult to slow or de-
lay senescence, death rates from high-b causes of death may decline more
slowly than death rates from low-b causes of death. This will increase the
proportion of deaths in old age from high-b causes of death, raising the
value of all-cause b (level effect hypothesis). Second, if mortality rises from
various CODs, including many of both high-b and low-b causes of death,
become steeper, all-cause b will increase (slope effect hypothesis). Using
French data for the period 1979-1994, they found strong evidence support-
ing the second hypothesis.
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Nau and Firebaugh analysis’, starting from the consideration that, in
the United States, lifespans are more variable for blacks than for whites,
have tried to explain this difference using a cause-of-death approach. They
have decomposed the black-white difference in V0 into allocation (blacks
are more likely than whites to die of causes that tend to strike the young
as well as the old), spread (blacks and whites might die of the same causes
at the same rates, but yet the variability in age at death could be greater
for any or all causes among blacks), timing (the age distributions of specific
causes are centered on different mean ages for blacks and whites) and joint
effect (captures the part of the racial difference in lifespan variance that is
attributable to simultaneous differences in incidence and in cause-specific
variances).
In their study, the all-cause spread component accounts for about 87% of
the disparity, indicating that lifespans are more variable for blacks largely
because age at death varies more for blacks than for whites among those
who succumb to the same cause. The all-cause allocation component is
about 12%, indicating that only about 12% of the disparity in lifespan vari-
ance would persist if blacks and whites differed only with regard to cause-
specific death rates. The all-cause timing component is even smaller and is
negative (-4.7%), indicating that lifespans would vary less for blacks than
for whites if blacks and whites differed only with respect to variance in the
average age at death across causes. The all-cause joint component is also
small, about 5%. The cause-specific spread components show that age at
death in the United States varies more for blacks than for whites for al-
most all causes of death. As one would expect, the most common causes
of death contribute the most to the spread component. Heart disease, for
example, is the biggest contributor, with a spread component of 29%. The
profile is very different for the cause-specific allocation components. Rela-
tively rare causes of death AIDS, homicide, suicide, and accidental poison-
ing contribute much more to the allocation component than do much more
common causes of death, such as heart disease, cancer and cerebrovascu-
lar diseases. Moreover, unlike the cause-specific spread components (all of
which are either positive or negligibly negative), the cause-specific alloca-
tion components largely offset one another. Homicide’s large allocation ef-
fect (38%), for example, is almost entirely offset by the combined allocation
effects of suicide (-22%) and accidental poisoning (-15%). The timing and
joint components contribute very little to the disparity in lifespan variance.
Their contributions are minimal because virtually all of their cause-specific
components are negligible. In the case of timing, accidental poisoning has
the largest effect by far (-14.9%).
2.1.5 Implications of changes in lifespan variability
The changes in mortality observed over the course of the last two centuries
must have had an impact on other areas of human life besides death. A
first question that has to be answered is whether or not humans are aware
of their own mortality risk. If human behavior is sensitive to changes in
lifespan variability, indeed, persons have to be some consciousness of it.
The information coming from studies on mortality risk perception have
given mixed outcomes. Empirical evidence have shown that objective risk
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measurement, experts’ risk estimate and people’s perceptions differ (Sun-
stein, 2002). In judging their own mortality risk, people are heavily in-
fluenced by their own experience (e.g. death of a parent or spouse or a
friend) and by how they perceive the risk. Also the gender seems to be
an important factor: females perceive health and environmental risks as
greater than males do (Brown and Cotton, 2003; Dosman et al., 2001; Liu
and Hsieh, 1995; Lundborg and Andersson, 2006; Lundborg and Lindgren,
2004; Savage, 1993). Hurd and McGarry, using data from the Health and
Retirement Survey, have discovered that the self-assessed survival proba-
bilities of those who survived between two waves this longitudinal survey
were considerably higher in comparison to those who died during the in-
terval between the two surveys, showing a good predictive power of re-
spondents’ self-assessments of their own survival probabilities (Hurd and
McGarry, 2002). Similar results have been found by Mirowsky, who using
data from the 1995 Aging, Status and the Sense of Control survey and com-
paring them to actuarial tables for the United States, found that on average
subjective and actual life expectancies agree, even though younger persons
fail to account for expected improvements in survival over time (Mirowsky,
1999). High income and high education level seem to be two characteristics
which reduce individual perception of risk (Dosman et al., 2001; Savage,
1993). The reason could lie in the fact that wealthier and better-educated
people may have the opportunity, through money and/or consciousness,
to actually expose themselves to less risk. Sunstein has also found an op-
timistic bias in how people perceive voluntary risks which are judged to
be controllable by personal action (Sunstein, 2002). An attempt to disen-
tangle the preference for greater certainty in timing of death from the de-
sire for greater longevity has been done by Edwards (Edwards, 2009). He
proposed a model which, based on the ratio of the expected utilities from
greater certainty and greater longevity, theoretically permits to determine
the amount of life expectancy one would be willing to give up in order to
be more certain about the timing of death. Edwards’ finding shows that an
average person would renounce to 0.5 year of average life span for a 1 year
reduction in variability of age at death.
Another aspect of the possible consequences of the decline in variability
of age at death surely concerns psychological implications. It may be that
human being are less scared of death when there is greater certainty on the
time of its occurrence: death has seen as something natural and expected
among old people and therefore less traumatic. But, on the contrary, it may
also be that such certainty could increase fear of death because deaths that
occur outside of the natural order are perceived as more awful. This sec-
ond reasoning is supported by a study of attitudes towards death among
impoverished persons in Brazil suffering high rates of mortality in infancy
and childhood, which shows that mothers are relatively indifferent to the
deaths of their children (Scheper-Hughes, 1992). Another study, reporting
evidence from the past, suggests that maternal attitudes regarding infant
death changed considerably from the mid XVIIIth to early XXth century in
the United States (Dye and Smith, 1986). While earlier, Americans mother
held a deterministic attitude toward infant deaths, in the more recent era
this gave way to a recognition of the role of human agency, which in turn
put pressure on mothers to ensure their children’s survival.
Thus, the psychological implications of the decline in variability of age
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at death are still vague and not so much studied and, to a certain extent,
the same can be said for the economic implications. For instance, Edwards
and Tuljapurkar state that the effect of this greater certainty on age at re-
tirement is still unclear (Edwards and Tuljapurkar, 2005). Persons might
retire earlier if life span is more uncertain if they view retirement as a bene-
fit for years of work. However, they might also be inspired to work longer
in order to accumulate savings because they are more uncertain about the
transition to ill-health. Likewise, it is difficult to determine how uncertainty
about timing of death will affect saving behaviors because it is not simple to
understand whether bequests are intentional or circumstantial. About the
public pension system, on the contrary, the situation seems to be clearer:
higher is the uncertainty in timing of death at the population level higher
is also the cost for a public pension system. The costs of supporting those
who live longer, indeed, are not balanced by earlier deaths because income
is collected by the dependents of those who die early. Also, those who
die earlier have contributed less to the system and those who live longer
collect greater benefits as the poor have a survival disadvantage (Edwards
and Tuljapurkar, 2005). Apart from the pension system, an important ques-
tion regarding the exceptional growth of the elderly population brought
by mortality compression (and the rising in life expectancy) is how much it
will cost to support this aging population. A key factor to answer this query
is whether or not mortality compression will be accompanied by morbidity
compression.
The tremendous growth of the elderly population implied by the de-
cline of variability in age at death, also poses a demographic question about
the population growth. If it is true that at the individual level fertility is go-
ing down, this does not mean that the number of births decreases at popu-
lation level since more individuals are surviving to their childbearing ages
as deaths are compressed into older ages. Demographically speaking, an-
other implication of the decreasing lifespan inequality is that the risk of
being orphaned for children is much lower than in the past as well as mar-
ried persons are much less likely to be widowed during their reproductive
years in comparison to previous generations. As a result persons can rely
more heavily on the nuclear family. But, if on one hand mortality compres-
sion seems to ensure a solid family structure, on the other greater certainty
in timing of death and longer life expectancy have also probably brought
an increase in the number of divorces, a phenomenon that weakens the nu-
clear family unity. Persons unhappy in their marriage may be more likely
to seek divorce if they expect their partner to live a long time and if their
own survival prospects are such that they have many years to seek out a
new relationship.
2.2 An overview of the morbidity and mortality tran-
sition in Italy
The demographic transition theory was firstly developed by Thompson who
observed a transition from high birth and death rates to low birth and death
rates in developed societies which passed from a pre-industrial to an in-
dustrialized economic system (Thompson, 1929). The theory was then de-
veloped more formally by Notestein who noted that the mortality decline
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preceded the fertility decline producing, as a consequence, a fast popula-
tion growth (Notestein, 1945). Such transition started, in each of the Eu-
ropean countries, in different periods. England is regarded as the first in
which the transition began, at the end of the XVIIIth century, followed by
France, Norway and Sweden after a few decades while In Italy the transi-
tion started only in the late XIXth century. Improvements in food supply,
water supply, hygiene and sanitation are regarded as the major force driv-
ing the transition in its first stage, allowing a dramatic reduction of mor-
tality, especially infant and childhood mortality. The consequent fertility
reduction also started for a variety of factors such as an increase in the sta-
tus and education of women, the diffusion of contraception, a reduction in
the value of children work and the urbanization.
A theoretical explanation of the changes in mortality observed over the
course of time, using an epidemiological approach, was firstly given by
Omran (Omran, 1971). Omran’s epidemiological transition theory consists of
three different stages:
• The age of pestilence and famine. In this phase mortality, is high and fluc-
tuating with life expectancy around 30 years. Infectious diseases rep-
resent the first cause of death and the fluctuations are a consequence
of the cyclical famine.
• The age of receding pandemics. This is the stage of the transition, life
expectancy rises thanks to the infectious diseases reduction.
• The age of degenerative and man-made diseases. After a long period of de-
creasing, mortality levels off. Much of deaths are due to degenerative
diseases (cardiovascular diseases, neoplasms, diabetes mellitus) and
man-made diseases (suicide, alcoholism, traffic accidents, pollution).
Omran’s theory is based on the idea of a transition from a stable regime
of high mortality to another stable regime of low mortality. This theory,
highly descriptive, is strictly connected to the historical period in which it
was conceived and for this reason, at that time, it was able to explain the
terrific mortality reduction and its posterior stabilization observed during
the 60s of the XXth century. In the following decades, however, the hypoth-
esis of a new stable mortality regime was contradicted: death rates started
to fall again thanks to a considerable reduction of cardiovascular diseases.
A new theory, thus, called health transition theory, was proposed in 1991 by
Frenk (Frenk et al., 1991). It adds other two stages to the three proposed by
Omran:
• Consistent decrease of the cardiovascular diseases due to the recent
medical knowledge improvements.
• A possible further drop of death rates caused by the reduction of neo-
plasms and senescence-related mortality
Focusing the attention on what happened in Italy, Figure 2.7 displays
life expectancy trends for females, males and total population from 1872 to
2013. As mentioned before, in Italy the transition to a regime of low mortal-
ity started later than in England or other northern European countries and
this can be clearly noted by the fact that in 1872 the average lifespan was
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equal to 30.2 years for females and 29.2 years for males, values in line with
the pre-transition stage described by Omran.
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FIGURE 2.7: Life expectancy trends for females, males an
total population in Italy from 1872 to 2013. Source: HMD
From that moment life expectancy started a steady and almost linear
rise, interrupted only during World War I and World War II. In particular,
during the 1914-1919 period, the effects of World War I were further aggra-
vated by the outbreak of the Spanish Flu epidemic (Caselli and Egidi, 1991).
Nowadays, females are enjoying a mean lifespan of 84.4 years while males
of 79.7 years. The gender gap became clear only after World War II and
reached its peak in 1979 when the difference between the sexes was of 6.75
years.
Such exceptional improvements in life expectancy can be better assessed
looking at Figure 2.8, which displays the surface of age-specific death prob-
abilities of Italian males and females over the period from 1872 to 2013. The
figure extends the one of Barbi et al. in which the death probabilities are
reported over the period from 1887 to 1994 (Barbi et al., 2000). The two
World Wars impact on mortality can be easily identified on the maps by the
elongated rays of high mortality crossing all ages. For men, these effects are
visible also some years after the wars among the cohorts that were born or
grew up during the war years (Barbi et al., 2000).
Omran’s outlook about a new stabilization of mortality after decades
of improvements is detected for males, who experienced no substantial de-
cline in the probability of dying, especially at ages above 60, until the 70s of
the XXth century. It was this leveling off, also observed in other developed
countries, that led to the consideration, then proved as wrong, that all the
attainable decline of mortality had been reached and further improvements
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were impossible. This stage of stabilization was not reported by females
for whom the probability of dying steadily went down from the end of the
XIXth century. Beginning from the mid-1970s, a new stage of mortality de-
cline took off, even for the elderly, initially at a slower pace for men than
for women, while in the last decade the situation seems to be reversed.
A deeper insight into the mortality transition is given breaking down
the gain in life expectancy according to underlying cause of death and age,
as done by Caselli and Egidi who have interpreted this rising trend in the
light of the health transition started in Italy at the end of the XIXth century
(Caselli and Egidi, 1991; Caselli, 1991). In their study they assess that out of
the 33 and 39 years gained by males and females respectively from 1885 to
1986, 25 years are due to the fall in mortality from infectious diseases, and
more specifically to tuberculosis, pneumonia and influenza. Those causes
strongly reduced their lethality in particular in early infancy as a conse-
quence of improvements in living conditions, nutrition, hygiene and ad-
vancement made in medical treatment and prevention. On the other hand,
in the period considered by the study, the contribution of diseases of the
circulatory system to the gain in life expectancy has been less than 1 year
for men and less than 2 years for women, thank principally to the decline in
mortality among the elderly. The situation is even reversed for malignant
neoplasms which had a negative contribution to life expectancy of about 1.5
years for males and 0.5 years for females, although in the last two decades
analyzed some improvements were registered for under 45’s men.
Barbi et al. analyze the passage to a more modern mortality regime from
another point of view, looking at the first leading group of causes of death
from 1895 to 1993 for both sexes, from birth to age 98 (Barbi et al., 2000).
In this analysis all the stages of the transition come up precisely: infectious
diseases were predominant, especially at young ages, until the 1940s, to
then leave space to a more modern regime in which external causes for the
young, neoplasms for adults and circulatory diseases for the elderly are the
most relevant causes of death. Especially for females, the predominant role
of circulatory diseases started to decrease, from the 1960s, in favor of cancer
in particular between age 40 and 60. In Chapter 4 I will extend the study of
the leading group of causes of death of Barbi et al., first by adding other 20
years to the series and second by using a deeper level of analysis in terms
of causes for deaths since 2003.
2.3 Reconstructing coherent series of causes of death
The main purpose of this dissertation is studying mortality compression in
Italy using a cause-of-death approach. In order to accomplish this task I
used data on causes of death in Italy from 1980 to 2013. As always when
working with causes of death the main problem is represented by the fact
that such causes are registered according to different classifications. Since
1900, indeed, the International Classification of Diseases (ICD) has under-
gone ten revisions. These revisions are necessary because of changes in
medical knowledge, changes in disease profiles and changes in how dis-
eases are perceived and understood (Meslé, 2008). In my case two revisions
are involved, ICD-9 and ICD-10. ICD-10 was introduced in Italy in 2003
and consequently discontinuities in the statical series of mortality by cause
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of death were produced. Details on the reconstruction of the Italian series
will be given in Chapter 3, here I summarize the history of International
Classification of Diseases and I review the statistical method developed to
deal with the issue of harmonizing different classifications.
2.3.1 International Classification of Diseases
The botanist and medical doctor Francois Bossier de Laroix(1706-1777) is
credit as the first person who tried to develop a classification of diseases
(Bossier de Laroix, 1763). Until the mid-XIXth century, however, the most
used classification of diseases, ideated by William Cullen (1710-1790), was
the "Synopsis nosologiae methodicae" (Cullen, 1785). Cullen’s classification
was taken as a model by William Farr (1807-1883) who tried to improve it
and decisively push toward the adoption of a unique classification: "The ad-
vantages of a uniform statistical nomenclature, however imperfect, are so obvious,
that is surprising no attention has been paid to its enforcement in Bills of Mor-
tality. Each disease has, in many instances, been denoted by three or four terms,
and each term has been applied to as many different diseases: vague, inconvenient
names have been employed, or complications have been registered instead of pri-
mary diseases. The nomenclature is of as much importance in this department of
inquiry as weights and measures in the physical sciences, and should be settled
without delay." (Farr, 1839).
The utility of a uniform classification of causes of death was recognized
only in 1853 during the First International meeting of Statistics that took
place in Bruxelles. In the second meeting, two years later, William Farr
and Marc D’Espine (1806-1860) presented two different classifications that
were based on different principles. Farr’s classification was divided into
five groups: epidemic diseases, general diseases, local diseases differenti-
ated by the anatomic location, development disorders and diseases caused
by violence. D’Espine, instead classified the diseases according to their
nature (gouty, erpetic, hematic etc). The board of the meeting decided to
adopt a classification resulting from the union of the two. Despite this clas-
sification was never used at the international level it constituted the basis
on which ICD-1 would be shaped a few decades later. Another important
figure in the development of a unique classification was Jacques Bertillon
(1851-1922) who in 1891 presented in Wien a new classification of diseases
that was adopted two years later, in 1893, by the International Statistical
Institute of Chicago. Bertillon’s classification was based on the principle,
proposed by Farr, of the distinction between general diseases and local dis-
eases differentiated by the anatomic location. This list consisted of three
main categories, the first formed by 44 chapters, the second by 99 and the
third by 66. In a few years Bertillon’s classification started to be used in
many countries and in 1898 the American Public Health Association recom-
mended its adoption. Finally, in 1900, the first conference for the revision of
the international classification of diseases was organized in Paris. Starting
from Bertillon’s classification, experts from 26 countries compiled ICD-1.
A second revision took place 9 years later, in 1909, also this time in Paris
and lead to ICD-2. The three following revision didn’t bring any really im-
portant change. It was in 1948, with ICD-6, that some important provisions
were introduced. First of all, it was approved the international medical
certificate of causes of death; secondly it was accepted that the underlying
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cause of death was the origin of the process leading to death; thirdly there
were defined the rules for the selection of the underlying cause of death.
Moreover the World Health Organization (WHO) delineate a series of reg-
ulamentation on compiling statistics of mortality and morbidity that, all the
countries adopting ICD-6, were recommended to follow. This collaboration
between the statistical offices of each country and WHO surely represents
an important turning point in the development of the international homo-
geneity in mortality and morbidity statistics.
The seventh revision took place one more time in Paris, in 1955, while
the eighth in Geneva 10 years later. Either ICD-7 or ICD-8 didn’t change
considerably the structure of ICD-6. During the ninth revision, instead,
some relevant modifications were introduced. The level of detail increased
remarkably from 2862 listed diseases to 5614 and a new codification system
was introduced. Moreover, some technical adjustments were made to make
ICD-9 more flexible and easier to use, facilitating the production of statistics
and indicators.
The tenth revision was finished in 1992, even if, due to its complexity,
its introduction worldwide was really slow. This complexity comes, prin-
cipally, from an impressing level of detail: the 5600 items of ICD-9 were
replaced by more than 10000 items and the codification system switches
from numeric to alphanumeric (the 22 main Chapters of ICD-10 and their
codes are reported in Table 2.2). To each disease, indeed, are associated
two letters and four numbers (four-digit level of detail). More than other
revisions, ICD-10 made numerous changes to the way deaths are classified
by cause. Chronic viral hepatitis, for instance, which was classified as di-
gestive diseases in ICD-9, is now classified as infectious diseases, whereas
other or unspecified forms of chronic hepatitis continue to come under di-
gestive diseases (Meslé, 2008). Another important difference with ICD-9 is
the changes to the rules governing the selection of the underlying cause of
death. In the death certificate, indeed, more than one disease is often re-
ported but only one has to be selected as underlying cause of death. From
a reconstruction of coherent time series point of view, the introduction of
these new rules is considerably important since it brings, more than ever,
statistical disruptions in the time series of causes of death.
The eleventh revision is planned for 2018.
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Chapter Title Code
I Certain infectious and parasitic diseases A00–B99
II Neoplasms C00–D48
III Diseases of the blood D50–D89
IV Endocrine, nutritional and metabolic diseases E00–E90
V Mental and behavioural disorders F00–F99
VI Diseases of the nervous system G00–G99
VII Diseases of the eye and adnexa H00–H59
VIII Diseases of the ear and mastoid process H60–H95
IX Diseases of the circulatory system I00–I99
X Diseases of the respiratory system J00–J99
XI Diseases of the digestive system K00–K93
XII Diseases of the skin and subcutaneous tissue L00–L99
XIII Diseases of the musculoskeletal system and con-
nective tissue
M00–M99
XIV Diseases of the genitourinary system N00–N99
XV Pregnancy, childbirth and the puerperium O00–O99
XVI Certain conditions originating in the perinatal pe-
riod
P00–P96
XVII Congenital malformations, deformations and
chromosomal abnormalities
Q00–Q99
XVIII Symptoms, signs and abnormal clinical and labo-
ratory findings, not elsewhere classified
R00–R99
XIX Injury, poisoning and certain other consequences
of external causes
S00–T98
XX External causes of morbidity and mortality V01–Y98
XXI Factors influencing health status and contact with
health services
Z00–Z99
XXII Codes for special purposes U00–U99
TABLE 2.2: ICD-10 main chapters and codes.
30 Chapter 2. Literature Review
2.3.2 Reconstruction method
The issue of harmonizing different ICD classifications to get coherent time
series of deaths by cause has been popularized by two researchers, Jacques
Vallin and France Meslé. Their reconstruction of French deaths from 1925 to
1978 was the first in the history of demography and epidemiology (Vallin
and Meslé, 1988). Until that moment any long-term statistical analysis of
causes of death was impossible as successive change in the ICD resulted
in disruptions in the series. Nowadays, thanks to the method developed
by Vallin and Meslé, reconstructions for many countries, especially of the
former Soviet Union, are available (Shkolnikov et al. 1996; Meslé and Vallin,
2003; Meslé and Vallin, 2008).
In many countries, the major difficulty in reconstructing coherent time
series is caused the absence of a cross-classification between successive ICD
version which would allow determining the exact transfer from old items to
new ones making possible to calculate transition coefficients and to redis-
tribute deaths according to the most recent classification in use. Such cross-
classification, also known as bridge-coding, is available for USA, Canada,
UK, Sweden and Norway, but it was never used for the reconstruction. This
is probably due to the fact that it regards just a too small sample of deaths
that don’t permit a robust and statistically significant reconstruction. Also
in Italy a cross-classification between ICD-9 and ICD-10 is available. In this
case the sample is extraordinary big (78% of total deaths). However, any
reconstruction was performed. I will use such bridge-coding data to recon-
struct the Italian series from 1980 to 20132. However, it is worth reviewing
Vallin and Meslé method since the reconstruction procedure starting from
the cross-classification is similar, to a certain extent, to their technique.
The method consists of three phases: the construction of a dual cor-
respondence table linking the items of the two revisions, the definition of
fundamental association of items gathering the same medical diagnosis at
both revisions and ensuring a statistical continuity and finally the elabora-
tion of a transition table indicating how to redistribute the deaths (Meslé
and Vallin, 1996).
• The correspondence table
For each item of the old revision, all the items of the new revision that
have in common with it one or more conditions have to be found.
Conversely, for each item of the new revision, all the items of the old
revision that have in common with it one or more conditions have
to be found. At the end of this step two correspondence tables are
produced (Table 2.3 and 2.4 respectively). For instance, in Table 2.3
one can see that the condition in item 0.000 of the old classification,
Classical cholera, is the same as that found in item 001.0 of the new
classification, Cholera due to Vibrio cholerae. Thus, in this case the most
recent revision didn’t introduce any change. Instead, to match the
condition in item 412.0 of the old classification, Chronic ischemic heart
disease with hypertension, seven items of the new classification have
to be picked up, meaning that serious disruptions are produced. On
the other hand, the same reasoning can be done for items of the new
classification with items of the old one, as shown in Table 2.4.
2All the limitation of the procedure are explained in Chapter 3.
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Old classification New classification
Item Name Item Name
000.0 Classical cholera 001.0 Cholera due to Vibrio
cholerae
...
...
...
...
162.1 Malignant neoplasms of
bronchus and lung
162.2 Malignant neoplasms of
main bronchus
162.2 Malignant neoplasms of
upper lobe, bronchus or
lung
162.3 Malignant neoplasms of
middle lobe, bronchus or
lung
162.4 Malignant neoplasms of
lower lobe, bronchus or
lung
162.8 Other malignant neoplasms
of bronchus and lung
...
...
...
...
411.0 Other acute forms of is-
chemic heart disease with
hypertension
411 Other acute form of is-
chemic heart disease
411.9 Other acute forms of is-
chemic heart disease with-
out hypertension
411 Other acute form of is-
chemic heart disease
412.0 Chronic ischemic heart dis-
ease with hypertension
411 Other acute form of is-
chemic heart disease
412 Old myocardial infarction
414.0 Coronary atherosclerosis
414.1 Aneurysm of heart
414.8 Other forms of ischemic
heart disease
414.9 Chronic ischemic heart dis-
ease unspecified
429.2 Cardiovascular disease un-
specified
...
...
...
...
TABLE 2.3: Selected items of the correspondence table from
the old to the new classification. Adapted from Mesle, 1996.
* In the article the two classifications are ICD-8 and ICD-9.
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New classification Old classification
Item Name Item Name
001.0 Cholera due to Vibrio
cholerae
000.0 Classical cholera
...
...
...
...
162.2 Malignant neoplasms of
main bronchus
162.1 Malignant neoplasms of
bronchus and lung
...
...
...
...
411 Other acute form of is-
chemic heart disease
411.0 Other acute forms of is-
chemic heart disease with
hypertension
411.9 Other acute forms of is-
chemic heart disease with-
out hypertension
412.0 Chronic ischemic heart dis-
ease with hypertension
412.9 Chronic ischemic heart dis-
ease without hypertension
...
...
...
...
TABLE 2.4: Selected items of the correspondence table from
the new to the old classification. Adapted from Mesle, 1996.
* In the article the two classifications are ICD-8 and ICD-9.
• Fundamental associations of items
To better illustrate the modifications introduced by the new classifi-
cation the fundamental association of items has to be built. These
associations are constructed in a stepwise manner. The second corre-
spondence table (Table 2.4) gives for the first item of the new classifi-
cation, the item(s) of the old one that matches it. The following step
is to turn back to the first correspondence table (Table 2.,3) to check
whether this/these item(s) of the old classification incorporate(s) con-
ditions found in other items of the new classification. If this is not the
case the fundamental association is complete, otherwise it is needed
to go back to the second correspondence table to check whether these
other items of the new classification incorporates, in turn, conditions
belonging to other items of the old classification and so on, until the
fundamental association is complete. Then, the same procedure has to
be repeated for all other items not involved in previous associations.
In the end, four different kinds of association will result:
a) Only one item of each revision is involved
b) The item of the old classification is split up into various items of
the new classification
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New classification
Old classification Cause A Cause B Cause C Cause D Total deaths
Cause 1 22 18 30 0 70
Cause 2 0 13 2 41 56
Cause 3 342 37 54 33 466
TABLE 2.5: Cross-classification of an hypothetic fundamen-
tal association of item of type d)
New classification
Old classification Cause A Cause B Cause C Cause D Sum
Cause 1 0.31 0.26 0.43 0 1
Cause 2 0 0.23 0.04 0.73 1
Cause 3 0.73 0.08 0.12 0.07 1
TABLE 2.6: Transition coefficients derived from Table 2.5
c) The item of the new classification is split up into various items of
the old classification
d) This is the most complex case: the changes introduced by the new
revision consist of splitting up of certain item of the old revision into
several elements and the reconstruction of several items of the new
revision by assembling these elements differently.
• The transition table
The fundamental associations of items allow the calculation of tran-
sition coefficients to pass from the old to the new classification. This
step basically consists of producing a cross-classification between two
successive revisions manually and then from such cross-classification
finally get the transition coefficients. Depending on the type of the
association, different procedure are required.
In case of association of type a) the solution is very simple, 100% of the
old classification item goes to the new classification item. In case of
association of type b), the deaths classified at the old revision item are
redistributed among the new revision items proportionally to the dis-
tribution of the year in which the new classification was introduced.
In case c) 100% of each item of the old classification goes to the item of
the new classification. The only difficulties are represented by associ-
ations of type d). Following the same approach used for association
of type b), so redistributing deaths proportionally, a lot of cases have
only one solution. If, instead, different solutions are possible, a prag-
matic decision has to be taken (Meslé and Vallin, 1996).
Table 2.5 displays the final cross-classification of a hypothetic funda-
mental association of item of type d). Three causes of the old classifi-
cation are linked to four causes of the new classification. At the end of
the redistribution procedure, 22 of the 70 deaths belonging to "Cause
1" according to the old classification, now are transferred to "Cause
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A" of the new classification, 18 to "Cause B", 30 to "Cause C" and 0 to
"Cause D". The same reasoning can be done for "Cause 2" and "Cause
3". To get the transition coefficients contained in Table 2.6, every cell
is then divided by the corresponding number of total deaths. Now,
assuming that the coefficients obtained for one year are acceptable for
the entire period covered by the ICD version under consideration, it
is possible to reconstruct the time series according to the most recent
classification in use. Transition coefficient are applied by sex and age
groups, so for instance, the number of deaths of "Cause A" from age x
to age x+n in year i, ndAix, is computed as follow:
ndA
i
x = nd1
i
x ∗ 0.31 + nd2ix ∗ 0.00 + nd3ix ∗ 0.73 (2.7)
Where nd1ix, nd2ix and nd3ix are the number of deaths, from age x to
age x+n in year i, of "Cause 1", "Cause 2" and "Cause 3" respectively.
When the reconstruction is over the results have to be checked statis-
tically to detect if there is still any remaining disruption in the series.
This procedure, done by cause, age group and sex, usually consist of
assessing by eyes the presence of any break, looking at the graph of
the series of the total number of deaths. Recently, however, Camarda
and Pechholdova have developed an R package to statistically assess
the presence of disruptions in cause-specific mortality series thanks to
which the long visual inspection procedure can be avoided (Camarda
and Pechholdova, 2014). The method relies on a (back)forecasting of
the trend from the revision year to the first year considered in the
study.
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Chapter 3
Data and Methods
In this Chapter, I provide information about the data and the methods used
to carry out my investigation on lifespan variability in Italy through causes
of death.
3.1 Data
The analysis contained in any Chapter of this thesis, rely on two datasets:
the Human Mortality Database (HMD) and the Italian cause-specific database
by age and sex from 1980 to 2013.
The first can be downloaded from the website www.mortality.org and
was helpful for any long-term and all-cause mortality analysis of Italy and
other countries; the second was provided to me by the Italian national insti-
tute of statistics (ISTAT) and represents the main source of the dissertation,
giving information on cause-specific mortality in Italy. Apart from these
two datasets, useful information on Italian bridge-coding data are taken
from the ISTAT report "Analisi del bridge coding ICD-9 ICD-10 per le statis-
tiche di mortalità per causa in Italia" (Frova et al. 2010). Such information will
be helpful in the reconstruction of coherent Italian time series of causes of
death.
Below, all data’s features and problems are discussed.
3.1.1 Human Mortality Database
The Human Mortality Database is probably the most dominant collection
of high-quality data on all-cause mortality available on-line. It contains, for
38 countries, information on:
• Annual live births count by sex.
• Annual deaths count by sex and age.
• Deaths by Lexis triangles
• Annual estimates of population size on January 1st.
• Annual estimates of the population exposed to the risk of death
• Life tables for period and cohort data.
Data availability and the time interval covered vary country by country.
Sweden has the longest data series (1751-2014), Chile the shortest (1992-
2005). In the case of Italy, period data time series starts in 1872 and ends
in 2013, for all the above-listed information. With regard to cohort data,
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exposure to risk and death rates are available from 1794 to 1982, while life
tables from 1872 to 1921.
A file named Background and documentation, containing detailed advice
and metadata, is provided for each country. The file includes information
on the source of the data, on data coverage, completeness and issues. In
Italy the data sources are official vital statistics, census counts and popu-
lation estimates published by ISTAT. Issues are present for 1872-1905 due
to problems with data quality. For most of these early years, indeed, the
original death counts were available only in five-year age groups with an
open age interval at age 75+. Thus, life tables by single year of age are
based on estimates (HMD, 2016). The decision I took was not to consider
this time interval, beginning the all-cause mortality analysis in 1906. This
criterion is also applied to all other countries which appear throughout the
dissertation.
The HMD was launched in 2002 by researchers from the department
of Demography at the University of California (Berkeley, USA) and the
Max Planck Institute for Demographic Research (Rostock, Germany). In
recent years also the French Institute for Demographic Studies (INED) has
supported the development of the database. The scope and principles are
clearly stated in the overview page of the website: "The main goal of the
Human Mortality Database is to document the longevity revolution of the mod-
ern era and to facilitate research into its causes and consequences. As much as
possible, we have followed four guiding principles in creating this database: com-
parability, flexibility, accessibility, reproducibility". The database is constantly
and punctually updated as well as the number of countries included has
been rising over time. However, since the database is limited by design
to populations where death registration and census data are virtually com-
plete (HMD, 2016), it is mainly representative of the experience of more
developed countries because they fulfill the strict data quality standards
required by the creators.
3.1.2 Causes of death in Italy and bridge-coding information
The core of the thesis, represented by a cause-specific approach to the issue
of lifespan variability in Italy, is developed using the dataset on causes of
death in Italy provided by ISTAT.
The dataset covers the period from 1980 to 2013. For each year the
dataset provides deaths count by:
• Cause-of-death at the most detailed level possible (4 digit level)
• Age (single year of age, without any open-ended category)
• Sex
The tenth revision of the International Classification of Diseases (ICD-
10) was introduced in Italy in 2003. Therefore deaths from 1980 to 2002
are classified according to ICD-9 while deaths from 2003 to 2013 according
to ICD-10. The problem of missing data is almost nonexistent, only for 11
deaths the age at death was not known. In such cases, the decision was to
take over the unknown values with the modal age at death (so the most
probable value) of the year in which deaths were registered.
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The main problem to solve it is represented by the disruptions in the
series caused by the introduction of ICD-10 in 2003. In Chapter 2, where a
comprehensive literature review of the topic was given, we have seen that
in the presence of bridge-coding data (a cross-classification between suc-
cessive ICD version) it would be possible to determine the exact transfer
from old items to new ones and calculate coefficients of redistribution. To
complete the reconstruction it would be enough to assume that the coeffi-
cient obtained for one year are acceptable for the entire period covered by
the ICD version under consideration (Meslé and Vallin, 1988). Fortunately,
bridge-coding data between ICD-9 and ICD-10 in Italy exists. In 2003, in-
deed, ISTAT had classified a sample of causes of death according to both
revisions. This sample is large, 454’897 deaths out of 580’200 (78% of total
deaths) and includes all the 2’124 deaths happened in the first year of life in
2003. Unfortunately, such bridge-coding data are not available at the mo-
ment. However, in the publication of Frova, mentioned in paragraph 3.1,
a significant number of information on the Italian bridge-coding are given
(Frova et al. 2010). Such information are sufficient to perform a reconstruc-
tion of the series, even if not at a very detailed level. Indeed, the data taken
from the ISTAT report on bridge coding allows only the reconstruction of
seventeen groups of causes. In the publication, in fact, the information are
not reported at the finest level of detail possible, making unrealizable the
reconstruction for a bigger number of causes. The mentioned seventeen
groups of causes for which the reconstruction is performed are reported in
Table 3.1. These almost correspond to the ICD-10 main chapters reported
in Table 2.2. The difference is that some chapters are grouped into only one.
For instance, while in ICD-10 diseases of the nervous system, diseases of the
eye and adnexa and diseases of the ear and mastoid process constitute three
different chapters, they form only one chapter in the classification used for
the reconstruction.
The decision to still use bridge-coding data, even if they allow the re-
construction only of a limited number of causes, comes from the consid-
eration that the transfer of items between ICD-9 and ICD-10 is more com-
plex than ever and bridge-coding data offers a statistically really valid so-
lution to the problem. Of course reconstructing the time-series only for
seventeen groups of causes brings some limitations to the analysis at the
epidemiological level. For example, it would be very interesting to distin-
guish between "Ischaemic diseases" and "Cerebrovascular diseases" inside
the "Diseases of the circulatory system" group or to split the "Neoplasms"
group into several subsets ("Malignant neoplasms of bronchus and lung",
"Malignant neoplasms of pancreas", "Malignant neoplasms of breasts" etc).
However, even if such more specific analysis cannot be done for the whole
period 1980 to 2013, they are feasible from 2003 to 2013, in the ICD-10 pe-
riod, where no problems of disruptions caused by different revisions are
involved. So, although for a shorter time interval, more detailed analysis at
the cause-of-death level will be carried out. To do that it will be used the
intermediate classification (104 causes) proposed by the Human Cause-of-
Death Database (HCOD, 2016). The complete classification is reported in
the Appendix.
More in detail, the macro data on bridge-coding, taken from the publi-
cation of Frova et al., consists of two correspondence tables, one for deaths
occurred in the first year of life and one for deaths above age 1, in which
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Cause ICD-10 code ICD-9 code
Certain infectious and parasitic diseases A00–B99 001-139,
279.1
Neoplasms C00–D48 140-239
Diseases of the blood D50–D89 279-281
Endocrine, nutritional and metabolic dis-
eases
E00–E90 240-278
Mental and behavioural disorders F00–F99 290-319
Diseases of the nervous system G00–H95 320-389
Diseases of the circulatory system I00–I99 390-459
Diseases of the respiratory system J00–J99 460-519
Diseases of the digestive system K00–K93 520-579
Diseases of the skin and subcutaneous tissue L00–L99 680-709
Diseases of the musculoskeletal system and
connective tissue
M00–M99 710-739
Diseases of the genitourinary system N00–N99 580-629
Pregnancy, childbirth and the puerperium O00–O99 630-676
Certain conditions originating in the perina-
tal period
P00–P96 760-779
Congenital malformations, deformations
and chromosomal abnormalities
Q00–Q99 740-759
Ill-defined causes R00–R99 780-799
External causes of mortality V01–Y98 E800-E999
TABLE 3.1: The seventeen group of causes for which the
reconstruction is performed.
deaths are cross-classified, between ICD-9 and ICD-10, for seventeen group
of causes. As already said, the sample for which the double coding was per-
formed includes the totality of deaths at age 0. Thus, the correspondence
table in the first year of life represents exactly the match between the two
ICD revisions. This is not the case for the correspondence table of deaths
above age 1 because it doesn’t contain all deaths but just a sample of them.
Anyway, given the considerable largeness of the sample the accuracy of the
results is ensured. Having two correspondence tables, that split deaths into
below and above age 1, it’s an advantage for the reconstruction. It per-
mits to compute coefficients of redistribution separately for these two age
groups improving the reliability of the reconstruction since deaths at age 0
are really particular in terms of causes of death and their cross-classification
it is likely to be very different from the one of other age groups.
Table 3.2 displays the correspondence table of deaths above age 1 for
a subset of the seventeen causes for which the cross-classification is avail-
able (the two complete transition matrices are reported in the Appendix).
In the first row it is possible to see that, in the sample of double classified
deaths, 3713 were assigned to infectious diseases according to ICD-9. Out
of this 3713 deaths, 3192 were also assigned to infectious diseases accord-
ing to ICD-10, while 101 to neoplasms, 4 to external causes and so on. On
the other hand, the first column can be read in a specular way: 4635 deaths
were assigned to infectious diseases according to ICD-10 and out of these
4635 deaths, 3192 were also assigned to infectious diseases according to
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ICD-10→ Infectious Neoplasms . . . External causes Total-9
ICD-9 diseases
↓
Infectious 3192 101 . . . 4 3713
diseases
Neoplasms 97 127626 . . . 24 128509
...
...
...
. . .
...
...
External
causes 13 137 . . . 5466 6163
Total-10 4635 130959 . . . 5911 452773
TABLE 3.2: Transition matrix of deaths above age 1 in Italy,
2003. Subset of the seventeen causes for which the cross-
classification is performed. Adapted from Frova et al., 2010.
ICD-9, while 97 to neoplasms, 13 to external causes and so on. This corre-
spondence table, and the one of deaths below age 1, will be used to compute
coefficients of redistribution and eventually reconstruct the time series. A
full explanation of the method will be given soon in Paragraph 3.2.2.
3.2 Methods
In this section I provide a broad overview of the methods on which I rely
my studies about length of life variability. Some details on the methodolog-
ical strategies performed, however, can also be found in the substantive
Chapters of the dissertation.
3.2.1 Measures of lifespan variability
In Chapter 2 I have given a formal definition of lifespan variability and I
have listed a series of measures which have been used to assess mortality
compression and/or the rectangularization of the survival curve. Among
all of them I decided to rely my analysis on S10 and SD(M+). Before laying
out my reasoning for adopting them I give a formal definition of these two
indicators.
Let x be the age at death, dx the number of deaths that occur at age x,
ax the average time lived from age x to x+1 for those dying in the interval,
M10 the average age at death for those who survive to age ten ( e10+10), M
the modal age at death and w the oldest age group. The standard deviation
of ages at death above age 10, S10, and the standard deviation above the
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modal age at death, SD(M+), are defined as follow:
S10 =
√√√√√√√
w∑
x=10
(x+ ax −M10)2dx
w∑
x=10
dx
(3.1)
SD(M+) =
√√√√√√√
w∑
x=M
(x+ ax −M)2 ∗ dx
w∑
x=M
dx
(3.2)
S10 has been popularized by the work of Edwards and Tuljapurkar (Ed-
wards and Tuljapurkar, 2005; Edwards, 2009b; Edwards, 2009a; Tuljapurkar
and Edwards, 2009) while SD(M+) was firstly used by Kannisto (Kannisto,
2000; Kannisto, 2001) and more recently especially by Cheung and Robine
(Cheung and Robine, 2007; Cheung et al., 2009). The formulas can, of
course, be adapted to causes of death just by using the cause-specific den-
sity function instead of the all-cause density function and the cause-specific
M10 instead of the all-cause M10.
As seen in Paragraph 2.1.1, over the course of last decades the study
of lifespan inequality has produced a lot of indicators to analyze this phe-
nomenon. All these measures capture a different kind of variability and it
is the researcher that has to choose the one that best fits his/her aims. I, first
of all, decided to use two indicators because I intend to study two distinct
aspects: lifespan variability over the whole age range and lifespan variabil-
ity over a little age range, the one of very old. This decision comes from the
consideration that, in the era of longevity extension, has become increas-
ingly important to monitor the evolution of lifespan variability at old age
but, at the same time, it is also important to look at how the shape of the
age-at-death distribution is changing in its whole.
A possible alternative to SD(M+) could be the standard deviation above
the third quartile or the mean square deviation around the modal age at
death or the standard deviation of ages at death after a given age such as
65 or 70. SD(M+), however, it is better linked to parametric mortality mod-
els and its relationship with the rate of aging make possible a deeper in-
terpretation of its evolution over time. Moreover, the fact that SD(M+) is
(obviously) related to M is also an advantage. Indeed, as seen in Paragraph
2.1.2, the modal age at death, although not a measure of compression, can
be very useful when studying lifespan variability. It quantifies how much
the age-at-death distribution is shifting to the right and, as seen before, the
number of deaths at the mode, d(M), can be related to lifespan variability in
various parametric mortality models.
About the choice of S10 an initial consideration has to be made. Vari-
ability indicators that take into account the entire age range, as known as
unconditional indicators, are heavily influenced by infant and child mor-
tality. The truncation at age 10 eliminates this problem, that instead is still
present in measures like IQR, SDM and e†. Moreover, truncation also pro-
duces a distribution that is relatively normal making it unnecessary to em-
ploy percentile based measures like IQR and C50, which would be more
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advantageous if the distributions were heavily skewed (Edwards and Tul-
japurkar, 2005). Finally, the standard deviation is invariant on an additive
scale, i.e. if every death is postponed by 5 years the standard deviation re-
mains the same. On the contrary measures like the Gini index or the Theil
index are invariant on a proportional scale, i.e. if every lifespan is doubled
these measures stay the same. While some would argue that invariance on
a proportional scale is preferable in the case of income inequality, Edwards
argues that demographers are more interested in additive differences in life
span thus a measure of inequality that is invariant on an additive scale is
more desirable (Edwards, 2009b).
3.2.2 Putting together ICD-9 and ICD-10
As explained in Paragraph 3.1.2, in the ISTAT database deaths are assigned
to a certain cause according to two different ICD revisions, ICD-9 and ICD-
10. ICD-10 was introduced in 2003, therefore the aim is to redistribute
deaths from 1980 to 2002, that were classified in line with ICD-9, accord-
ing to the most recent revision, ICD-10. The reconstruction of the series
represents the basis of any further study of lifespan variability in Italy by
cause of death. Before analyzing data, indeed, it necessary to ensure the
coherence of their information and so to perform the reconstruction of the
time-series of causes of death.
The reconstruction carried out in this dissertation relies, as already said,
on the macro information available in the ISTAT report "Analisi del bridge
coding ICD-9 ICD-10 per le statistiche di mortalità per causa in Italia" about the
bridge-coding performed in Italy in 2003 (Frova et al., 2010). In Paragraph
2.3.2, I have given an overview of the reconstruction method developed by
Vallin and Meslé. This method consists of three steps: the construction of a
dual correspondence table linking the items of the two revisions, the defini-
tion of fundamental association of items gathering the same medical diag-
nosis at both revisions and ensuring a statistical continuity and finally the
elaboration of a transition table indicating how to redistribute the deaths.
Thanks to the macro information on Italian bridge-coding, it is possible to
skip the first two steps and directly elaborate the transition table. As said
in paragraph 3.1.2, these information consist of two correspondence tables,
i.e. the cross-classification of deaths between ICD-9 and ICD-10 for seven-
teen groups of causes of death. One correspondence table regards deaths
occurred in the first year of life while the other one deaths above age 1.
This latter table is then used to get one tailored for men. In fact, since
males’ death cannot be caused by "Pregnancy, childbirth and puerperium"
the horizontal and vertical cells corresponding to this cause of death, have
to be converted to 0.
To compute the transition coefficient and reconstruct the series, each
cell of the correspondence table is divided by the correspondent total row,
just as in the Vallin and Meslé method. This leads to the tuning of other
two matrices which contains the transition coefficients at age 0 and at age
greater then 0 separaely (these two matrices can be found in the Appendix).
The advantage of having specific coefficient for age 0 is that, since at this age
the deaths cross-classification it is likely to be very different from the one of
other age groups, it ensures a higher reliability when the reconstruction is
performed.
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The coefficient are then applied for one-year age group and for each
sex separately. Of course, age 0 has is own transition coefficient while to
any other age group are applied the same coefficients. So, for instance, the
number of deaths due to infectious diseases at age 0, in year i (i=1980, . . . ,
2002), is computed as follow:
id
Inf
0 =i d
Inf
0 ∗ 0.767 +i dNeo0 ∗ 0 +i dBlo0 ∗ 0 +i dENM0 ∗ 0.00+
+id
Men
0 ∗ 0 +i dNer0 ∗ 0 +i dCir0 ∗ 0 +i dRes0 ∗ 0+
+id
Dig
0 ∗ 0 +i dSki0 ∗ 0 +i dMus0 ∗ 0 +i dGen0 ∗ 0+
+id
Per
0 ∗ 0.200 +i dCon0 ∗ 0.033 +i dIll0 ∗ 0+
+id
Ext
0 ∗ 0
(3.3)
While at any other age x:
id
Inf
x =i d
Inf
x ∗ 0.860 +i dNeox ∗ 0.027 +i dBlox ∗ 0.013 +i dENMx ∗ 0.006+
+id
Men
x ∗ 0.004 +i dNerx ∗ 0.008 +i dCirx ∗ 0.020 +i dResx ∗ 0.013+
+id
Dig
x ∗ 0.029 +i dSkix ∗ 0.007 +i dMusx ∗ 0.004 +i dGenx ∗ 0.005+
+id
Pre
x ∗ 0 +i dConx ∗ 0.001 +i dIllx ∗ 0.001+
+id
Ext
x ∗ 0.001
(3.4)
The assumption underlying the reconstruction is, thus, that the coeffi-
cients are valid for the entire period (1980-2002) covered by the ICD revision
under consideration.
Once coefficients are applied to all age groups and causes the recon-
struction is accomplished. The work, however, is not finished yet. As
mentioned in the literature review chapter, the results obtained have to be
checked to detect if any important disruption is still present. Consequently,
to assess the goodness of the reconstruction, the presence any potential dis-
ruption is checked by eyes, looking at the graph of the series of the expected
total number of deaths for each cause, age group and sex. Although rough,
this method it is still considered by the expert the better one (Meslé, 2010).
Luckily, since the number of reconstructed causes is only 17, the number of
graphs to be checked is still reasonable. In case of particular indecision, the
mathematical method (see Paragraph 2.3.2), developed by Camarda and
Pechholdova, to detect statistically significant discontinuity, was also used
to support the final decision (Camarda and Pechholdova, 2014).
In order to get the expected total number of deaths and assess the pres-
ence of any disruption devoid of changes in age structure of the population,
let D = (dij) be the matrix of deaths at age i=1, . . . ,110 and year y=1980, . . . ,
2013 and E = (eij) be the matrix of exposure to risk over the same dimen-
sions. The matrix of cause specific death rates can be easily computed as
follow:
M = (mij =
dij
eij
) (3.5)
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The standardized death rates are given by:
Ms = diag(p) ∗M (3.6)
Where p = (pi) :
∑110
i=1 pi = 1 is the standard age structure of the popula-
tion (in this case the age structure of the Italian population in 2000). Then,
to get the expected number of deaths over age and year,M s is multiplied by
a factor k which represent the average of the population size (in the period
covered by the analysis) in a specific age group:
Dsi = ki ∗Ms (3.7)
After the visual inspection on the expected number of deaths for each
cause, age group and sex a few a-posteriori corrections have been made,
especially for young ages. Then, the new transition coefficients, obtained
after these corrections, are applied again in the same way as before to get,
finally, the reconstructed series of causes of death.
3.2.3 Smoothing densities: P-Splines
After completing the reconstruction, data are ready to be analyzed. To
study cause-specific lifespan variability, I assumed that causes of death
were mutually exclusive and exhaustive, using the principles of the multiple-
decrement life-table (Preston et al., 2000).
In this context, the all-cause force of mortality, µ(x), is defined as the
sum of cause-specific force of mortality, µk(x):
µ(x) = lim
∆x→0
P (x < X < x+ ∆x|X > x)
∆x
(3.8)
µk(x) = lim
∆x→0
P (x < X < x+ ∆x, k = k|X > x)
∆x
k = 1 . . .K (3.9)
µ(x) = µ1(x) + µ2(x) + · · ·+ µk(x) + · · ·+ µK(x) (3.10)
The cause-specific density function (i.e the cause-specific age-at-death
distribution), dk(x), thus, can be written as follow:
dk(x) = µk(x)l(x) k = 1 . . .K (3.11)
Where l(x) is the all-cause survivorship function.
These equations are presented in a continous setting whereas the data
are in a discrete setting (one year age interval). Assuming a constant cause-
specific force of mortality over each one year age interval, µk(x) is estimated
by the central death rate, mk(x) = Dk(x)/e(x), where Dk(x) is the number
of deaths of cause k at age x and e(x) is the number of persons exposed to
the risk of dying at age x.
Once calculated cause-specific density function, dk(x), and all the other
usual function of a multi-decrement life table, the two indicators used to
assess cause-specific mortality compression in this dissertation, S10 and
SD(M+), can be easily calculated from equation 3.1 and 3.2 respectively.
Very often, indeed, these two measures are computed taking directly the
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age-at-death distribution extracted from life tables (multi-decrement life ta-
bles in this case). Another option, many times used in literature, it is to
fit the function using a parametric model. These two choices, however,
present both some problematic. The first use an age-at-death distribution
that tends to be erratic, at least in some points (this is much more evident
for cause-specific age-at-death distributions because the number of deaths
is lower). The age at death, in fact, can be seen as a random process and ir-
regularities in the distribution are likely to be caused by chance. Therefore,
the computation of S10 and SD(M+), or any other compression indicator,
based on life table densities (again, multi-decrement life tables densities
in case of cause-specific approach) could be not very accurate. The use
of a parametric model allows avoiding this erratic age-at-death distribu-
tion problem. Parametric models, however, are sometimes too rigid and/or
do not fit the data well. A solution to these issues is offered by the adop-
tion of non-parametric models. As parametric models do, non-parametric
models overcome the issue of irregularities in the age-at-death distribution
since they smooth the cause-specific density function, dk(x), but they also
have the advantage not to impose any predetermined structure on the data.
Thus, thanks to this flexibility, the problematics related to the use of para-
metric models mentioned above, is overcome too.
For these reasons I decided to use a non-parametric approach, whose
outcomes are exploited for the construction of continuous life tables and
multi-decrement life tables and then for analyzing the changes in the shape
of all-cause and cause-specific density functions. Indeed, S10 and SD(M+),
and the modal age at death, M, will all be computed based on the smoothed
density. The estimation of the modal age at death is particularly interesting.
As mentioned above, the age-at-death distribution of life table tends to be
erratic, and this is particularly true in the area surrounding the mode. In
the past various methodologies have been proposed to estimate the modal
age at death (Pearson, 1902; Kannisto, 2001; Canudas-Romo, 2008; Cheung,
Robine and Caselli, 2008; Thatcher et al. 2010). One of the most used is
Kannisto’s quadratic procedure, which consists of fitting a quadratic model
using life table deaths at ages M, M-1 and M+1. A problem with this ap-
proach is that M doesn’t always emerge clearly and so there are various age
candidates which of course lead to different estimates of the modal age at
death. The smoothing provides a solution to this problem and the ability to
refine the monitoring of changes in modal age at death over time (Ouellette
and Bourbeau, 2011). The estimation of M will be implemented just finding
the (unique) maximum of smoothed density functions:
Mˆ = max
∀x∈X
d(x) X = 10, . . . , 110 (3.12)
The non-parametric approach adopted in this dissertation is called P-
splines which has been already used in demography in the latest years (Ca-
marda, 2008; Ouellette and Bourbeau, 2011; Diaconu et al., 2016). Among
all non-parametric models available, the choice of P-splines is justified by
its good properties in the context of mortality. First of all, this method has
not boundary effects and thus it performs well at the border of the domain
over which smoothing operates (very old age at death in this case). Sec-
ondly, even if in the domain there are some zeros - there are ages at which
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no deaths occur - P-splines works finely as well. Moreover, P-splines is sim-
ple to use, program, understand and previous studies have already demon-
strated that it performs well for smoothing anomalously distributed data
such as mortality data (Currie et al., 2004; Camarda, 2008; Ouelette and
Bourbeau 2011).
In this dissertation, P-splines is applied to data from age 10, because in-
fant and child mortality present unique features that would require the use
of a smoothing method suited for ill-posed data (Ouelette and Bourbeau,
2011). This is not a problem, however, because both indicators used to as-
sess mortality compression do not consider deaths before age 10.
P-splines can deal with aggregated data which are assumed to be Pois-
son distributed. Now, to smooth mortality data with P-splines, let dk de-
note the vector of observed death counts, ek the vector of exposure to risk
and µk the vector of force of mortality, for a given cause of death k. The
response variable, dk, is assumed to follow a Poisson distribution dk ∼
P(ek ∗ µk), so the expected value is the product of exposure to risk and
force of mortality. It is possible to model the Poisson data introducing the
linear predictor ηk:
ηk = ln(E|dk|) (3.13)
ηk = ln(ek ∗ µk) = ln(ek) + ln(µk) = ln(ek) +Ba (3.14)
The P-splines approach is then used to estimate the unknown param-
eters that through a linear combination model ηk. B is the B-spline basis
matrix and a is the vector of respective regression parameters to estimate:
ηˆk = ln(ek) +Baˆ (3.15)
Taking the exponential of equation 3.15 gives smoothed death counts.
Those are, however, not standardized by age because influenced by expo-
sure to risk and as a consequence not comparable. To get age-standardized
death counts, one must extract the smoothed forces of mortality from the
smoothed death counts. Given equation 3.15, a smoothed trend for the force
of mortality is readily obtained as (Ouellette and Bourbeau, 2011):
µˆk = exp(Baˆ) (3.16)
The penalized log-likelihood function to maximize in order to find aˆ is:
l∗k = l(a;B;d)−
1
2
λa
′
D
′
Da (3.17)
Where λ represent the scalar smoothing parmeters and D the difference
matrix.
The non-parametric approach of P-splines has been implemented through
the R package "Mortality Smooth" (Camarda, 2012). Figure 3.1 displays, as
an example, a comparison between the life table age-at-death distribution
and the smoothed age-at-death distribution of infectious diseases in Italy
in 2008. As expected, the two curves are very similar, but the smoothed
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FIGURE 3.1: Comparison between life-table and smoothed
cause-specific density. Infectious diseases, 2008. Total pop-
ulation.
one has the additional advantage of eliminating chance, and so irregulari-
ties, from the distribution leading to better estimates of variability measures
and M.
Not all the analysis conducted in this dissertation, however, will rely on
smoothed densities. Indeed, the investigation on old age mortality com-
pression, here measured by SD(M+), will be largely carried out using
the simplified logistic model with two parameters. Therefore in Chapter
6, where the topic of old age lifespan variability is treated, SD(M+) will
be not only estimated according to smoothed densities but also according
to Kannisto model. The model, already briefly shown in Chapter 2, will be
presented more in detail in Paragraph 3.2.6.
3.2.4 Decomposition techniques
Decomposition techniques are often used in demography to disentangle the
single components of a phenomenon. In this dissertation, to have a better
comprehension of lifespan variability in Italy, I decompose both trends in
S10 over time and differences in S10 between sexes. In particular, the results
of the decomposition will quantify either the contribution of changes in age
and cause-specific mortality rates, mx,k, from 1980 to 2013 to change in S10
over the same period or the contribution of differences in age and cause-
specific mortality rates between sexes to the difference in S10 between sexes
at fixed point in time (1980 and 2013).
Among the several decomposition techniques available, I rely my anal-
ysis on a method recently developed by Horiuchi et al. that can be applied
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to any dependent variable and its covariates, as long as the former is a dif-
ferentiable function of the latter (Horiuchi et al., 2008). So, here the interest
is in determining how the total change in the dependent variable S10 is
decomposed into the contribution of changes of the covariates, i.e. age and
specific cause-of-death mortality rates. First of all, it is necessary to express
S10 in terms of mx,k (Zurieck, 2010):
S10 =
√√√√√√√
w∑
x=10
(x+ ax −M10)2dx
w∑
x=10
dx
(3.18)
=
√√√√√√√
w∑
x=10
(x+ ax −M10)2lxmx
w∑
x=10
lxmx
(3.19)
=
√√√√√√√
w∑
x=10
(x+ ax −
w∑
x=10
x(exp(−∑x0 mx))mx)2(exp(−∑x0 mx))mx
w∑
x=10
(exp(−∑x0 mx))mx (3.20)
=
√√√√√ w∑x=10(x+ax− w∑x=10x(exp(−∑xa=0∑jk=1ma,k))∑jk=1mx,k)2(exp(−∑xa=0∑jk=1ma,k))∑jk=1mx,k)w∑
x=10
(exp(−∑xa=0∑jk=1ma,k))∑jk=1mx,k
(3.21)
In general, the method holds that for y = f(x1, x2, . . . , xn) the change in
y from time 1 to time 2 (or between males to females) can be expressed as:
y(2)− y(1) =
n∑
i=1
ci (3.22)
ci =
∫ Xi2
Xi1
δy
δxi
dxi
dt
dt (3.23)
So, the change in the dependent variable y is the sum of the contribu-
tions, ci, of each covariate, xi. Xi1 and Xi2 are the values of xi at time 1 and
time 2 respectively (or the values of xi for males and females respectively).
For the purposes of this dissertation, I want to take partial derivatives
of S10 with respect to mx,k to get the contribution of changes in age and
cause-specific mortality rates, mx,k, to changes in S10:
S10(2)− S10(1) =
w∑
x=1
j∑
k=1
cx,k (3.24)
cx,k =
∫ Xx,k,1
mx,k,2
δS10
δmx,k
dmx,k
dt
dt (3.25)
The same decomposition techniques have been used to test the level
effect hypothesis and slope effect hypothesis, in Chapter 6, in the context of
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old-age lifespan variability. More details about this decomposition will be
given in Paragraph 6.2.1.
The method has been implemented through the R package "Decom-
pHoriuchi" (Riffe, 2011).
3.2.5 Sensitivity analysis
As said in Chapter 2, understanding why lifespan variability (the second
moment of the density function dx) decrease or increase is much more com-
plex than understanding why life expectancy (the first moment of the den-
sity function dx) decrease or increase. A decline (rise) in mortality rates at
any age, indeed, acts incrementing (declining) the average length of life,
while this is not always the case for variability measures: the effects of
mortality decline or rise on lifespan variability varies by age. In particu-
lar, for e† (life expectancy lost due to premature death) and Vx (Variance
of age at death after age x), has been demonstrated that exists an age before
which avoiding deaths reduces inequality and after which avoiding deaths
increases inequality (Gillespie et. al, 2014; Zhang and Vaupel, 2009).
An important tool to understand how changes in mortality rates affect
variability of age at death is sensitivity analysis. In the field of demography,
sensitivity analysis has been mainly developed by Caswell and his collabo-
rators and allows quantifying, for each age, the potential effects of propor-
tional mortality increase/decrease on a certain lifespan variability measure
(Caswell, 1978; Caswell 2006; Caswell, 2008; Caswell, 2009; Caswell, 2010;
Caswell and Ouellette, 2015; Van Raalte and Caswell, 2012.). The method
rilies on matrix calculation and it is formulated in terms of a Markov chain
1. Let P be the transition matrix for the Markov chain:
P =
[
U 0
M I
]
(3.26)
Where U is a matrix with survival probabilities on the subdiagonal and
zeros elsewhere, describing transitions among the transient states in the
Markov chain; M is a diagonal matrix in which deaths, the absorbing state
of the Markov chain, are classified by age class, 0 is a matrix of zeros and I
is the identity matrix.
The statistical properties of longevity, i.e. the time to absorption in the
Markov chain, can be computed directly from P. For instance, the mean
time spent in age class i, conditional on starting in age class j is given by the
(i, j) entry of the matrix:
N = (I−U)−1 (3.27)
The mean time to absorption, η, can be computed by the column sums
of N:
ηT = eTN (3.28)
1An exhaustive explanation of the method can be found in Caswell, 2008; Caswell, 2009;
Caswell, 2010.
3.2. Methods 49
where e is a vector of ones. Instead, the vector of variances in longevity
conditional upon survival to age class i, v, is given by:
vT = eTN(2N− I)− ηT ◦ ηT (3.29)
where ◦ denotes the element by element product (as knows as Hadamard
product).
The standard deviation in longevity conditional upon survival to age
class i, s, is simply the square root of v:
s =
√
v (3.30)
Here, the aim is to compute the sensitivity of S10 to a proportional drop
in mortality rates. This is obtained by taking the derivative of the standard
deviation in longevity upon survival to age class 10 vector with respect to
the vector of underlying age-specific mortality rates, θ. In formula:
δs
δθT
=
1
2
diag(s)−1
δv
δθT
(3.31)
In this way it will be possible to figure out what would be the contribu-
tion of each age to a change in S10 if mortality decreased proportionally. As
a consequence, the results of sensitivity analysis will also permit to identify
a threshold age, T10, before which mortality decline decreases S10 and after
which mortality decline increases S10.
3.2.6 Kannisto model
The first noticeable attempt to model mortality was made by Benjamin
Gompertz in 1825, who described the force of mortality as an exponential
function, i.e. mortality increases exponentially with age (Gompertz, 1825).
In 1860, Makeham added an age-independent component to the Gompertz
model to capture those deaths which are not related to aging (Makeham,
1860). The Makeham model describes adult mortality accurately until age
80 but it is not able to capture the late-life mortality deceleration since it
has been shown in many populations that the force of mortality increases
at a decreasing rate at very old ages. To solve this problem, logistic models
have been proposed to model mortality since the presence of the denomi-
nator bends the curve downwards at high ages. They have been published
in different forms, but all can be converted into the following expression:
µ(x) =
k ∗ aebx
1 + aebx
+ c (3.32)
To investigate on old-age variability I adopt a simplified version of the
logistic model with 2 parameters instead of 4, known as Kannisto model. In
this model, indeed, the k parameter is equal to 1 and the c parameter, rep-
resenting background mortality introduced by Makeham, is set to 0 since
his value is insignificant above age 70. So, the function modeling mortality
in the Kannisto model, already reported in Chapter 2, is as follow:
µ(x) =
aebx
1 + aebx
(3.33)
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Using the logit function the model can be expressed as:
logit(µ(x)) = ln(a) + bx (3.34)
Meaning that the force of mortality will lie on a straight line - the logit
line-, represented by equation 3.30. The fact that, in modern population,
mortality above age 70 fits the logit line well has been shown in many stud-
ies (Cheung and Robine, 2007; Kannisto, 1992; Thatcher, 1998, Thatcher et
al., 2010).
What is appealing of this model is the property of linking the rate of
aging and mortality compression. According to the model, indeed, at old
ages SD(M+) is uniquely determined by the rate of increase in mortality,
i.e. the rate of aging, which is measured by the parameter b: as b increases
SD(M+) decreases. So, mortality compression occurs if the logit of the
death rate at younger ages falls faster than the logit of the death rate at
older ages or, in other words, if the slope of the logit line becomes steeper
as time passes by.
The other parameter of the model, a, which indicates the level of mor-
tality - the intercept of the logit line-, doesn’t influence SD(M+). Indeed,
even if age-specific death rates depend on both a and b, compression de-
pends only on b. The exact relationship between b and SD(M+) it is as
follow:
SD(M+) =
√√√√ ∞∑
x=M
x2(
1 + b
1 + bebx
)1/b
bebx
1 + bebx
2 (3.35)
As it will be possible to see in Chapter 6, the steepness of the logit
line’s slope has increased over time in both males and females in Italy over
the course of the considered period (1980-2013), even though the increase
has been more marked for males. As a consequence, the uncertainty of
deaths above the mode has been reduced. Results about the compression
of SD(M+) and the role played by the various causes in increasing the b
parameter are presented in Chapter 6.
To apply the model, the parameter b has to be estimated. As shown by
Thatcher et al., since b is the slope of the logit line, it is sufficient to know
the value of µ(x) at any two ages, x1 and x2, where x2 > x1. The slope of
the line between these ages is then given by (Thatcher et al., 2010):
b =
logit(µ(x2))− logit(µ(x1))
x2 − x1 (3.36)
To estimate b from lifetable, the force of mortality µ(x) is approximated
by the central death rate mx:
b =
logit(m(x2))− logit(m(x1))
x2 − x1 (3.37)
How to choose ages x1 and x2? The study of Thatcher et al. picks 70
as x1 and 90 as x2. Their choice has been made considering the follow-
ing criterions. First, x1 has to be high enough for the model to fit data
well: the background mortality component, here set to 0, may have some
effects at younger old ages. But, on the other hand, x1 has to be under the
2For a proof of the equation see Thatcher et al., 2010
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modal age at death. Secondly, the age range between x1 and x2 should be
wide enough because a wider difference will make the standard error of
b smaller. However, it is also desirable for x2 not to be an extremely old
age because the small number of deaths may notably increase the standard
error of logit(m2), and in turn, that of b.
Considering these issues, ages 70 and 90 seems to be the best possible
choice and are also used in this dissertation to apply the Kannisto model.
Age 70, indeed, is high enough in order to not consider background mortal-
ity but also low enough to be under all-cause and cause-specific modal age
at death. To choose x2 I compared the results of ages 70-85, 70-90 and 70-95.
The parameter trends were shown to be less erratic for age 70-90 than 70-85
and 70-95, and so age 90 was chosen.
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Causes of death in Italy after
reconstructing coherent
time-series
In this Chapter I intend to show how the reconstruction has changed causes
of death series in Italy, i.e. how deaths from 1980 to 2002, originally clas-
sified according to ICD-9, are reclassified according to the most recent re-
vision, ICD-10. Then, having in hand coherent time-series, I will present
elaborations on cause-specific mortality in Italy over the course of the pe-
riod considered in this dissertation (1980-2103), with the aim of reviewing
the state of the health transition in Italy.
4.1 Reconstructing the 1980-2013 time series
As seen in Paragraph 2.3.2, the introduction of a new ICD revision brings
disruptions in the causes time-series for many reasons. Here these disconti-
nuities will be quantified and analyzed to reconstruct coherent causes of
death series for the years 1980-2013, making possible, in later chapters,
a logical and consistent analysis of the length of life variability through
causes of death.
4.1.1 The changes introduced by ICD-10
The introduction of ICD-10 represented, surely, a moment of big innovation
in the history of the International classification of diseases. Such innovation
comes from the impressing increase in the level of detail (from 5600 items
of ICD-9 to more than 10000 items of ICD-10) and the changes in the rules
governing the selection of the underlying cause of death.
Tables 4.1 gives a first idea of the magnitude of changes introduced by
the new classification in the cause-specific time-series. It reports, for each
of the 17 causes, the percentage of deaths that are assigned to the same
group according to both the new and the old ICD classification. In total,
the 93.81% of deaths remained in the same cause of death group. This great
value is primarily driven by the fact that for the two major causes of death,
namely neoplasms and diseases of the circulatory system, which represent
more than two third of the total deaths, the percentage of deaths staying in
the group it is considerably high. This is especially true for neoplasms for
which the percentage is slightly below 100%.
On the other hand, the percentage of deaths that are assigned to the
same group according to both ICD-9 and ICD-10 it is noticeably lower for
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diseases of the blood (65.25%), mental and behavioral disorders (60.67%)
and congenital malformations (70,34%).
Cause Percentage of deaths
remaining in the group
Certain infectious and parasitic diseases 85.93
Neoplasms 99.31
Diseases of the blood 65.25
Endocrine, nutritional and metabolic diseases 93.71
Mental and behavioural disorders 60.67
Diseases of the nervous system 91.80
Diseases of the circulatory system 94.40
Diseases of the respiratory system 87.54
Diseases of the digestive system 93.12
Diseases of the skin and subcutaneous tissue 87.46
Diseases of the musculoskeletal system 89.06
and connective tissue
Diseases of the genitourinary system 91.34
Pregnancy, childbirth and the puerperium 100.00
Certain conditions originating 100.00
in the perinatal period
Congenital malformations, deformations 70.34
and chromosomal abnormalities
Ill-defined causes 91.55
External causes of mortality 88.71
Total 93.81
TABLE 4.1: Percentage of deaths assigned to the same group
according to both ICD-9 and ICD-10.
Another, and complementary, question arising after the reconstruction
it is how deaths that don’t stay in the same cause of death group are then
redistributed among other groups. In this respect, Table 4.2 reports, for each
of the 17 groups of causes, the corresponding group where the majority of
the deaths (in percentage) move to passing from ICD-9 to ICD-10.
In 9 cases the diseases of the circulatory system are the cause of death
which receives more deaths than the others. The fact is certainly not sur-
prising, the diseases of the circulatory system are, especially in the era of
longevity extension, frequently involved in the process of death even if not
always codified as underlying cause of death but as contributing cause of
death (Desesquelles et al., 2010; Desesquelles et al., 2016). As seen in Para-
graph 2.3.1, the changes to the rules governing the selection of the underly-
ing cause of death between ICD-9 and ICD-10 played a major role in bring-
ing statistical disruptions. Thus, due to the new rules, in many cases where
the diseases of the circulatory system were previously selected as contribut-
ing cause are now selected as underlying.
The second cause in terms of number of deaths, neoplasms, are instead
the group where the majority of deaths move to only in one case, one of
the diseases of the blood. Another fact to be noted is the mutual exchange
of deaths between infectious diseases and the diseases of the digestive sys-
tem. Finally, since for pregnancy and conditions of the perinatal period the
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Cause Cause where the majority
of deaths move to
Certain infectious and parasitic diseases Diseases of the digestive system
Neoplasms Diseases of the circolatory system
Diseases of the blood Neoplasms
Endocrine, nutritional and metabolic diseases Diseases of the circolatory system
Mental and behavioural disorders Diseases of the circolatory system
Diseases of the nervous system Diseases of the circolatory system
Diseases of the circolatory system Diseases of the respiratory system
Diseases of the respiratory system Diseases of the circolatory system
Diseases of the digestive system Certain infectious and parasitic diseases
Diseases of the skin and subcutaneous tissue Diseases of the circolatory system
Diseases of the muscoloskeletal system Diseases of the nervous system
Diseases of the genitourinary system Diseases of the circolatory system
Pregnancy, childbirth and the puerperium -
Certain conditions originating -
in the perinatal period
Congenital malformations, deformations Diseases of the circolatory system
and chromosomal abnormalities
Ill-defined causes Infectious diseases
External causes of mortality Diseases of the circolatory system
TABLE 4.2: Redistribution of deaths that don’t stay in the
same cause of death group passing from ICD-9 to ICD-10.
For each of the 17 groups of causes it is shown the corre-
sponding group where the majority of the deaths move to.
percentage of deaths remaining in the group is 100%, as seen in Table 4.1,
they haven’t a corresponding match in this type of analysis.
4.1.2 New coherent time-series
A more comprehensive view of how the reconstruction has changed the
profile of each cause of death it is offered by Figure 4.1. It displays the
standardized number of death, i.e. the expected number of deaths devoid
of changes in the population age structure, that are computed as shown
in Paragraph 3.2.3, for each of the 17 causes of death either before or after
the reconstruction. Thus, the graphs allow visualizing how specific causes
of death time-series have changed after redistributing the 1980-2002 deaths
according to ICD-10. The results are shown at the level of total population
since there aren’t particular differences between the sexes.
The sign (whether the reconstruction has increased or decreased the
number of deaths of a given disease) and the intensity of the changes largely
vary cause by cause. Moreover, it is feasible, even if unlikely, that the sign
could be reversed over the time-period covered, i.e. the reconstruction can
increase the number of deaths in some years and decrease the number of
deaths in some other years. This is possible because, although the same co-
efficients are applied for any years, the exchange between causes, in terms
of number of deaths, it is not predetermined a-priori: cause x will always
take the same percentage of deaths from cause y and not the same number.
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FIGURE 4.1: Reconstructed and original time-series of
causes of death in Italy. Total population.
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Finally, since the figures show the number of standardized deaths, they
also permit an evaluation of the trends over time of each cause. For instance
the number of standardized deaths due to diseases of the digestive system
has constantly been declining while it is exactly the opposite for the diseases
of the nervous system. This point, however, will not be touched in this
Paragraph (but in Paragraph 4.2.1) since here the only aim is to show how
the reconstruction has modified the number of deaths attributable to each
cause of death.
The time-series of the three major causes of death, namely neoplasms,
diseases of the circulatory system and diseases of the respiratory system,
don’t present a dramatic change after performing the reconstruction. This
is especially true for the diseases of the respiratory system for which the red
and black lines overlap almost perfectly, while deaths attributable to neo-
plasms according to ICD-10 are slightly greater than those of ICD-9 and the
opposite occurs for the diseases of the circulatory system. A similar pattern
of homogeneity between the two ICD revisions is also followed by diseases
of the digestive system, diseases of the genitourinary system, perinatal dis-
eases and, even if to a lesser extent, by endocrine, nutritional and metabolic
diseases, ill-defined and external causes. For the rest of the causes of death
considered in this dissertation, instead, the disruptions produced by the
ICD-10 introduction are more relevant. In particular, the number of deaths
due to infectious diseases, diseases of the nervous system, diseases of the
skin, diseases of the muskoloskeletal system, pregnancy and related and
congenital malformations are considerably underestimated by ICD-9 com-
pared to the one of ICD-10. The situation is instead reversed for diseases of
the blood, while mental and behavioral disorders present a mixed situation
over time.
4.2 Cause-specific mortality in Italy from 1980 to 2013
In the previous section I have quantified and analyzed the statistical disrup-
tions in the causes of death time-series due to the introduction of the new
ICD classification and I have shown how the reconstruction has led then to
new, and coherent, time-series for each of the 17 causes of death considered
in this dissertation. Now, having in hand these new reconstructed series,
I intend to give an overview of mortality, by causes of death, in Italy from
1980 to 2013 giving new insights on the state of the health transition.
Specifically, this section is divided into three parts: 1) Figure out how
the percentage of deaths attributable to each cause of death has changed
over time in this period; 2) Investigate on the leading cause of death by age
and year for the two sexes using Lexis’ surface; 3) Investigate on tempo-
ral dynamics of mortality rates over age and time by estimating surfaces
of mortality improvements. The results will be helpful in understanding if
mortality declined uniformly or not across causes of death, so revealing if
there is only one pattern of mortality change or more. Definition of mor-
tality improvements and the related methodology to carry out the analysis
are reported in detail in Paragraph 4.2.3.
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4.2.1 Density broken down by cause of death
The first overview of mortality in Italy is given by looking at the density
function broken down by cause of death. Since the area of a density func-
tion has to sum up to 1, breaking it down by cause of death and sum-
ming up the area of the cause-specific densities, gets back the percentage
of deaths attributable to each cause of death.
This view is displayed in Figure 4.2 and 4.3, in which life table densities
in 1980-84 and 2010-13 are broken down by causes of death for men and
women and in Table 4.3 and 4.4 which give support to the figure report-
ing exactly the percentage of deaths attributable to each of the 17 group of
causes, in seven points of time, again for the two sexes separately.
What has to be primarily noted is the tendency of neoplasms and dis-
eases of the circulatory system, the groups which collect the majority of
deaths. In 1980-84 the 42.97% of deaths among males and the 52.74% among
females were due diseases of the circulatory system. In the following decades
the percentage of deaths attributed to this cause declined constantly and
it was equal to 36.05% for males and 43.26% for females in 2010-13. On
the other hand, neoplasms weight on total mortality increased by 6.46%
for males (from 24.83% to 31.29%) and 3.97% for females (from 18.08% to
22.05%). So diseases of the circulatory system are still the cause provoking
the majority of deaths but their difference with respect to neoplasms is re-
duced, especially among males. Indeed, despite the population aging and
the consequent higher number of total deaths in 2010-13 than 1980-84, the
number of deaths attributed to circulatory diseases in the population went
down from 250’730 to 221’508.
The postponement of mortality and the consequent population aging
reflect the rise of three groups of causes highly related with age: infectious
diseases, mental and behavioral disorders and diseases of the nervous sys-
tem. The first, which in the pre-transition era was the main cause of death
during the childhood, now in the era of longevity extension, has become
typical of old ages. In fact, at old ages, when death is frequently due to a
mix of causes, infectious diseases have increased their lethality (Dorn and
Moriyama, 1964; Desesquelles et al, 2012). The rise in the percentage of
deaths attributable to mental and behavioral disorders is really noticeable:
it is almost four times higher for males (from 0.55% to 2.12%) and even ten
times higher for females (from 0.37% to 3.89%). The increase is less pro-
nounced for the diseases of the nervous system, but not for that less impor-
tant. This group of causes, which contains diseases highly correlated with
age like Parkinson and Alzheimer, has augmented either for men (from
1.56% to 3.44%) or women (from 1.57% to 4.34%). External causes, which,
as it will be possible to see in later Chapters, is a group of big interest in the
context of lifespan variability, have decreased their percentages, visibly for
males (from 5.27% to 4.19%) and slightly for females (from 3.54% to 3.20%).
About the remaining groups of causes, to be noted is the doubling of dis-
eases of the blood and diseases of the skin and the reduction of ill-defined
causes and diseases of the digestive system.
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Cause 1980-84 1985-89 1990-94 1995-99 2000-04 2005-09 2010-13
Certain infectious 0.98 0.89 1.21 1.23 1.05 1.33 1.79
and parasitic diseases
Neoplasms 24.83 27.70 29.42 29.89 30.98 31.57 31.29
Diseases of the blood 0.21 0.27 0.29 0.33 0.35 0.40 0.42
Endocrine nutritional 2.51 2.60 2.73 2.98 3.13 3.62 3.91
and metabolic diseases
Mental and behavioural disorders 0.55 0.61 0.91 1.09 1.18 1.57 2.12
Diseases of the nervous system 1.56 1.86 2.07 2.33 2.64 3.19 3.44
Diseases of the circulatory system 42.97 40.77 39.97 39.82 39.14 37.27 36.05
Diseases of the respiratory system 8.10 8.05 7.61 7.77 8.08 8.45 8.65
Diseases of the digestive system 6.14 5.70 5.04 4.44 4.13 3.87 3.71
Diseases of the skin 0.06 0.08 0.09 0.11 0.11 0.11 0.13
and subcutaneous tissue
Diseases of the musculoskeletal 0.24 0.28 0.31 0.34 0.33 0.35 0.33
system
Diseases of the genitourinary 1.72 1.50 1.40 1.43 1.52 1.85 2.05
system
Pregnancy, childbirth - - - - - - -
and the puerperium
Certain conditions originating 0.89 0.65 0.51 0.34 0.25 0.22 0.21
in the perinatal period
Congenital malformations, 0.54 0.47 0.42 0.36 0.32 0.21 0.22
deformations
and chromosomal abnormalities
Ill defined causes 3.04 3.09 2.55 1.94 1.74 1.50 1.53
External causes of mortality 5.27 5.03 4.99 4.70 4.54 4.44 4.19
Total 100 100 100 100 100 100 100
TABLE 4.3: Percentage of deaths attributable to each of the
17 groups of causes at different point in time: 1980-84, 1985-
89, 1990-94, 1995-99, 2000-04, 2005-09, 2010-13. Males.
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Cause 1980-84 1985-89 1990-94 1995-99 2000-04 2005-09 2010-13
Certain infectious 0.68 0.62 0.69 0.82 0.90 1.22 1.80
and parasitic diseases
Neoplasms 18.08 19.77 20.96 21.08 21.92 22.12 22.05
Diseases of the blood 0.22 0.28 0.32 0.37 0.42 0.56 0.59
Endocrine nutritional 4.51 4.62 4.56 4.46 4.53 4.85 4.91
and metabolic diseases
Mental and behavioural disorders 0.37 0.51 0.98 1.41 1.85 2.91 3.89
Diseases of the nervous system 1.57 2.02 2.39 2.84 3.33 4.01 4.34
Diseases of the circulatory system 52.74 50.44 49.66 49.33 48.16 45.56 43.26
Diseases of the respiratory system 5.97 5.76 5.38 5.60 5.91 5.95 6.30
Diseases of the digestive system 4.09 4.25 4.25 4.08 3.93 3.85 3.72
Diseases of the skin 0.12 0.16 0.18 0.22 0.23 0.23 0.24
and subcutaneous tissue
Diseases of the musculoskeletal 0.30 0.40 0.47 0.58 0.61 0.82 0.73
system
Diseases of the genitourinary 1.22 1.24 1.27 1.36 1.51 1.76 1.99
system
Pregnancy, childbirth 0.03 0.02 0.02 0.01 0.01 0.01 0.01
and the puerperium
Certain conditions originating 0.71 0.54 0.41 0.30 0.22 0.19 0.17
in the perinatal period
Congenital malformations, 0.44 0.38 0.35 0.31 0.29 0.20 0.20
deformations
and chromosomal abnormalities
Ill defined causes 5.05 4.85 3.94 2.65 2.37 2.28 2.45
External causes of mortality 3.54 3.68 3.68 3.60 3.39 3.32 3.20
Total 100 100 100 100 100 100 100
TABLE 4.4: Percentage of deaths attributable to each of the
17 groups of causes at different point in time: 1980-84, 1985-
89, 1990-94, 1995-99, 2000-04, 2005-09, 2010-13. Females.
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4.2.2 Leading cause of death
Another point of view to look at cause-specific evolution of mortality is
offered by the investigation on the leading cause of death (i.e. the cause of
death which provokes the higher number of deaths) by age and over time.
The results of this three-dimensional study are shown in Figures 4.4, adding
20 years of analysis to the one conducted by Barbi et al. and summarized
in Paragraph 2.2 (Barbi et al., 2000).
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FIGURE 4.4: Leading cause of death from 1980 to 2013 for
males (left) and females (right) using the list of 17 group of
causes.
Reviewing almost a century (from 1895 to 1993), Barby et al. have shown
how the passage to a more modern mortality regime is clearly visible also
looking at the trend of the leading cause of death. What happened in the
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next 20 years it is here analyzed. Males and females graphs look like sim-
ilar at first sight, but some interesting distinctions emerge. At young ages
external causes of death (which in this case means transport accident as we
will see later) are much more predominant for men than women. Among
males, external causes are the leading cause of death at any age between
15 and 35 over the whole period (with the only exception of infectious dis-
eases from 1993 to 1996) while from 2 to 14 they are often reported as lead-
ing cause of death in the first decade (1980-89) to then leave space to the
emergence of cancer. Among females, instead, external causes are the lead-
ing cause of death in a smaller range, basically between 18 and 28, and in
some cases during the childhood. Between 28 and 35, whereas for men ex-
ternal causes are predominant, for women neoplasms are the leading cause
of death. Consequently, the red central area, indicating neoplasms as lead-
ing cause, is wider for females. In 1980 cancers were the leading cause from
32 to 63 for women and from 39 to 63 for men. In the following decades,
for both sexes, the lower boundary of this range has remained almost con-
stant, while the upper boundary has raised noticeably (at the beginning at a
faster pace for men) reaching age 80 for males and 78 for females. The area
at the top of the figure, so the one representing very old ages, is character-
ized by the circulatory diseases as leading cause. The upper boundary just
described for neoplasms represent the lower boundary of circulatory dis-
eases. Consequently while in the 1980s this cause was the leading one also
at young-old ages (the sixties) in more recent years is not the case anymore.
Among centenarians, and especially for males, other two causes appear, in-
fectious diseases and ill-defined. At extremely old ages death is due to a
mixture of causes which act simultaneously and the two mentioned above
seem to be the prevailing. A final note must be made for the black areas
in the mid-1990s, around age 30, representing the emergence of AIDS’ epi-
demic. Of course that area represents the whole group of infectious diseases
and not only AIDS because using the list of 17 causes the level of detail is
not so fine.
To have a deeper epidemiological understanding, Figure 4.5 displays
the results obtained using the HCD intermediate list (104 causes). Of course,
since the reconstruction has not been performed at such level of detail, only
the period 2003-2013 can be analyzed.
If using the 17 causes’ list male’s and female’s graph looked like pretty
similar, now there are only some analogies and many differences. Until
age 12 (males) and 15 (females), the situation is not uniform, with several
causes, especially different kind of neoplasms (nervous system, haematopoi-
etic system and other malignant neoplasms) and transport accident which
alternate throughout the considered period. At young ages, the area that
using the less detailed list pertained to external causes, it is now, not sur-
prisingly, dominated by transport accident. Also in this case, the area is
wider among males for whom transport accident is the leading cause until
age 40, while for females until around age 30. To be noted is the emergence
of suicide, starting from 2009, for men between age 30 and 40.
After the transport accident related deaths, males mortality is domi-
nated by ischaemic heart disease between age 40 and 55 and then by neo-
plasms of bronchus and lung whose upper boundary has increased from 70
in 2003 to 76 in 2013, while the lower has remained almost constant. For
females, those ages are instead uniformly characterized by only one cause,
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neoplasm of breast. At old ages ischaemic heart disease return to be the
leading cause of death among males, although at very old ages the pat-
tern is more mixed as also other heart diseases and cerebrovascular disease
emerge. This last cause is much more predominant for females, especially
between age 75 and 95.
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FIGURE 4.5: Leading cause of death from 2003 to 2013 for
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4.2.3 Rates Of Mortality Improvement (ROMI)
The previous analysis were very useful for depicting Italian cause-of-death
mortality but, to get a complete and informative portrait, the force of mor-
tality must also be considered. Looking at the evolution of age and cause-
specific death rates, mx,k, enable to understand which pattern of decline
mortality is following and if this pattern is similar or not among causes of
death.
Here the investigation on mortality’s rates dynamics over age and time
is conducted by estimating surfaces of mortality improvements. For each
cause k, mortality improvements are assessed through the Rate Of Mortality
Improvements (ROMI) over age x and time t, rx,k,t, which is computed as
follow:
rx,k,t = −(mx,k,t+1
mx,k,t
− 1) (4.1)
So, ROMI tells us, in which percentage, a given age-specific death rate
has grown or declined with respect to the previous year and therefore it
can be regarded as the time derivative of age-specific death rates. Equation
4.1 is a transformation of the equation to estimate the rate of growth and
the minus sign ensures that reductions in mortality result in positive values
(Andreev and Vaupel, 2005; Bokh and Rau, 2017; Keyfitz, 1977).
In my opinion, using ROMIs gives a deeper understanding of the age
pattern of mortality change than using age-specific death rates themselves.
To clarify this statement, Figure 4.6 displays on the top panel males and fe-
males death rates on the Lexis surface and on the bottom panel males and
females ROMIs values on the Lexis surface as well. In the first case areas
with the same color imply the same level of mortality (from black, the high-
est, to light green, the lowest) while in the latter case they imply the same
level of mortality change (the various shades of blue indicate a worsening
in mortality while the various shades of magenta indicate an improvement
in mortality). Both pictures highlight that mortality conditions have been
improving over the considered time period. In the top panels these im-
provements are pointed out by the fact that a given color reach higher ages
as time passes by and in the bottom panels by the evident predominance
of magenta areas with respect to blue areas. However, the intensity of the
changes in mortality, and the specific ages at which they occur, are better
visualized using ROMIs. For instance, the bad impact of AIDS epidemic
between the 1980s and 1990s on mortality at young ages appear much more
clearly through using ROMIs than simple death rates. Moreover, while the
current level of death rates determines actual values of life expectancy and
variability of age at death, it is the age-specific rate of change that deter-
mines their evolution into the future (Bokh and Rau, 2017; Kannisto et al.,
1994; Vaupel, 1997). Therefore, using ROMIs, mortality dynamics and their
consequences on the most important mortality indicators are better cap-
tured than using death rates.
ROMIs computation is based on smoothed death rates, obtained by the
P-spline method (Currie at al., 2004; Eilers and Marx, 1996). In this case
the smoothing procedure is more important than ever. Indeed, comput-
ing rx,k,t using the raw estimate of death rates, mx,k,t, would lead to a
confusing scenario. With regard to this issue, Figure 4.7 shows ROMIs
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FIGURE 4.6: Top panel: smoothed death rates for males and
females in Italy from 1980 to 2013. Bottom panel: ROMI
based on smoothed death rates for males and females in
Italy from 1980 to 2013.
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FIGURE 4.7: ROMI based on not smoothed death rates for
males and females in Italy from 1980 to 2013
values obtained by using not smoothed death rates. A comparison with
the bottom panel of Figure 4.6, whereas ROMIs values were obtained by
smoothed death rates, clearly reveals the importance of the smoothing pro-
cedure. Indeed, due to the high variability of raw estimate of death rates, a
clear understanding of the mortality improvements pattern is not percepti-
ble. By smoothing mx,k,t, the distortion caused by random noise processes
is removed, leading to what can be regarded as the "true" Lexis surface of
mortality improvements, as shown by bottom panels of Figure 4.6.
Cause-specific Lexis surfaces of mortality improvements are reported in
Figure 4.8. In particular, the Figure displays results of infectious diseases,
neoplasms, diseases of the nervous, circulatory, respiratory and digestive
system and external causes of death. Remaining causes of death are re-
ported in the Appendix. Before commenting cause-specific results, how-
ever, it is worth going back into ROMIs outcome for all-cause mortality.
As already said, the various shades of blue indicate a worsening in
mortality while the various shades of magenta indicate an improvement
in mortality. The deeper is the color the stronger are rates of worsening or
improvement. In particular the deepest blue is associated with an increase
in death rates greater than 3% while the deepest magenta is associated to a
decline in death rates greater than 5%. Generally speaking, both males and
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females mortality was decreasing at all ages and the highest rate of decline
are registered at ages 0-35, while at adult and in particular old ages the de-
cline was more contained (between 2% and 4%). A noticeable change of
age-specific pattern of mortality occurred at young ages between the mid-
dle 1980s and early 1990s: a rapid increase in death rates took place both
among males and females due to the well known AIDS epidemic. Mortality
conditions got worse especially for males who experienced, in these years,
a considerable rise in death rates from age 20 to 40. The epidemic’s impact
on females, even if really relevant, was more contained as already noted by
previous studies (Geddes et al., 1994; Longo et al., 2008). From the mid-
dle 1990s, once the epidemic was over, death rates between age 20 and 40
started to decrease rapidly, recovering the disadvantage accumulated in the
previous years. Another pattern to note concern the cohort effect in mor-
tality improvements rates, more marked for males than females, of those
in their forties in 1980. Indeed, there is an easily identifiable diagonal line,
from age 40-50 in the 1980s to 70-80 in the 2000s, where the rates of im-
provement were about 4% and 5% for males and 3% and 4% for females. It
would be possible to speculate whether these cohort effects show an excep-
tional mortality pattern of a particular group of cohorts or it is caused by
period and age factors. However, this question will not be taken here.
Cause-specific results are rather heterogeneous: the age pattern of mor-
tality change among causes varies considerably. Lets commenting first the
outcome of the two major causes of death, neoplasms and diseases of the
circulatory system, which, as pointed out in Paragraph 4.2.2, are respon-
sible for about two-third of total deaths. In both males and females, mor-
tality improvements are more marked for diseases of the circulatory sys-
tem than for neoplasms. Indeed, a wide proportion of circulatory diseases
Lexis’ surface displays a rate of decrease in death rates of 4% or greater
while for neoplasms the majority of the improvements are between 1% and
3%. In particular, circulatory’s diseases rate of decrease has been very pro-
nounced, especially for females, from the middle 1990s to the late 2000s
and for the cohort in their forties and fifties in 1980. From the late 2000s,
however, between age 35 and 70 a deceleration in the rate of mortality im-
provements is detected in both sexes. Such deceleration may be a sign of the
economic crisis impact on health. Prevention, indeed, often plays a major
role in avoiding diseases of the circulatory system related deaths and with
the economic crisis it may be that, especially people belonging to lower
class, have renounced to a proper prevention. With regard to neoplasms,
the major decline in death rates has been registered at young ages (0-15) in
both sexes and middle ages (40-60) for males. Another important difference
between these two groups of causes concern ROMIs’ values at old ages:
while at those ages mortality has been going down for circulatory diseases
all over the considered period (apart from few years in the middle 1990s at
very old ages for females), the same cannot be said for neoplasms. Indeed,
neoplasms’ Lexis surface shows an increase in death rates at old ages (and
also at young-adult ages in the 1980s) which stopped in middle 1990s for
females and only in late 2000s for males. The rate of increase was especially
pronounced at ages above 85 during the 1980s. This is particularly true for
males who registered an increase greater than 3%.
Coming to minor causes of death, infectious’ diseases outcome is par-
ticularly intriguing. As expected, AIDS’s epidemic led to a deep worsening
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FIGURE 4.8: Cause-specific surface of mortality improve-
ments based on smoothed death rates in Italy from 1980 to
2013.
of mortality at young and middle ages between 1980s and middle 1990s.
The impact was so strong that, as seen before, it was clearly visible also at
the all-cause mortality level. After the years of AIDS’ epidemic, mortality
started decreasing again at young and middle ages and the rate of such de-
cline has been really considerable, almost always greater than 5%. At old
ages, for both sexes, infectious diseases mortality change pattern may be di-
vided into two distinct phases: until early 1990s, death rates declined con-
siderably while after early 1990s the situation is completely reversed since
death rates started increasing at a pace often greater than 3%. This result is
in line with what found in Paragraph 4.2.2 about the rise in the percentage
of deaths due to infectious diseases.
An increase in old-age death rates is also found for diseases of the ner-
vous system for both males and females. Again, this confirms the results
found in Paragraph 4.2.2 about the rise in the percentage of deaths due to
diseases of the nervous system. The outcome might be related to the post-
ponement of mortality and the emergence of senescence-related diseases.
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The group of diseases of the nervous system, indeed, include several dis-
eases (e.g. Parkinson and Alzheimer) highly correlated with age and very
typical of the era of longevity extension.
ROMIs values for diseases of the respiratory system show a substantial
(often greater than 3%) and generalized (in terms of ages) rate of decreases
for both males and females. As in the case of diseases of the circulatory
system is possible to note a cohort effect for those in their fifties and sixties
in 1980 whose rate of decrease was particularly high.
Also diseases of digestive system display a huge decrease in death rates,
apart from an increase at old ages in the 1980s for males and the 1980s and
1990s for females. The decline has been particularly strong for males, espe-
cially at young and adult ages.
It is finally worth noting the considerable rate of decrease of external
causes of death at young ages. Therefore, despite transport accidents are
still the leading cause of death at young ages, noticeable improvement has
been made. As we will see later (Paragraph 5.3.1) such decline played a
major role in reducing lifespan variability, especially for males, over the
considered period.
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Reconstruction of coherent cause of death time-series, presented in Chapter
4, is the starting point for the epidemiological analysis of lifespan variability
in Italy from 1980 to 2013 which represents the main goal of this disserta-
tion.
This Chapter has four main aims: 1) Figure out gender and cause-specific
differences in the distribution of lifespans 2) Understand how the age pat-
tern of mortality change interact with S10 and its evolution over time 3)
Determine, for each sex, which causes of death are producing the observed
compression of mortality in the period under study 4) Establish which causes
of death are responsible for the variability gender gap in favor of females.
The first goal is achieved through the computation of all-cause and cause-
specific mortality trends in M and S10 for each sex. I anticipate that neo-
plasms (and congenital malformations) are the only group of causes which
report a higher variability among females than males. For this reason, and
also for the great importance of this group of causes, a whole paragraph
will be dedicated to a focus on neoplasms. Conducting a detailed analy-
sis at the cause of death level in the period 2003-2013, it will be possible to
figure out if the greater variability registered by females is attributable to
some specific types of neoplasms or if it is more generalized.
Sensitivity analysis is then exploited to get insight about aim 2. As
stated in Paragraph 3.2.5, sensitivity analysis allows understanding which
ages, after a proportional reduction of death rates, would produce a de-
crease or an increase in S10 and the intensity of this potential decrease or
increase. Moreover, it allows identifying a threshold age T10, that is the age
at which the contribution to a change in S10, due to a reduction in mortality,
is reversed from negative to positive. Thanks to the information obtained
through sensitivity analysis, it will be then possible to break down S10
trends into the effects of mortality change below and above the previously
determined young-old threshold, understanding how these two contrast-
ing force have eventually produced the observed lifespan variability.
Finally, decomposition methods are used to reach goals 3 and 4. The
results will quantify:
a) the contribution of changes in age and cause-specific mortality rates,
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mx,k, from 1980 to 2013 to change in S10 over the same period. The out-
comes allow to exactly identify, for each sex, the age and specific-cause pro-
file determining changes in variability of age-at-death in the period under
analysis.
b) the contribution of differences in age and cause-specific mortality
rates, mx,k, between sexes to the difference in S10 between sexes at fixed
point in time (1980 and 2013). In this case the results give a cause-of-death
explanation of females advantage in lifespan variability.
5.1 Changing in position and shape of the age-at-death
distribution: M and S10
Since mortality transition started, in any developed country the age-at-
death distribution has greatly changed its position and shape. The im-
provements in mortality conditions, indeed, led to either a shift on the right
or a compression of the distribution.
Figure 5.1 illustrates how the age-at-death distribution has evolved from
1906 to 2013 for the Italian population.
In this section, the shift, or in other words longevity extension, is sum-
marized by the change in the modal age at death M, while the compression
by the standard deviation of age at death above age ten S10.
As stated in Chapter 2, evidence suggests that life expectancy at birth
underestimate progress made in longevity extension when principally driven
by improvements in the survival of the elderly and that life expectancy at
some middle or early old ages, such as 50 or 65, strongly depend on an
arbitrary selection of the age limit, and hence on an arbitrary definition of
‘old’ (Diaconu, 2016; Canudas-Romo, 2010; Kannisto, 2001). Thus in the era
where the extension of human life is primarily due to the reduction of old-
age mortality, the adoption of M, which is determined by adult mortality
only, as a longevity indicator, seems to be preferable.
With regard to the standard deviation of age at death above age ten S10,
its choice was largely described in Paragraph 3.2.1 and principally related
to the advantage of truncation at age 10.
5.1.1 All-cause long time trends in M and S10
As just seen thanks to Figure 5.1, mortality changes in Italy in the last cen-
tury were impressive. Thus, before going to the analysis of cause-specific
age-at-death distributions, I briefly summarize long-term (1906-2013) chan-
ges occurred in the Italian age-at-death distribution with regard to all-cause
mortality. The estimation of M and S10 is based on smoothed density result-
ing from P-Splines, whose advantages have been mentioned in Chapter 3.
Figure 5.2 and 5.3 display, respectively, M and S10 values for males and
females over the course of more than a century. About the modal age at
death, M, has to be noted that, during the years of World War I and II, the
adult modal age at death is reported. In these periods, indeed, the mode of
the distribution was around 20 years. Since here we are interested in the
shift on the right of the old age bell-shaped part of dx, only the adult modal
age at death is taken into consideration. On the left panels are displayed
trends from 1906 to 2013 while on the right panels only the trends from
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FIGURE 5.1: Smoothed dx function for males and females in
1906 and 2013.
1980, to get a better visual inspection of the evolution of the two measures
in the period for which cause-of-death data are available.
From 1906 to 2013 the mode has risen by 12.07 years for males (73.82 -
85.89) and by 16.23 years for females (72.93 - 89.30). Until the end of World
War II the two trends almost overlap each other but then, from the 1950s,
they started to separate. While females mode continued its linear rise at a
pace of about 1.6 years per decade, the males mode reached a plateau for
more than 20 years. It is during this period that the gender gap in the mode
was generated. It would have been interesting, having cause-specific data
for this period, to give an epidemiological interpretation of that fact. The
most reliable hypothesis is that smoking-related diseases had a major role
in generating the gap. From the early 1980s, however, males modal age
at death started increasing again. It rose at a noticeable pace of about 2.5
years in the 1980s decade, to then slow down its increase from the 1990s.
Trends in M for both sexes keep increasing in recent years, demonstrating
how progress in longevity extension is still going on.
The great shift of the age-at-death distribution just described was also
accompanied by a compression of mortality. S10 decreased by 6.43 years for
males (19.10 - 12.67) and by 8.28 years for females (19.79 - 11.51). As for the
mode, lifespan variability in the first four decades of the XXth century was
almost equal between the sexes with females even showing a slightly higher
variability in age-at-death. Only in the second half of the XXth century the
two trends started to separate, from that moment S10 females values have
been constantly lower than males values. A special mention has to be done
for the two Wolrd War periods. The wars clearly had a worse impact on
males than females about uncertainty about the timing of death. This is
especially true in the case of World War II, with lifespan variability rising
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tremendously for men an only in a limited manner for females. During the
World War I period, instead, the difference in the rose of S10 between the
sexes was less accentuated. These, indeed, are also the years of Spanish Flu
which, on the contrary of the war, indiscriminately hit both sexes.
The hypothesis of a shifting mortality scenario does not fit the Italian
case yet. Even if at a lower pace mortality compression is still occurring
and lifespans are becoming more and more concentrated in a narrower age
interval. Only during the 1990s, especially for males, S10 slightly increased
for a few years (an increase mainly due to AIDS as we will see soon). The
gender gap reached its peak in 1992 when the difference between the sexes
was of 2.06 years. From that moment males have been partially recovered
the disadvantage and nowadays the difference is only of 1.16 years.
In the next paragraphs, thanks to data on causes of death, it will be
possible to give an epidemiological interpretation of the all-cause mortality
compression, as measured by S10, in the period from 1980 to 2013.
5.1.2 Cause-of-death trends in M and S10
What basically emerged from the previous section is that in Italy longevity
extension is still going on (the modal age at death is rising) and that, despite
a slow down in the pace of compression, the duration of life is becoming
less and less uncertain. But, how this two processes of longevity extension
and compression differ from cause of death to cause of death?
Progress in cause-specific longevity extension is displayed in Figure 5.4.
First, cause-specific modal age-at-death estimates differ greatly in terms of
level. In both sexes, the lower limit is represented by neoplasms which re-
port the lowest M and the upper limit by ill-defined causes which report
the highest M while other causes are concentrated in a range of about 5
years. Second, although this variation in terms of level, all causes followed
a steady upward trend since 1980. Moreover the increase in cause-specific
modal age at death estimates occurred at a strikingly similar pace for most
causes (a pace greater for males than females reflecting the all-cause M evo-
lution seen in the previous paragraph). Among males the average increase
was 9 years, mental disorders registered the greater rise (12.9 years) and
ill-defined causes the lesser rise (3.9 years). Among females, instead, M in-
creased 7 years on average and diseases of the blood registered the major
improvements (10.2 years) while ill-defined causes the smaller (4.5 years).
Third, the higher all-cause M registered among females reflects also into a
general higher cause-specific M. For each cause the modal age at death is
indeed higher, all over the considered period, for females than males.
Going into the cause of death detail, as previously said, neoplasms are
the cause-of-death with smaller M. Thus, their age-at-death distribution is
the one that reaches the peak earlier than any other, highlighting how this
group of causes is not really typical of extremely old-ages. On the other
hand, it is not surprising to find ill-defined causes as the one with higher
modal age at death since, at extremely old-ages, death is often due to sev-
eral factors and no specific cause can be reported as underlying. The re-
maining causes are quite close each other in terms of M. Among them, dis-
eases of the circulatory and respiratory system, external causes and diseases
of the skin are the one that reached major progress in longevity extension,
while infectious diseases, diseases of the digestive system and endocrine,
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FIGURE 5.4: Cause-specific trend in the modal age at death
M from 1980 to 2013 in Italy. Males (left panel) and females
(right panel).
nutritional and metabolic diseases the minor progress. Hence, it is clear that
the shift to the right of the age-at-death distribution concerns not only all-
cause mortality but also cause-specific mortality since longevity has been
extended for all causes.
Regarding lifespan variability, the situation is less homogeneous. Figure
5.5 reports the standard deviation of age at death above age ten, S10, for the
various causes of death here considered, from 1980 to 2013 and for each sex
separately.
The pattern emerging from an overall view could be summarized as
follow: a) for most causes (12 out of 15) compression of death is occurring.
Among those with declining lifespan variability, the pace of the compres-
sion vary greatly. Only endocrine, nutritional and metabolic diseases, con-
genital malformations and ill-defined causes show a value of S10 higher
in 2013 than in 1980. b) S10 cause of death levels differ noticeably. Dis-
eases of the circulatory and respiratory system report the most compressed
age at death distribution while external causes and congenital malforma-
tions the most variable one. The difference between these extremes is huge.
c) lifespan are less uncertain among females for 13 causes out of 15. In
some cases the gender gap is considerable (ENM diseases, mental disor-
ders, nervous system, circulatory system, digestive system, ill-defined and
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external causes) while in other less pronounced (infectious diseases, dis-
eases of the blood, diseases of the skin) or close to zero (respiratory system,
muskoloskeletal system, genitourinary system). Neoplasms and congeni-
tal malformations are the only exceptions, reporting a reversed situation in
which lifespan is less uncertain among males. The intriguing finding for
neoplasms, as said in the introduction, will be investigated in depth in the
next paragraph. For the moment it is worth noting that males advantage is
quite important. On average, during the considered period, the difference
in terms of lifespan variability was 1.55 years.
Now, turning the analysis into the cause-of-death perspective, other pe-
culiarities emerge. The consequence of AIDS epidemic, which causes thou-
sands of deaths at young ages, led to a considerable increase in infectious
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diseases lifespan variability from the middle 1980s to early 1990s (more pro-
nounced for males). Unsurprising those are also the years in which S10 all-
cause values jumped up as seen in Figure 5.3. Passed the epidemic, S10
started to decrease at a remarkable pace either for males or females. During
the years of AIDS epidemic an upward jump of lifespan variability, even if
much more contained compared to the one reported by infectious diseases,
was registered also for other causes of death, especially in males trends
(diseases of the blood, ENM diseases, mental disorders, diseases of the di-
gestive system, diseases of the skin, diseases of the muskoloskeletal system,
diseases of the genitourinary system). AIDS impact on the whole health it
is well known, being correlated to some type of neoplasms, problems of the
respiratory and digestive system and diseases of the skin (Greenspan et al.,
1996; Jung et al., 1998; Tschachler et al., 1996; WHO, 2007). It may be, thus,
that even if AIDS was not registered as underlying cause it had played a
role in the process leading to death. If so, during the epidemic also other
causes than infectious diseases may experience an increase in lifespan vari-
ability. This hypothesis would be tested using multiple cause-of-death data
which allow to verify the presence of AIDS as contributory cause of death
and not just as underlying. Without multiple cause-of-death data, it is hard
to clarify this issue. However, looking back at information coming from sur-
faces of mortality improvements shown in Paragraph 4.2.3, it appears that
many diseases related to AIDS report an increase in death rates at young
ages during the 1980s and early 1990s. It may be a clue that AIDS epidemic
played a role not only in rising infectious diseases variability but also other
causes of death variability.
The two major causes of death, neoplasms and circulatory diseases, re-
veal a similar pattern of slow compression. Almost a scenario of shifting
mortality characterize them: their age-at-death distributions are shifting to
the right (M is rising) but almost retaining the same shapes. On the other
hand these two causes present differences. The first regarding variability
level: S10 results higher for neoplasms than circulatory diseases. This con-
firms as neoplasms still affect young-adult mortality while circulatory dis-
eases are more prevalent at older ages. The second, already mentioned, re-
gards the gender gap which sees males having an advantage in neoplasms
and females in diseases of the circulatory system.
As circulatory diseases, also diseases of the respiratory system register
low variability level. In this case, though, the compression is a bit more
marked and the gender gap less pronounced. Even more marked is the
compression registered for diseases of the blood, mental disorders, diseases
of the nervous system, diseases of the genitourinary system and external
causes. This last group is also the one with higher variability (along with
congenital malformations). The decrease in S10 for external causes was of
a bit less than 4 years and a bit more than 4 years for males and females
respectively. Despite this gain, their variability levels are still high, around
22 years for males and 18 years for females. Such great uncertainty in length
of life is the consequence of traffic accidents, suicide and homicide which,
as seen in Paragraph 4.2.2, play a big role at young ages.
A better understanding of how a given cause of death influence the all-
cause S10 trend is offered by Figure 5.6. The Figure displays what would be
the all-cause S10 trend if a specific cause of death was removed. The results
are shown only for the causes having a major impact on S10 (infectious
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FIGURE 5.6: S10 trends for males (left panel) and females
(right panel) eliminating a specific cause of death from the
computation.
diseases, neoplasms, circulatory diseases, respiratory diseases and external
causes) while the other are grouped all together.
Removing circulatory diseases from the computation, the standard de-
viation of ages at death above age 10 increases greatly either for males or
females. It emerges, thus, how this group of causes plays a major role in
shaping the all-cause age-at-death distribution and consequently its vari-
ability. Also eliminating respiratory diseases S10 rises, but this time the rise
is almost negligible. On the other hand, the effect of removing neoplasms
from calculations, it is of lowering S10. The impact, however, it is much
more contained for males than for females. One more time it comes up
that neoplasms lifespans are more variable for women than men and how
such difference it is considerable. As expected removing external causes
of death lead to a decrease in S10, and as expected the decrement is more
pronounced for males, who, as seen before, report higher variability for this
group of causes than females. As a consequence, a hypothetical elimination
of external causes would implicate a drastic reduction of the lifespan in-
equality gender gap (a better quantification of such reduction will be given
in Paragraph 5.3.2). Finally, it is interesting to look at the role played by in-
fectious diseases. Not surprisingly, the effect is to lower S10 for both males
and females. What is more interesting is the trend between late the 1980s
and middle 1990s. Any of the causes examined until now produced an in-
crease or a decrease in S10, but the shape of the trend was pretty much sim-
ilar to the one reported by all-cause S10. In the case of infectious diseases,
instead, apart from S10 reduction, it is also possible to note a modification
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of the trend’s shape between the late 1980s and middle 1990s. As stated
earlier, these years were characterized by an increase in lifespan variability,
but removing infectious diseases this increase almost disappears. It means
that most of S10 rise during those years was attributable to infectious dis-
eases and in particular to AIDS epidemic, confirming what hypothesized
above.
5.1.3 A focus on neoplasms
One of the most intriguing findings of the previous paragraph surely con-
cerns the higher variability of neoplasms age-at-death distribution among
females than males. Why is it so? Is it attributable to a specific type of
neoplasms? As mentioned in Paragraph 3.1.2, a deeper level of analysis is
feasible from 2003 to 2013, i.e. the ICD-10 period, and will permit to answer
the question.
A first reasonable hypothesis to explain the finding is the following: the
females higher lifespan variability is not generally true for any type of neo-
plasm, but attributable to neoplasm of breast. As seen in Figure 4.5, indeed,
neoplasms of breast are a) typical of young-adult ages, consequently lead-
ing to spread out of the age-at-death distribution b) much more frequent
among females, for whom it is the leading cause of death from age 30 to 60.
This hypothesis can be tested simply, computing neoplasms S10 remov-
ing neoplasm of breast. If true, the variability gender gap would disappear,
if false it would persist. The answer is given by Figure 5.7, which shows,
for both sexes, neoplasms S10 trends and neoplasms S10 trends removing
neoplasm of breast.
11.5
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FIGURE 5.7: Neoplasms and neoplasms after removing
brest’s cancer males and females S10 values from 2003 to
2013.
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The results evidence that, even if removing neoplasm of breast has the
effect of lowering neoplasms S10 for females of about 0.5 years, while for
males it produces basically no changes, a considerable gap between the two
sexes inequality persists. Thus, neoplasm of breast surely contribute to the
observed male advantage regarding lifespan variability but, on the other
hand, it cannot be addressed as the only cause.
As a consequence, the gender gap is also attributable to other types of
neoplasms. Table 5.1 reports, for males and females, S10 values in 2003 and
2013 for 21 different types of neoplasms (the 21 types of neoplasms reported
by the HCD intermediate classification). The results are clear: lifespan is
more unequal for females than males for almost every type of neoplasms.
Thus, the males advantage in S10 for neoplasms doesn’t come from specific
cancer location but is more generalized. In the period covered by the study,
indeed, a part from malignant neoplasms of liver and pancreas for which
S10 values are more or less the same between the sexes, for any other kind of
cancer the age-at-death distribution is more compressed for males than for
females. The difference is particularly big for malignant neoplasms of oral
cavity, oesophagus, rectum, larynx, lung, skin, breast and genital organs.
Type of neoplasms Males 2003 Males 2013 Females 2003 Females 2013
Malignant neoplasms of oral cavity 12.78 12.98 14.98 15.61
Malignant neoplasms of oeshophagus 11.22 11.39 15.23 13.88
Malignant neoplasms of stomach 11.26 11.41 12.83 12.76
Malignant neoplasms of colon 10.85 10.99 13.20 13.12
Malignant neoplasms of rectum 11.35 11.19 12.47 13.24
Malignant neoplasms of liver 10.17 10.77 10.10 10.88
Malignant neoplasms of pancreas 11.21 11.04 11.07 11.40
Other malignant neoplasms 11.01 10.87 12.09 11.48
of the digestive system
Malignant neoplasms of larynx 11.09 11.22 13.06 15.08
Malignant neoplasms of lung 10.00 10.04 12.20 12.39
Malignant neoplasms of skin 14.19 14.69 17.31 17.85
Malignant neoplasms of breast 12.97 12.25 14.57 14.94
Malignant neoplasms of genital organs 8.67 8.54 13.26 13.79
Malignant neoplasms of kidney 11.34 11.95 12.31 12.45
Malignant neoplasms of bladder 9.70 9.60 10.08 10.92
Malignant neoplasms of nervous system 14.51 14.76 15.77 15.58
Leucemia 14.97 14.31 15.49 15.80
Other malignant neoplasms of the 14.43 14.12 16.02 16.11
lymphoid and hematopoietic tissue
Malignant neoplasms of indipendent 12.96 12.44 13.01 12.99
multiple sites
Other neoplasms 11.75 11.18 12.47 12.01
Benign neoplasms and neoplasms 12.84 11.86 12.93 12.12
of uncertain or unknown behaviour
TABLE 5.1: S10 values for 21 different types of neoplasms in
2003 and 2013 for males and females.
A part from gender differences, the results shown in Table 5.1 enable
to find out the variability of the age-at-death distribution for each type of
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neoplasms and therefore to know the current differences, in terms of lifes-
pan inequality, between different cancer’s location. As we have seen before,
from 1980 to 2013, males reported a quite stable trend in S10, a bit above 11.5
years, for the macro-chapter of neoplasms. This level of variability is also
reported for many specific types of cancer, like malignant neoplasms of oe-
sophagus, stomach, colon, rectum, pancreas, larynx, kidney and other neo-
plasms. Well above this average value are, instead, malignant neoplasms of
oral cavity, skin, breast, nervous system, other malignant neoplasms and
leucemia. On the other hand malignant neoplasms of liver, lung, geni-
tal organs and bladder are the types of cancer for whom the age-at-death
distribution is more compressed. For females, even if at a higher level of
variability, the situation is quite similar. Also for them, indeed, malignant
neoplasms of oral cavity, skin, breast, nervous system and leucemia are the
one with highest value of S10, while malignant neoplasms of liver, lung and
bladder the one with low value of S10.
5.2 Sensitivity analysis of S10
All-cause mortality lifespan variability trend, as measured by S10, has re-
vealed that the age-at-death distribution, of either males or females, is still
becoming more and more compressed, highlighting how a scenario of shift-
ing mortality it is still not conceivable for Italy.
A powerful tool to deeper understand the reasons behind the observed
reduction in the age-at-death distribution variability is represented by sen-
sitivity analysis. In particular, through this method, it is possible to in-
vestigate on the relationship between the age pattern of mortality change
and trends in variability of age at death. As illustrated in Paragraph 2.1.2
and 3.2.5, using S10 as measure of lifespan variability, improvements in
mortality don’t automatically translate into a lower variability of the age-
at-death distribution, conversely, "young" ages decline (increase) produces
compression (expansion) while "old" ages decline (increase) produces ex-
pansion (compression).
A full comprehension of this mechanisms is of fundamental importance
since it reveals the manner in which variability in length of light evolves
over time. Probably, at first sight, such double effect of mortality improve-
ments on lifespan variability could appear nonsense. A better understand-
ing of this scenario was pointed out in Chapter 2 and displayed by Fig-
ure 2.4: from the top panels one can see that the effect of reducing mor-
tality rates, mx, at young ages is to decrease the variability of the density
function, dx , as deaths are pushed out further on the tail of the age-at-death
distribution. From the bottom panels, instead, one can see that the effect of
reducing mortality rates at old ages is to increase the variability of the den-
sity function as deaths of the right-hand tail of the age-at-death distribution
are more spread out and concentrated at later ages.
Of course, mortality reduction has to be always seen as advantageous
even though at later ages it produces an increase in the variability of the
age-at-death distribution. What matters is that the variability’s rise pro-
duced by "old" age mortality decline is compensated (or even better over-
taken) by the "young" age mortality decline. Therefore, the increase in lifes-
pan variability due to a reduction of "old" age death rates can be regarded
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FIGURE 5.8: Sensitivity of S10 in 1980 and 2013 to a propor-
tional 1% decrease in mortality rates at all ages.
as something positive since such increase comes from a shift on the right of
the age-at-death distribution.
Figure 5.8 shows, for each sex separately, the sensitivity of S10, in 1980
and 2013, to a proportional 1% drop in mortality rates at all ages, i.e. what
would be the contribution of each age to a change in S10 if mortality de-
creased by 1% at all ages. As already said, sensitivity analysis’ outcome
is important in three ways. First, they allow understanding which ages,
after a reduction of death rates, would produce a decrease or an increase
in S10. Second, they assess the magnitude of this potential decrease or
increase. Third, they identify a threshold age T10, which individuate, re-
garding lifespan variability, the "young" and old "age" range, or in other
words, the "early" and "late" deaths.
What emerges from Figure 5.8 is as follow. Before the threshold, i.e.
where mortality decline acts reducing S10, males’ sensitivity presents two
bumps, the first at young ages, more precisely between age 15 and 25, and
the second at adult ages, more precisely between age 40 and 50 in 1980 and
between age 45 and 60 in 2013. The first bump, considerably reduced in
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2013 with respect to 1980, is the result of the rapid increase in mortality
produced by external causes of death at those ages. As a consequence, a
decline in mortality between 15 and 25 would have a greater impact on S10
than a decline at immediately previous ages (10-14) or immediately sub-
sequent ages (26-30). The second bump reflects the fact that at adult ages
mortality is no more as low as at young ages and, therefore, improvements
would lead to a more considerable decline of S10. After T10, instead, the
contributions are bell-shaped, with the maximum positioned about 15 years
after the threshold.
Females’ pattern looks like quite similar to males’ pattern, with the ma-
jor difference represented by a very contained bump between ages 15-25 as
a result of their considerable mortality advantage at those ages due to the
minor impact of external causes on mortality rates.
In the period under analysis, the age separating "early" and "late" deaths
moved forward considerably, from 61 to 71 years for males and from 69 to
76 for females. Thus, as time passes by, negative contributions have more
ages available as T10 shifts to the right, but also a slightly lower sensitiv-
ity, while positive contributions have fewer ages available and roughly the
same sensitivity’s levels.
Sensitivity analysis is surely really intriguing, but it only allows under-
standing how S10 would react to a proportional mortality decline. How-
ever, in reality, death rates do not decline proportionally at all ages and, of
course, in some cases they could even increase. Therefore, in order to un-
derstand how the actual age pattern of mortality change from 1980 to 2013
has affected all-cause S10 trend, I computed, for each age, the actual contri-
bution to changes in S10. The results obtained are displayed in Figure 5.9
using Lexis’ surface. Areas with the same color imply the same contribu-
tion’s level to changes in variability of age at death. Negative contributions,
i.e. the ones that act lowering S10, are green colored, while positive contri-
butions, i.e. the ones that act incrementing S10, are red colored. The deeper
is the color the higher is the contribution (in both senses).
The clear partition of negative and positive contributions to changes in
S10 along ages can be immediately seen. The threshold T10 distinctly sep-
arates ages which contribute to reduce variability in length of life after a
reduction of mortality rates from those which contribute to increase vari-
ability in length of life after a reduction of mortality rates. Therefore, red
areas before T10 and green areas after T10 indicate an increase in mortality.
In particular, it is possible to note the great impact (especially for males)
that AIDS epidemic had in increasing S10 between the late 1980s and early
1990s, explaining the increase in uncertainty about the time of death regis-
tered in those years.
The most important feature emerging from Figure 5.9 comes from the
analysis of how trends in lifespan variability are determined by these two
opposing forces. As stated before, the increase in S10 attributable to old-age
death rates reduction, cannot be seen itself as something negative since such
greater variability is the result of the postponement of deaths at older ages.
On the other hand, enlarging inequality in lifespan can never be seen as
something positive as well. So, it results of basic importance that young-age
mortality reduction is strong enough to overtake the increase of uncertainty
in the timing of death produced by a shift on the right of the age-at-death
distribution at old ages. Thankfully, this is exactly what is happening in
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FIGURE 5.9: Age-specific contributions of changes in S10
from 1980 to 2013.
the Italian population: as shown in Paragraph 5.1.1, inequality in lifespan
continues to go down in both sexes. Such observed reduction in variability
of age at death, it is due to the capability of mortality changes before T10 to
be more influent than mortality changes after T10.
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5.3 Cause-of-death decomposition of S10
Which causes are responsible for the observed mortality compression? Which
causes are responsible for the gender gap in lifespan variability? In this
paragraph, I will answer to these questions exploiting decomposition tech-
nique.
With regard to the first question, I have previously shown that from
1980 to 2013 S10 has decreased of 1.45 years for males and of 1.02 years
for females. In section 5.3.1, these two differences will be decomposed into
the contribution of changes in age and cause-specific mortality rates, mx,k,
from 1980 to 2013 to change in S10 over the same period. In this way, for
each sex separately, it will be possible to understand the age and cause pro-
files that have determined the observed mortality compression. The results
are displayed in Figure 5.10. The bars under the zero line indicate particular
age-cause profiles which contribute to the observed mortality compression
measured by S10, while the bars above the zero line indicate particular age-
cause profiles which acted oppositely, i.e. expanding mortality.
With regard to the second question, in section 5.3.2, the lifespan variabil-
ity gender gap in 1980 (1.59 years) and 2013 (1.16 years) will be decomposed
into the contribution of differences in age and cause-specific mortality rates,
mx,k, between sexes to the difference in S10 between sexes. The results are
displayed in Figure 5.11. In this case, the bars under the zero line indicate
particular age-cause profiles which positively contribute to the observed
female’s advantage in S10, while the bars above the zero line indicate par-
ticular age-cause profiles which contribute reducing the lifespan variability
gender gap.
5.3.1 Decomposing the change over time of S10
In this section, for each sex separately, the first question stated above, i.e.
which causes are responsible for mortality compression? is going to find an
answer.
Figure 5.10 shows decomposition’s result with males in the top panel
and females in the bottom panel. Before entering into details, it is worth
noting the shape of the contribution of changes in mx,k from 1980 to 2013
to changes in S10 over the same period displayed by both sexes. Negative
and positive contribution are not equally distributed along the x-axis, rep-
resenting age. The first dominate from the first considered age (10) up to
adult-old ages, the latter prevail at old and very old ages. Why this pat-
tern? As just seen in the previous paragraph, the effect of mortality decline
on S10 varies by age: up to a certain age mortality reduction acts lowering
lifespan variability and after such age acts incrementing lifespan variability.
Therefore, the observed mortality decline, which both males and females
experimented from 1980 to 2013, did not always produce a decline in S10,
as it would be for life expectancy.
Table 5.2 and 5.3 are helpful to better distinguish such contrast between
young-adult ages and old ages and thus have a better comprehension of
decomposition’s outcomes. The tables report, for each cause, the overall
contribution to changes in S10 split into two categories. The categories are
identified using the first age at which a decline in mortality rates would in-
crease S10 as the upper limit of the young-adult category and lower limit of
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Cause of Death Untill 66 After 66 Total
All causes -3.25 1.80 -1.45
Infectious diseases -0.04 -0.01 -0.05
Neoplasms -0.71 0.02 -0.69
Diseases of the blood -0.01 0.00 -0.01
Endocrine Nutritional and Metabolic -0.02 0.00 -0.02
Mental disorders -0.05 -0.03 -0.08
Diseases of the nervous system -0.08 -0.03 -0.11
Diseases of the circulatory system -0.69 1.28 0.59
Diseases of the respiratory system -0.10 0.22 0.12
Diseases of the digestive system -0.37 0.10 -0.27
Diseases of the skin 0.00 0.00 0.00
Diseases of the muskoloskeletal system -0.01 0.00 -0.01
Diseases of the genetourinary system -0.03 0.05 0.02
Congenital malformations -0.02 0.00 -0.02
Ill-defined causes -0.02 0.16 0.14
External causes -1.10 0.04 -1.06
TABLE 5.2: Contribution of changes in age and cause-
specific mortality rates from 1980 to 2013 to change in S10
over the same period in Italy. Males
Cause of Death Until 73 After 73 Total
All causes -2.54 1.52 -1.02
Infectious diseases -0.03 -0.02 -0.05
Neoplasms -0.62 0.05 -0.57
Diseases of the blood -0.01 0.00 -0.01
Endocrine Nutritional and Metabolic -0.07 0.02 -0.05
Mental disorders -0.02 -0.08 -0.10
Diseases of the nervous system -0.06 -0.04 -0.10
Diseases of the circulatory system -0.71 1.21 0.50
Diseases of the respiratory system -0.08 0.13 0.05
Diseases of the digestive system -0.25 0.03 -0.22
Diseases of the skin 0.00 0.00 0.00
Diseases of the muskoloskeletal system -0.01 0.00 -0.01
Diseases of the genetourinary system -0.06 0.00 -0.06
Pregnancy and related conditions -0.02 0.00 -0.02
Congenital malformation -0.01 0.00 -0.01
Ill-defined causes -0.04 0.22 0.18
External causes -0.55 0.05 -0.50
TABLE 5.3: Contribution of changes in age and cause-
specific mortality rates from 1980 to 2013 to change in S10
over the same period in Italy. Females
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the old category. This age can be placed at 66 for males and 73 for females.
It is to be noted that such threshold age is conceptually different from those
found in Paragraph 5.2. The thresholds of Paragraph 5.2 tell us at which age
the effect of a decline in death rates on S10 is reversed from negative (low-
ering lifespan variability) to positive (increasing lifespan variability) given
the age pattern of mortality change registered in each year. The threshold
found in the current Paragraph, instead, tells us at which age the effect of a
decline in death rates on S10 is reversed from negative to positive all over
the period 1980-2013, thus considering the whole age pattern of mortality
change observed from 1980 to 2013.
About males’ results, the registered mortality compression of 1.45 years
has been primarily driven by the reduction of external causes death rates,
especially from age 10 to 30. The contribution of this group of causes in low-
ering S10 is really remarkable (-1.06 years) and explain more than the 70%
of males reduction in uncertainty in the timing of death. Intriguing is the
role played by neoplasms and diseases of the circulatory system. The two
major causes of death act in a similar way up to age 66, whereas the sign
of their contribution is reversed. Until that age, indeed, neoplasms pro-
duce a reduction of S10 equal to 0.71 years and diseases of the circulatory
system of 0.69 years. Their contribution in lowering lifespan variability is
particularly important at adult ages, from age 45 to 60. At old ages, where
a decline in mortality rates produce an increase in lifespan variability, in-
stead, they behave differently. With regard to diseases of the circulatory
system the dramatic decrease in mortality rates acts rising S10, with a no-
ticeable effect of 1.32 years. For neoplasms the effect is really close to 0:
up to age 82 they produce a small increase of S10 which is however off-
set by a decline of S10 from age 83, meaning that from this age, mortality
rates have been growing in the period under study. Summing up all ages,
the overall contribution to changes in lifespan variability of the two major
causes is negative (-0.69) for neoplasms and positive (0.59) for diseases of
the circulatory system. Another group of causes with a considerable effect
is diseases of the digestive system, whose contribution in reducing S10 is
of 0.27. To be noted is also the role played by diseases of the respiratory
system (lowering lifespan variability by 0.10 years at young-adult ages and
incrementing lifespan variability by 0.22 years at old ages), which is com-
parable to the one of diseases of circulatory system but at a lower level of
intensity, and the role played by ill-defined causes that, due to a consistent
reduction in old ages mortality rates, produced an increase in S10 equals to
0.14 years.
Females’ results are quite similar to males’ results, either regarding the
age or cause profile contribution pattern. Also in this case neoplasms play
a major role in lowering lifespan variability (-0.57) while diseases of the cir-
culatory system act incrementing S10 (0.50). The major difference regards
external causes of death, whose impact on mortality compression is much
less remarkable (0.52 years). This outcome is not surprising. As seen in
Paragraph 4.2.3, external causes of death mortality rates decline at young
ages has been noticeable in both sexes. Males’ decline, however, has led to
a greater compression of the age-at-death distribution because their mortal-
ity rates at young ages are much higher than the one of the females. In other
words, males’ S10 is more sensitive to a reduction in mortality at those ages
than females’ S10 (see Paragraph 5.2). Less remarkable is also the role of
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diseases of the digestive system producing a decline of S10 equal to 0.22
years and diseases of the respiratory system (-0.08 at young-adult ages and
0.13 at old ages).
5.3.2 Decomposing differences between sexes in S10
Italian females have been experiencing a more certain length of life than
italian males. An epidemiological explanation of the female advantage in
lifespan variability is given by figuring out which causes of death are deter-
mining such advantage through the decomposition of the S10 gender gap.
Since the decompositions are performed for 1980 and 2013 it will also be
possible to evaluate potential changes in the causes of death profiles gener-
ating the gap over the course of the considered period.
The shape of the contribution of differences in mx,k between sexes to
difference in S10 between sexes presents a similar pattern of the previously
analyzed decomposition over time of S10. The reason is clearly the same:
lower mortality rates are an advantage in terms of lifespan variability only
up to a certain age, thus the fact that males have higher rates than females at
any age leads to a situation in which young and adult ages produce the gen-
der gap while old and very old ages reduce it. So, in this case, the thresholds
founded (65 in 1980 and 74 in 2013) tell us at which age the effect of hav-
ing lower death rates, between sexes, on the S10 difference, between sexes, is
reversed from negative to positive.
In 1980, the 1.59 years of difference in S10 between males and females
was primarily driven by external causes at young and adult ages: 1.19
years, of which most between ages 15 and 30. At those ages external causes
of death basically mean transport accidents: females less risky behavior
substantially explain more than half of the lifespan variability gender gap
in 1980. The role played by neoplasms and diseases of the circulatory sys-
tem is ambiguous: if on one hand they are surely important (red and yellow
bars stand out clearly in the graph) on the other hand their contribution to
the S10 gender gap is quite small. Their young-adult ages contribution
generating the males-females difference in lifespan variability (0.36 years
for neoplasms and 0.55 years for diseases of the circulatory system) is, in-
deed, basically offset by their old and very old ages contribution which acts
in the opposite way (0.32 years for neoplasms and 0.45 years for diseases
of the circulatory system). About the remaining causes of death, what is
worth mentioning, it is the role played by diseases of the digestive system
which positively contribute to the gender gap by 0.19 years and the role
played by diseases of the respiratory system which, instead, reduce female
advantage by 0.15 years.
The 2013’s decomposition reveals a similar pattern: lifespan variability
gender gap is generated by females advantage in mortality rates up to age
74 to be then reduced at older ages for the same reasoning. Neoplasms and
diseases of the circulatory system contribution to the sex difference in S10
are a bit more pronounced than in 1980. Neoplasms young-adult ages pro-
duce an advantage for females of 0.24 years while old ages advantage males
of 0.36 years. Thus, overall, neoplasms are not responsible for the gender
gap in lifespan variability but to the contrary, they actually behave oppo-
sitely since the total effect is of 0.12 in favor of males. This is in line with
what observed in Paragraph 5.1.2 and 5.1.3 about higher females neoplasms
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FIGURE 5.11: Contribution of differences in age and cause-
specific mortality rates between sexes to the difference in
S10 between sexes in Italy. 1980 (top panel) and 2013 (bot-
tom panel).
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Cause of Death Until 65 After 65 Total
All causes -2.74 1.15 -1.59
Infectious diseases -0.06 0.01 -0.05
Neoplasms -0.36 0.32 -0.04
Diseases of the blood -0.01 0.00 -0.01
Endocrine Nutritional and Metabolic -0.02 -0.02 -0.04
Mental disorders -0.06 0.01 -0.05
Diseases of the nervous system -0.06 0.02 -0.04
Diseases of the circulatory system -0.55 0.45 -0.10
Diseases of the respiratory system -0.07 0.19 0.12
Diseases of the digestive system -0.27 0.08 -0.19
Diseases of the skin 0.00 0.00 0.00
Diseases of the muskoloskeletal system 0.00 0.00 0.00
Diseases of the genetourinary system 0.00 0.05 0.05
Pregnancy and related conditions 0.00 0.00 0.00
Ill-defined causes -0.07 0.02 -0.15
External causes -1.21 0.02 -1.19
TABLE 5.4: Contribution of differences in ages and cause-
specific mortality rates between sexes to the difference in
S10 between sexes in Italy. 1980.
Cause of Death Until 74 After 74 Total
All causes -2.07 0.91 -1.16
Infectious diseases -0.08 0.01 -0.07
Neoplasms -0.24 0.36 0.12
Diseases of the blood 0.00 0.00 0.00
Endocrine Nutritional and Metabolic -0.06 0.01 -0.05
Mental disorders -0.02 -0.01 -0.03
Diseases of the nervous system -0.05 0.01 -0.04
Diseases of the circulatory system -0.53 0.27 -0.26
Diseases of the respiratory system -0.05 0.17 0.12
Diseases of the digestive system -0.11 0.02 -0.09
Diseases of the skin 0.00 0.00 0.00
Diseases of the muskoloskeletal system 0.00 0.00 0.00
Diseases of the genetourinary system -0.01 0.03 0.02
Pregnancy and related conditions 0.00 0.00 0.00
Ill-defined causes -0.10 0.00 -0.10
External causes -0.78 0.03 -0.75
TABLE 5.5: Contribution of differences in ages and cause-
specific mortality rates between sexes to the difference in
S10 between sexes in Italy. 1980.
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S10 trend, evidencing one more time how the neoplasms age-at-death dis-
tribution is more spread out among females than males. For diseases of the
circulatory system, instead, the young-adult ages contribution to the lifes-
pan variability gender gap (0.53) is higher than males advantage at old-ages
(0.27).
What really differentiates 1980 and 2013 is the role played by external
causes of death. In 2013, indeed, external causes’ contribution to the lifes-
pan variability males-females difference was equal to 0.75 years, a consid-
erable less amount than in 1980. Males are thus recovering their young-age
mortality disadvantage for this group of causes and this mostly explains
why the gender gap in S10 have been reduced over the time-period consid-
ered here (1.59 years in 1980 vs 1.16 years in 2013).
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Chapter 6
Old-age lifespan variability
and its relationship with the
age pattern of mortality change
In Chapter 5 the dispersion of deaths over a broad range of ages (10+) has
been examined. However, in the era of longevity extension, particular at-
tention has to be given to changes in the death distribution within old ages.
Thus, to tackle this issue, the current Chapter is entirely devoted to the in-
vestigation of variability in length of life at old ages.
Here, the standard deviation of ages at death above the mode, SD(M+),
is the indicator used to monitor the evolution of lifespan variability at old
ages. In particular, the study is carried out using a simplified version of
the logistic model - the Kannisto model - exploiting its well-known prop-
erty of linking the compression of deaths above the mode with the rate of
increase in mortality, i.e. the rate of aging. Moreover, to arrive to a deeper
understanding of lifespan variability at old ages, causes of death are taken
into consideration. Indeed, exploiting the cause-of-death decomposition of
the changes in lifespan variability above the modal age at death proposed
by Horiuchi and his colleagues (Horiuchi et al, 2012) new epidemiological
insights about the observed mortality compression will be given.
6.1 The steepening of the right-hand tail
In the last decades of the XXth century and the first decade of the XXIst
century a considerable decline in old-age mortality was registered in de-
veloped countries (Janssen, 2007; Kannisto, 1984; Staetsky, 2009). With re-
gard to Italy, in Paragraph 4.2.3, using the Rates Of Mortality Improvements
(ROMI), I have shown that death rates among the old have been decreas-
ing constantly from 1980 to nowadays in both sexes, with few exceptions
registered at extremely old ages.
Given that, a relevant question that demographers have to take into ac-
count is whether the remarkable improvements registered in old-age mor-
tality are associated with a steepening of the right-hand tail of the age-at-
death distribution or not. The importance of this question arises from the
consideration that, if deaths are becoming more and more compressed at
old ages, it may be an indication of increasing resistance to further longevity
extension, i.e. human’s beings lifespan is approaching a biological limit
(Horiuchi et al., 2012).
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To monitor the changes of the right-hand tail of the age-at-death distri-
bution, SD(M+) has been used firstly by Kannisto and then in various stud-
ies (Cheung et al., 2005, 2008, 2009; Cheung and Robine, 2007; Kannisto,
1984; Kannisto, 2000; Kannisto 2001; Ouellette and Barbeau, 2011; Robine
et al., 2006). These researches have demonstrated that compression of ages
at death above the mode is occurring in several developed countries even
though the pace of compression has been pretty slow.
A first evaluation of how the distribution of deaths above the modal
age at death is behaving can be simply done comparing its shape in two
different moments in time. Figure 6.1 helps visualizing such comparison. It
displays, for each sex separately, the shape of the right-hand tail of the age-
at-distribution in Italy for 1980 and in 2013. The comparison makes sense
because having age-M on the x-axis guarantees that both distributions have
the same starting point (age 0) and having dx/ dM on the y-axis guaran-
tees that both distributions have the same height (1) at that starting point.
What emerges from Figure 6.1 is that deaths above the mode have been
increasingly concentrated in a narrower age range over the considered pe-
riod 1980-2013. Although old-age compression is occurring in both sexes, it
is much more pronounced among males than females, i.e. the steepening of
the right-hand tail of the distribution is much more evident for males than
females.
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FIGURE 6.1: Distribution of deaths above the modal age at
death M for Italian males and females in 1980 and 2013.
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Even if quite useful, the information resulting from Figure 6.1 are nei-
ther able to precisely quantify the extent of the registered compression over
time nor the exact level of variability. An accurate assessment about the
dispersion of deaths above the mode can be only done computing SD(M+).
As already highlighted in Paragraph 2.1.2 and 3.2.6, Thatcher et al. have
demonstrated that, using the simplified logistic model with only two pa-
rameters (as known as the Kannisto model), it exists a relationship between
SD(M+) and the accelerating pace of age-related mortality increase, de-
noted by the parameter b in the model and measured by the logistic rate
of mortality rise. The exact relationship between SD(M+) and b is reported
by Equation 3.35 of Paragraph 3.2.6, and it holds that if mortality rises more
steeply with age (i.e. if the parameter b increases) then compression above
the mode will occur (SD(M+) will decrease). As a consequence, the param-
eter b itself can be used as a measure of the steepness of the right-hand tail
of the age-at-death distribution.
The appealing property of linking the rate of aging and mortality com-
pression combined with really good fit of the model at old ages for modern
populations, makes Kannisto model a suitable choice to investigate on the
evolution of lifespan variability of deaths above the mode. Thus, I adopted
the model to assess, quantificate and understand better the old-age com-
pression’s scenario previously revealed by Figure 6.1.
The model has been applied to males and females mortality rates be-
tween age 70 and 90 in the time interval from 1980 to 20131. Figure 6.2
displays the logit of mx (dots) and the estimated logit lines from the Kan-
nisto model for males and females in Italy for 1980 and 2013. First of all, it
can be clearly seen that the observed point, i.e. the logit of mx, look really
straight making the fit of the estimated logit lines almost perfect. This justi-
fies the application of the model, confirming the right choice of the logistic
equation to model mortality data at old ages. Secondly, it shows that as time
passes by death rates noticeably decreased at old ages and that the pattern
of mortality decline has not been proportional across ages. Indeed, the logit
lines in 1980 and 2013 do not have the same slope since death rates have
been fallen faster at age 70 than at age 90: the rate of aging, measured by
the parameter b of the model, has increased. Moreover, the increase in the
logit’s line slope has been more pronounced for males than females. This
basically confirms what was previously illustrated in Figure 6.1: from 1980
to 2013 compression above the mode has occurred, i.e. the right-hand tail
of the distribution has become steeper, and such compression results to be
more evident for males than for females.
Now, to precisely assess compression’s extent and gender differences it
is necessary to look at the trends in b parameter estimated from the Kan-
nisto model. The results are shown in Figure 6.3. Three essential features
emerge. Firstly, all over the considered period 1980-2013 females show
higher b’s values than males. This means that the rate of aging is higher
among females than males and as a consequence lifespan above the mode
are less unequal for females than males. Secondly, as expected, b’s values
have been growing up over time for both sexes: the rate of aging is increas-
ing and therefore compression above the modal age at death is occurring.
1For further methodological details on the model’s application see Paragraph 3.2.6.
106
Chapter 6. Old-age lifespan variability and its relationship with the age
pattern of mortality change
−4
−3
−2
−1
70 75 80 85 90
Age
lo
gi
t(m
x)
Males
−4
−3
−2
−1
70 75 80 85 90
Age
lo
gi
t(m
x)
Females
Estimated logit line 1980 Estimated logit line 2013 Logit of mx 1980 Logit of mx 2013
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in 1980 and 2013. Lines: estimated logit line for males and
females in Italy in 1980 and 2013 from the Kannisto model.
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FIGURE 6.3: Trends in the b parameter of the Kannisto
model for Italian males and females from 1980 to 2013.
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Thirdly, as expected again, b’s values increased more for males than fe-
males, confirming what was already clear from Figure 6.1 and 6.2. Precisely,
b’s values rose of 0.023 for males (from 0.105 in 1980 to 0.128 in 2013) and of
0.017 for females (from 0.127 in 1980 to 0.144 in 2013). Thus, if on one hand
lifespan variability above the mode is smaller among females, on the other
hand males are recovering their disadvantage.
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FIGURE 6.4: Standard deviation of ages at death above the
mode, SDM+, for Italian males and females from 1980 to
2013.
Even though b’s values are themselves a measure of compression above
the modal age at death, in practice it is hard to evaluate lifespan variability
extent only looking at them. To do that, it is better to monitor SD(M+)
trends since their unit of measurement is in years. Figure 6.4 illustrate
SD(M+) trends for Italian males and females from 1980 to 2013. The lines
represent the estimated SD(M+) values obtained by Kannisto model through
the application of formula 3.35. Dots, instead, represent the estimated SD(M+)
values obtained by non-parametric approach of p-slines (i.e. smoothed den-
sity) already extensively used in Chapter 5 where lifespan variability over
a wider age range was studied. SD(M+) estimated values do not differ a lot
between the two methodologies, confirming one more time the accuracy of
the simple logistic equation in modeling the data. In particular, SD(M+)
estimated values through smoothed densities appear to be systematically
lower than those estimated through the Kannisto model, but the differences
are, at most, in the order of few decimal of years. The results allow to as-
sess better what already emerged by looking at the trends of parameter b.
Females higher b’s values translate into smaller values of SD(M+) and the
greater increase of b among males in the considered time interval translate
into a reduction of males disadvantage as time passes by. Indeed, in 1980
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SD(M+) was equal to 7.82 years for males and to 6.67 years for females, a
difference of 1.15 years, while in 2013 the gender gap was reduced to 0.62
years with males having a SD(M+) of 6.61 years and females of 5.99 years.
6.2 Epidemiological assessment of the compression of
deaths above the mode
Until this moment, old-age lifespan variability investigation has relied on
all-cause mortality data. Now, to find an epidemiological interpretation
of the observed old-age mortality compression, causes of death are taken
into consideration. In particular, the following sections have two aims: a)
Understand which types of causes are significantly contributing to old-age
mortality compression b) Understand in what manners such causes are con-
tributing to old-age mortality compression.
6.2.1 Level and slope effect hypothesis
All-cause SD(M+) is declining as a consequence of the rise in the rate of
aging which is measured by the b parameter in the Kannisto model. What
are the effects of cause-specific mortality on the steepening of deaths above
the mode? To answer this question, one must firstly consider that causes
of death differ considerably in the rate of aging. Such differentiation in the
pace of mortality increase with age has been shown in some studies in the
past (Horiuchi 2006; Horiuchi and Wilmoth 1997; Horiuchi et al. 2003; Ho-
riuchi et al. 2012). In particular, causes of death such as congestive heart
failure, infarctive stroke, pneumonia, influenza, septicemia, renal failure,
accidental falls and ingestion accidents have reported elevated values in
the rate of aging being highly related with senescent processes. On the
other hand, the rate of aging seems to be much more modest in causes
such as neoplasms, multiple sclerosis, acute myocardial infarction, hem-
orrhagic stroke, emphysema, and liver cirrhosis which are instead highly
associated with some risk factors and tend to develop selectively and pre-
maturely (Horiuchi et al., 2012).
Based on this consideration, Horiuchi and his collaborators have hy-
pothesized two possible reasons for the observed old-age mortality com-
pression, i.e. two possible reasons for the increase of the all-cause b param-
eter:
• Cause-specific death rates decrease proportionally at old ages, but the
decrease in death rates for causes of death reporting high b values is
more moderate than the decrease in death rates for causes of death
reporting low b values. If so, at old ages, the proportion of deaths due
to high b causes of death will increase. This will result into a rise of
all-cause b even though cause-specific b remains constant.
• Cause-specific b is rising for both high b and low b causes of death, i.e.
cause-specific death rates don’t decrease proportionally. Of course
this will result into a rise of all-cause b.
In order to visualize these two mechanisms, they are reported in Figure
6.5. The first it is named level effect hypothesis since it focuses on differ-
ential levels of decrease of cause-specific death rates. An explanation for
6.2. Epidemiological assessment of the compression of deaths above the
mode
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this conjecture is that it could be difficult to slow down senescence and
thus mortality of high b causes may decrease slower than mortality of low b
causes. The second it is named slope effect hypothesis since it focuses on the
increase of death rates with age which is measured by the logit-mortality
slope.
In order to test these hypothesis, the changes over time of the b param-
eter of Kannisto model needs to be distinguished into cause-specific level
and slope effect. As seen in Paragraph 3.2.6, the parameter b is estimated
using the formula:
b =
logit(m(90))− logit(m(70))
90− 70 (6.1)
Taking causes of death into consideration equation 6.1 can be rewritten
as follow:
b =
logit
∑
i(mi(90))− logit
∑
i(mi(70))
90− 70 (6.2)
Where mi is the death rate of cause i.
Now, to separate the effects of changes in the level of cause-specific mor-
tality and effects of changes in the slope of cause-specific mortality, equa-
tion 6.2 must be expressed in terms of the sum and difference of cause-
specific death rates for the two considered ages:
si = logit(mi(90)) + logit(mi(70)) (6.3)
di = logit(mi(90))− logit(mi(70)) (6.4)
Indeed, since si/2 is the mean logit of death rates of cause i in the age
range, si can be regarded as a measure of cause-specific mortality level in
the age range; and since di/(90−70) is the logistic rate of mortality increase
of cause i in the age range, di can be regarded as a measure of cause-specific
rate of mortality increase. Equation 6.2 can be rewritten as:
b =
logit
∑
i
e(si+di)/2
1+e(si+di)/2
− logit∑i e(si−di)/21+e(si−di)/2
90− 70 (6.5)
So, b is a function of si and di:
b = f(s1, ..., si, ..., sn, d1, ..., di, ..., dn) (6.6)
and the changes in b over time, using the concept of line integral (Hori-
uchi et al., 2008), can be decomposed as:
b(2013)− b(1980) =
∫ 2013
1980
δb
δs1
δs1
δt
+ ...+
∫ 2013
1980
δb
δsi
δsi
δt
+ ...+
∫ 2013
1980
δb
δsn
δsn
δt
+
+
∫ 2013
1980
δb
δd1
δd1
δt
+ ...+
∫ 2013
1980
δb
δdi
δdi
δt
+ ...+
∫ 2013
1980
δb
δdn
δdn
δt
(6.7)
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If the level effect hypothesis holds, the changes in b will be mainly
attributable to
∫ 2013
1980
δb
δsi
δsi
δt while if the slope effect hypothesis holds, the
changes in b will be mainly attributable to
∫ 2013
1980
δb
δdi
δdi
δt . It has to be men-
tioned that the level and slope mechanisms can operate simultaneously, so
the aim is to figure out which of the two prevails and to which extent.
6.2.2 Cause-specific rate of aging
Before presenting decomposition’s results of changes in b over time, it is
worth looking at cause-specific b’s values and their evolution over time to
assess how much causes of death differ with respect to the rate of aging
and start understanding which of the two hypothesis seems to be more
reasonable.
Cause-specific b’s values are reported in Table 6.1, 6.2, 6.3, and 6.4. Table
6.1 and 6.2 show males’ results in 1980 and 2013 respectively while Table 6.3
and 6.4 show females’ results in 1980 and 2013 respectively. Inside tables,
causes of death are ranked according to their rate of aging.
As expected, the rate of increase in mortality with age greatly varies
from cause to cause and the results are rather coherent with previous stud-
ies. Of course, since all-cause b is higher for females than males, also cause-
specific b are generally higher among females. From 1980 to 2013 b rose for
all causes, a first clue suggesting that the level effect hypothesis is a wrong
prediction. In either both sexes or period ill-defined causes are, by far, the
one reporting the highest b. This particular group of causes gathers to-
gether all deaths for which a specific underlying cause was not found. This
situation is usually typical of extremely old ages whereas death is due to
several factors and no specific cause can be reported as underlying. It is not
surprising, thus, that ill-defined causes have the highest rate of mortality
increase with age since older is the age at death higher is the probability for
a given death to be recorded as ill-defined. At the bottom of the ranking, in-
stead, there are neoplasms. Their b’s values are extremely lower than those
of other causes even though a significant rise was registered as time passes
by: from 0.036 in 1980 to 0.064 in 2013 for males and from 0.042 in 1980 to
0.058 in 2013 for females. Also in this case the outcome is not surprising. As
it was shown in Paragraph 5.1.2 neoplasms are the cause of death reporting
the smaller modal age at death a signal that this group of diseases are not
highly associated with senescence process but rather related to some spe-
cific risk factors indipendent from age. Another important group of causes
showing low b’s values in both sexes are diseases of the digestive system,
although, as for neoplasms, their rate of aging increased noticeably along
the considered time interval: from 0.040 in 1980 to 0.100 in 2013 for males
and from 0.065 in 1980 to 0.119 in 2013 for females. Particularly interesting
is the tremendous growth of b for mental disorders in both sexes, a result in
line with what found in Paragraph 4.2.3 (a considerable growth of mortal-
ity rates at old ages) and 5.1.2 (a considerable growth of the modal age at
death). Finally, as expected, diseases of the circulatory and respiratory sys-
tem display a quite high rate of aging being strongly related with senescent
processes.
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Cause of death b
1 Ill-defined causes 0.203
2 Diseases of the skin 0.122
3 Diseases of the genetourinary system 0.114
4 Diseases of the circulatory system 0.112
5 Diseases of the respiratory system 0.104
6 External causes 0.092
7 Mental and behavioural disorders 0.084
8 Diseases of the muskoloskeletal system 0.082
9 Congenital malformations 0.073
10 Diseases of the blood 0.070
11 Infectious diseases 0.068
12 Diseases of the nervous system 0.061
13 Endocrine Nutritional and Metabolic diseases 0.048
14 Diseases of the digestive system 0.040
15 Neoplasms 0.036
TABLE 6.1: Cause-specific b for Italian males in 1980.
Cause of death b
1 Ill-defined causes 0.193
2 Mental and behavioural disorders 0.185
3 Diseases of the skin 0.167
4 Diseases of the genetourinary system 0.158
5 Diseases of the respiratory system 0.155
6 Diseases of the circulatory system 0.151
7 Diseases of the blood 0.141
8 External causes 0.128
9 Diseases of the muskoloskeletal system 0.127
10 Endocrine Nutritional and Metabolic diseases 0.112
11 Diseases of the nervous system 0.110
12 Infectious diseases 0.100
13 Diseases of the digestive system 0.100
14 Congenital malformations 0.070
15 Neoplasms 0.064
TABLE 6.2: Cause-specific b for Italian males in 2013.
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Cause of death b
1 Ill-defined causes 0.219
2 Diseases of the respiratory system 0.139
3 Diseases of the skin 0.135
4 Diseases of the circulatory system 0.133
5 External causes 0.126
6 Mental and behavioural disorders 0.103
7 Infectious diseases 0.101
8 Diseases of the nervous system 0.088
9 Diseases of the blood 0.081
10 Diseases of the genetourinary system 0.078
11 Congenital malformations 0.074
12 Diseases of the muskoloskeletal system 0.071
13 Diseases of the digestive system 0.065
14 Endocrine Nutritional and Metabolic diseases 0.047
15 Neoplasms 0.042
TABLE 6.3: Cause-specific b for Italian females in 1980.
Cause of death b
1 Ill-defined causes 0.217
2 Mental and behavioural disorders 0.216
3 Diseases of the skin 0.190
4 Diseases of the circulatory system 0.177
5 Diseases of the genetourinary system 0.161
6 Diseases of the respiratory system 0.157
7 External causes 0.156
8 Diseases of the blood 0.156
9 Diseases of the nervous system 0.129
10 Endocrine Nutritional and Metabolic diseases 0.127
11 Diseases of the digestive system 0.119
12 Diseases of the muskoloskeletal system 0.116
13 Infectious diseases 0.115
14 Congenital malformations 0.061
15 Neoplasms 0.058
TABLE 6.4: Cause-specific b for Italian females in 2013.
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FIGURE 6.6: Top panel: relationship between cause-specific
b in 1980 and change in b from 1980 to 2013 for Italian males
and females. Bottom panel: relationship between cause-
specific b and change in the mean logit death rate for ages
70 and 90 from 1980 to 2013 for Italian males and females.
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Now, in order to have a better understanding of decomposition’s result
of changes in b that will be presented in next section, Figure 6.6 shows, in
the top panel, the relationship between cause-specific b in 1980 and change
in cause-specific b from 1980 to 2013 for males and females and, in the
bottom panel, the relationship between cause-specific b and change in the
mean logit death rate for ages 70 and 90 from 1980 to 2013 for males and
females in the bottom panel.
In the case of the relationship between cause-specific b in 1980 and change
in cause-specific b from 1980 to 2013, if the level effect hypothesis was cor-
rect, the changes in b over time should be close to 0 or anyway moderate,
while in the case the relationship between cause-specific b and change in
the mean logit death rate, if the level effect hypothesis was correct, there
should appear a positive correlation in the scatterplot, i.e. the logit death
rates for causes of death with higher b in 1980 must decrease less between
1980 and 2013 than those for causes of death with lower b in 1980. In both
cases, the above described situations don’t show up. In fact, the rate of
aging increased considerably for almost any cause regardless of its value
in 1980 and there is no positive correlation between changes in logit death
rates and cause-specific b in 1980, on the contrary it seems that exactly the
causes of death reporting highest rate of aging are those experiencing the
major mortality improvements, a clear hint of the failure of the level effect
hypothesis.
6.2.3 Cause-of-death decomposition of the rise in the rate of aging
As seen in Paragraph 6.1, estimated all-cause b increased from 0.105 in 1980
to 0.128 in 2013 for males and from 0.127 in 1980 to 0.144 in 2013 for fe-
males. In this section, in order to understand which type of causes are re-
sponsible for the observed compression of deaths above the mode and in
what manner, the increment of 0.023 for males and of 0.017 for females has
been decomposed into seventeen cause-specific level effects and seventeen
cause-specific slope effects. The cause-of-death decomposition results con-
firm what found in the previous section, that is the failure of the level effect
hypothesis in favor of the slope effect hypothesis.
The outcomes, multiplied by 1000 in order to be more readable, are
shown in Table 6.5 (males) and 6.6 (females). In both sexes, the total level
effect has negative sign (-24.337 for males and -24.578 for females), mean-
ing that, overall, the levels of mortality of causes of death reporting high b
values declined more than those of causes reporting low b values, having
as a consequence the effect of lowering all-cause b. The level effect is can-
celed and overtaken by the total slope effect (47.303 for males and 41.894
for females) which actually led to to the registered rise in the rate of aging.
For males, causes of death with the strongest slope effect are diseases
of the circulatory system and neoplasms, whose preeminence is, obviously,
partially due to their considerable proportion of deaths at old ages which
enable them to have a greater impact than other causes of death. Notice-
able is also the slope effects of endocrine, nutritional and metabolic dis-
eases, diseases of the respiratory system, diseases of the digestive system
and external causes of death. Females show similar results. Diseases of the
circulatory system are abundantly the cause with the strongest slope effect,
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Cause of death Level effect Slope effect Total effect
Infectious diseases -0.023 0.425 0.401
Neoplasms -0.902 11.114 10.211
Diseases of the blood 0.006 0.216 0.222
Endocrine Nutritional and Metabolic diseases -0.035 2.192 2.157
Mental and behavioural disorders 0.633 1.262 1.896
Diseases of the nervous system -0.024 1.218 1.194
Diseases of the circulatory system -13.077 19.832 6.755
Diseases of the respiratory system -3.236 6.019 2.783
Diseases of the digestive system 0.710 2.741 3.451
Diseases of the skin -0.008 0.062 0.053
Diseases of the muskoloskeletal system -0.009 0.149 0.140
Diseases of the genetourinary system -0.718 1.270 0.552
Congenital malformations 0.010 -0.003 0.007
Ill-defined causes -7.281 -0.504 -7.786
External causes -0.383 1.307 0.924
Total -24.337 47.303 22.966
TABLE 6.5: Cause-of-death decomposition of change in the
logistic rate of aging (x1000) between age 70 and 90 from
1980 to 2013. Males
Cause of death Level effect Slope effect Total effect
Infectious diseases -0.047 0.188 0.141
Neoplasms 0.075 4.777 4.852
Diseases of the blood 0.012 0.291 0.303
Endocrine Nutritional and Metabolic diseases 0.308 3.880 4.188
Mental and behavioural disorders 1.183 1.746 2.929
Diseases of the nervous system -0.045 1.159 1.114
Diseases of the circulatory system -16.314 23.265 6.951
Diseases of the respiratory system -2.080 1.685 -0.394
Diseases of the digestive system 0.442 2.249 2.691
Diseases of the skin -0.021 0.109 0.088
Diseases of the muskoloskeletal system -0.039 0.251 0.212
Diseases of the genetourinary system -0.010 1.439 1.429
Congenital malformations 0.021 -0.046 -0.025
Ill-defined causes -7.400 -0.145 -7.544
External causes -0.665 1.044 0.379
Total -24.578 41.894 17.316
TABLE 6.6: Cause-of-death decomposition of change in the
logistic rate of aging (x1000) between age 70 and 90 from
1980 to 2013. Females
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followed by neoplasms, endocrine nutritional and metabolic diseases, dis-
eases of the digestive system, mental and behavioral disorders and diseases
of the respiratory system. It is worth nothing, however, the reduced impact
of neoplasms and diseases of the respiratory system with respect to the one
of males. These results are in line with what previously found analyzing
cause-specific increase in b over time. The increase in the rate of aging for
neoplasms and diseases of the respiratory system from 1980 to 2013, indeed,
has been much more remarkable among males than females (see Table 6.1,
6.2, 6.3 and 6.4).
Overall, cause-of-death decomposition’s outcome presented in this sec-
tion are pretty similar with what found by Horiuchi and his colleagues who
decomposed the increase in the logistic rate of aging from 1979 to 1994 for
French males and females (Horiuchi et al., 2012). Also in that case the re-
sults gave strong support to the slope effect hypothesis while the level effect
appeared to act in the opposite direction, i.e. lowering all-cause b. The im-
plications of such results are not fully clear, since they can be read in two
different ways. On one hand, indeed, the results claim that all-cause b in-
creased over time because cause-specific b increased as well. The increase
in cause-specific b was observed for all types of causes of death either with
high or average or low b values. It means that the logit death rate of all the
considered causes has decreased more at old ages (70 in this case) than at
older old ages (90 in this case). This result suggests that the observed old-
age mortality compression may be an indication of an increasing resistance
to further longevity extension. On the other hand, however, it also appears
that the old-age mortality decline of causes of death with high b values, i.e.
those causes which are considered to be more senescence related and so
less preventable, is stronger than the decline registered for causes of death
with medium or low b values. This finding advocates a positive prospect
for further reduction of senescent mortality and consequently for further
longevity extension.
6.3 Further considerations on longevity extension
A comprehensive analysis of whether humans lifespan is approaching or
not a biological limit goes beyond the purpose of my dissertation. However,
in the light of what found in the previous section, I would like to clarify
some points about this issue.
Table 6.7 shows average death rate registered in twenty developed coun-
tries in 1950, 1980 and 2014 at ages above 95 and their rate of change from
1950 to 1980 and from 1980 to 2014. The countries included in the analysis
are all those of the HMD which have available deaths count data from 1950
to 2014 2. Merging data from various countries gives a global understand-
ing of mortality changes at extremely old ages and thus of how populations
are aging.
As before, the outcomes highlight a situation that can be read in two
ways. On one hand, the rate of mortality decrease slows down with age,
i.e. the rate of aging is increasing. Undoubtedly, human mortality is finding
2The countries are: Australia, Austria, Belgium, Czech Republic, Denmark, England and
Wales, Finland, France, Hungary, Ireland, Italy, Japan, Netherlands, Norway, Portugal, Slo-
vakia, Spain, Sweden, Switzerland and USA.
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pattern of mortality change
Age mx 1950 mx 1980 mx 2014 % change 1950-1980 % change 1980-2014
95 0.399 0.351 0.270 -11.92 -23.12
96 0.425 0.378 0.298 -10.98 -21.05
97 0.451 0.405 0.328 -10.02 -18.99
98 0.477 0.433 0.360 -9.07 -16.96
99 0.503 0.461 0.393 -8.13 -14.97
100 0.529 0.490 0.427 -7.22 -13.04
101 0.554 0.519 0.461 -6.33 -11.21
102 0.580 0.548 0.496 -5.48 -9.47
103 0.605 0.576 0.531 -4.67 -7.84
104 0.629 0.604 0.566 -3.92 -6.33
105 0.653 0.632 0.601 -3.21 -4.97
106 0.676 0.658 0.634 -2.55 -3.73
107 0.698 0.684 0.666 -1.94 -2.63
108 0.719 0.709 0.697 -1.40 -1.68
109 0.739 0.732 0.726 -0.91 -0.86
110+ 0.758 0.755 0.753 -0.47 -0.26
TABLE 6.7: Average death rates of twenty countries of the
HDM at ages 95+ in 1950, 1980 and 2014 and their rate of
change over time.
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FIGURE 6.7: Number of deaths above age 100 in twenty
countries of the HMD.
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a kind of resistance or however a new barrier to tear down. On the other
hand, even at extremely old ages, until at least age 100, the reduction of
death rates in the last decades has been impressive. Moreover, the reduction
was stronger from 1980 to 2013 than to 1950 to 1980 endorsing the reasoning
that noticeable improvements against senescence keep going on.
Such great decline reflects into the emergence of centenerians and su-
percentenarians as shown in Figure 6.7. Thanks to remarkable old-age mor-
tality decline, the cumulative number of people died at age 100 or more in
the twenty countries is exponentially increasing from 1950 to 2014. Until
the 1970s the number of centenarians was small and the number of super-
centenarians nonexistent. Nowadays over those twenty countries, more
than 30’000 deaths occur at age 100, 5’000 at age 105 and about 250 above
age 110. In slightly more than 60 years longevity has been extended enor-
mously.
At the state of the knowledge, it seems that evidences are mixed. Progress
against senescence are remarkable but it is also undeniable that improve-
ments are facing some kind of resistence with age. The number of super-
centenarians is still too low and the variability of death rates above age
110 consequently too high. Thus, surely, to comprehend if further exten-
sions are feasible it is going to be important to better assess how death rates
above age 110 will behave and if new barriers may be overcome.
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Conclusion
The originality and innovation of my thesis does not lie into the methods
used to carry out my analysis but into the analysis itself through which I
obtained results that highlight new findings in a research field still scarcely
explored. Indeed, while the study of variability in human longevity has
a quite long tradition, the epidemiological understanding of the observed
reduction in the uncertainty about the timing of death has not been pointed
out yet. Only a few studies, in recent years, have started to tackle this issue
analyzing the impact of the various causes of death on changes in lifespan
variability.
In particular, the main purpose of my research was threefold. First, I
aimed to revisit cause-specific mortality in Italy in the last decades in the
light of reconstruction of coherent cause-of-death time series. Second, I
aimed to point out the great existing difference between causes of death
in terms of lifespan variability and I sought to explain, from a cause-of-
death perspective, why variability in length of life in Italy is declining and
what are the determinants of females advantage. Third, focusing the atten-
tion on old ages, I tried to understand the role played by causes of death
on the steepening of the right-hand tail of the age-at-death distribution and
if the observed compression of deaths above the mode may be a sign of a
biological limit to human lifespan.
In this chapter I summarize my results and their implications, I outline
the limitations of my analysis and describe avenues for further research.
7.1 Revisiting cause-specific mortality in Italy
The biggest problem in studying long-term series of cause-specific mortal-
ity it is represented by continuous revisitation of the classification of dis-
eases due to the greater and greater knowledge in the field of medicine.
From a purely statistical point of view, this means that a correct analysis
of cause-specific mortality strictly depends on the reconstruction of coher-
ent time series. Thus, in order to get an epidemiological understanding of
mortality compression in Italy over the last decades, the first issue I had
to face was to eliminate the statistical disruption in the cause-of-death se-
ries brought by the introduction of ICD-10 in 2003. Once solved this prob-
lem thanks to bridge-coding data provided by ISTAT, thus having in hands
coherent data for the 1980-2013 time interval, I exploited reconstruction’s
results not only to study trends in lifespan variability but also to revisit
cause-specific mortality in Italy.
First of all, using the modal age at death, M, as a longevity indicator, I
demonstrated that lifespan is lengthening for all types of causes of death
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here considered. Any cause-specific modal age at death, indeed, increased
remarkably from 1980 to 2013 in either males or females and, moreover,
that rise occurred at a similar pace among most causes of death. The anal-
ysis also highlights a noticeable diversity in terms of longevity extension
between causes of death. In both sexes neoplasms resulted to be the cause
with lower M and ill-defined causes the cause with higher M. The finding
that neoplasms’ age-at-death distribution reaches its peak earlier than any
other is particularly intriguing and demonstrates how cancer is not a dis-
ease typical of extremely old ages tending to affect people sooner than other
causes of death.
The considerable extension of longevity registered for any cause of death
is the consequence of the constant decline of cause-specific mortality as re-
vealed by the computation of Rates Of Mortality Improvements (ROMI)
in Paragraph 4.2.3. Death rates decrease over time has been particularly
strong at young and adult ages for all causes of death. At old and extremely
old ages, although mortality declined noticeably as well, the pace of the re-
duction was generally slower and, furthermore, it did not regard all causes
of death. Indeed, diseases like neoplasms, mental disorders, ENM diseases,
diseases of the nervous system and infectious diseases has shown an in-
crease in death rates at old and very old ages in time-period of my analysis.
This demonstrates that not all causes of death are following the same age
pattern of mortality change.
Diseases of the circulatory system are still the major cause of death even
though the percentage of deaths attributable to them has been lowered ei-
ther for males or females as a consequence of a strong reduction of their
death rates at any age and in any time-period from 1980 to 2013. This situ-
ation perfectly fits the fourth stage of the health transition theory proposed
by Frenk (Frenk, 1991). Computing ROMI, however, it also emerged, in the
last few years, a slow down in the pace of mortality reduction for circula-
tory system related deaths at adult ages. In Paragraph 4.2.3 I hypothesize
that such deceleration may be a sign of the economic crisis impact on health
since the worsening in the economic conditions could have lead the lower
class people to reduce prevention which, as well-known, plays a funda-
mental role in avoiding some types of circulatory diseases. A deceleration
in the pace of mortality improvements at adult ages from the late 2000s, or
even an increase in death rates at those ages, it is also registered for dis-
eases of the nervous and respiratory system, external causes of death and
infectious diseases. Even in this cases the reason could lie in the impact of
the recent economic crisis on health. However, this is just a speculation and
more years and more data are needed to evaluate better how the economic
crisis is influencing the health status of the Italian population.
The considerable lowering in the percentage of deaths attributable to
diseases of the circulatory system is leaving space to the emergence of oth-
ers causes of death. In particular, degenerative related diseases like neo-
plasms, mental disorders, ENM diseases, diseases of the nervous system
and infectious diseases are nowadays responsible for a greater proportion
of deaths than few decades ago. The emergence of such causes of death has
not been necessarily accompanied by a general worsening in their death
rates. Overall, indeed, significant reduction of mortality rates have been
registered for these causes of death in the time interval here considered.
Such reductions, however, as mentioned above, are principally reported at
7.2. Variability in human longevity and causes of death 123
young and adult ages while old and very old ages are actually experienc-
ing an increase in death rates. This is particularly true for diseases of the
nervous system and mental disorders. Computing ROMIs for these causes,
in fact, revealed, a long and often really noticeable (greater than 3%) rise
in their death rates, in both sexes, for ages above 70. Thus, if on one hand
young and adult ages improvements have lead to an extension of longevity
also for these causes of death highly related with degenerative processes
(as highlighted by the increase of their modal age at death) it is also true
that a considerable rise in their old-ages death rates is registered, likely as
a consequence of the population aging.
Among the above-analyzed diseases related with the degenerative pro-
cess, neoplasms certainly represent the most important cause of death. As
for the other, neoplasms overall burden on Italian mortality is increasing
and their pattern of mortality change shows a reduction of death rates
at young and adult ages (although that reduction has not been very pro-
nounced, usually between 1% and 3%) while an increase at old and ex-
tremely old ages which stopped in the middle 1990s for females and middle
2000s for males. Such age pattern of mortality change seems to suggest that,
thanks to improvements in medical knowledge and therapies, we are now
able to postpone neoplasms related deaths although not to really reduce
them.
7.2 Variability in human longevity and causes of death
Monitoring trends in lifespan variability is important for several factors.
First of all, as every measure of variability, it implies a form of inequality.
Measures of variability in length of life, indeed, can be recast as measures
of inequality in the length of life: the time we live is not the same for every-
body and that can be surely regarded as one of the most important forms of
inequality for humans. Thus, the observed reduction of lifespan inequality
(i.e. reduction of the variability of the age-at-death distribution) in devel-
oped countries is advantageous because it leads to a greater certainty in
timing of death and also to a more fair distribution of deaths. Moreover, as
widely highlighted in Paragraph 2.1.5 the compression of deaths in a nar-
rower age range has many implications on other areas of human life besides
death such as psychology, demography, economy and biology.
Despite the importance of studying the evolution of variability in length
of life is nowadays largely recognized, there is still a conspicuous lack of un-
derstanding the epidemiological reasons behind the reduction of the uncer-
tainty in timing of death. Exploiting data on causes of death in Italy from
1980 to 2013 my dissertation had the aim to fill this lack and get a better
comprehension of the observed changes in lifespan variability. In particu-
lar, my study of variability in length of life using a cause-of-death approach
have focused its attention on two distinct features of this phenomenon: the
dispersion of deaths over the entire range of adult ages (measured by the
standard deviation of ages at death above age 10, S10) and the dispersion
of deaths within old ages (measured by the standard deviation of ages at
death above the mode, SD(M+)). In this paragraph I draw my conclusion
with regard to the first feature while in the next paragraph with regard to
the latter feature.
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During the analyzed period, S10 considerably decreased for both sexes,
highlighting how mortality compression is still ongoing and the hypothesis
of shifting mortality not yet reasonable for Italy. Although females are cur-
rently enjoying a greater certainty in the timing of death than males, their
advantage has been reduced from 1.59 years in 1980 to 1.16 years in 2013 as
a result of a faster pace of compression among males (-1.45 years from 1980
to 2013) than females (-1.02 years from 1980 to 2013).
I began the epidemiological understanding of such scenario computing
cause-specific S10 values for each sex. To my knowledge this is the first
study to do that, thus allowing for the first time to assess differences be-
tween causes of death in terms of lifespan variability. The results demon-
strate that cause-specific S10 considerably differ each other, i.e. there is a
great diversity between causes of death in the way in which they distribute
deaths over ages. External causes and congenital malformations results
to be the group of causes with the highest lifespan variability while dis-
eases of the respiratory and circulatory system the group of causes with the
lowest lifespan variability. The difference between these two extremes is
huge, about 11 years on average. With regard to gender differences, the re-
sults demonstrated that, in line with all-cause’s outcome, even at the cause-
specific level duration of life is less variable among females than males. The
only two exceptions concern congenital malformations and neoplasms. The
fact that neoplasms’ S10 results to be higher among females than males is
surely one of the most surprising and interesting findings of my disser-
tation. Performing a deeper analysis at the cause-of-death level 1 I also
demonstrated that the gap in favour of males does not originate from a
specific neoplasm, as for instance neoplasm of breast, but it is attributable
to all types of cancer. In fact, lifespan variability has resulted to be higher
among females for all the 21 different typologies of neoplasms for which S10
was computed. This outcome proves that cancers tends to generally affect
females much more unequally than males. Another intriguing finding re-
vealed by the computation of cause-specific S10 is that while the reduction
of variability of age at death is occurring for the great majority of causes
(12 out of 15) the pace of the compression differs considerably between
causes. Minor causes of death such as infectious diseases, diseases of the
blood, mental disorders, diseases of the nervous system and diseases of the
muskoloskeletal system are those showing the greater reduction of lifespan
variability while in the case of diseases of the circulatory system and neo-
plasms, which are the two major causes of death, it seems that mortality
compression might be arrived at the end, since they are actually showing a
very slow decline in variability of age at death.
My epidemiological understanding of S10 trends continued seeking the
reasons behind 1) the observed compression of mortality registered from
1980 to 2013 by either males and females and 2) the variability gender gap
in favor of females. In order to get insight on these issues, I exploited de-
composition techniques that allowed me to figure out which causes and
which ages are responsible for the lowering of S10 over time and which
causes and which ages are responsible for the females advantage in terms
of S10.
1Performed only for the ICD-10 time interval (2003-2013), since the reconstruction of
coherent time series was carried out exclusively for the whole group of neoplasms
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Regarding the first issue, two patterns has to be distinguished, the age
pattern and the cause-of-death pattern. From the point of view of the age
pattern, the decomposition revealed that, in both sexes, changes in S10
over time are shaped by two contrasting forces. On one hand, mortal-
ity improvements registered from 1980 to 2013 before the threshold age
T10 acted lowering lifespan variability, while mortality improvements reg-
istered from 1980 to 2013 after the threshold age T10 acted incrementing
lifespan variability. Overall, mortality compression is occurring because
the contributions before the cross-over age (-3.25 years for males and -2.54
years for females) are bigger than the contributions after the cross-over age
(1.80 years for males and 1.52 years for females). This means that, as time
passes by, either males or females age-at-death distribution show a greater
dispersion of deaths at old ages which, however, it is overtaken by the com-
pression of mortality occurred at young and adult ages. With regard to
the cause-of-death pattern, the decomposition demonstrates that changes
in S10 over time are mainly driven by 3 causes of death: neoplasms, dis-
eases of the circulatory system and external causes. In particular, the de-
cline in external causes mortality, especially between age 10-30, accounts
for a wide proportion (73% for males and 49% for females) of the com-
pression of mortality occurred in Italy from 1980 to 2013. In other words,
the observed decline in lifespan variability is largely due to a reduction of
transport accident related deaths among the youngs. Also neoplasms play
an important role in lowering either males or females S10. As seen com-
puting ROMIs, major improvements in neoplasms mortality are registered
at young and adult ages while at old ages neoplasms death rates increased
until the 1990s to then start to moderately declining. Such age pattern of
mortality change explains the significant contribution of neoplasms in low-
ering S10 before the threshold age and the small contribution of neoplasms
in incrementing S10 after the threshold age. Diseases of the circulatory sys-
tem, instead, produced for both sexes, an increase of the variability in the
length of life in the period 1980-2013. This is due to the dramatic decrease of
circulatory diseases death rates at old ages which have lead to a remarkable
greater dispersion of the age-at-distribution in his latter part.
Regarding to the second issue, also here the age pattern and the cause-
of-death pattern has to be distinguished. For what concern the age pattern,
it looks like the one of the decompositions over time of S10. In this case, fe-
males mortality advantage before the cross-over age produced the gender
gap in their favor while females mortality advantage after the cross-over
age allowed males to make it smaller. Thus, the gender gap exists because
the contributions before T10 (-2.74 years in 1980 and -2.07 years in 2013) are
bigger than the contributions after T10 (1.15 years in 1980 and 0.91 years in
2013), although the difference has been reduced from 1980 to 2013. This
means that females age-at-death distribution, with respect to males age-
at-death distribution, results to be more compressed at young and adult
ages but also more dispersed at old ages. With regard to the cause-of-death
pattern, the decomposition revealed that the gender gap in S10 is basically
produced by external causes while the contribution of chronic and degen-
erative diseases, in most cases, almost balance out on either side of the
threshold age. This outcome demonstrates that the reason why females
are actually enjoying a greater certainty in the timing of death than males
fundamentally lies in their less risky behavior during their youth years.
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7.3 The compression of deaths above the mode and its
theoretical implications
There are many different ways of analyzing trends in lifespan variability.
Looking at how the distribution of ages at death is changing as whole, as
I did in Chapter 5, is surely important because it allows understanding if,
overall, inequality in the length of life has been reduced or not. However,
in developed countries an higher and higher proportion of deaths is nowa-
days occurring at advanced ages and thus the study of variation in lifespan
among survivors to older ages has become increasingly important and in-
teresting. I investigated on time trends in old-age lifespan variability in the
last substantive Chapter of my dissertation, Chapter 6, where using SD(M+)
I examined the changes over time of the right-hand tail of the age-at-death
distribution. As advocated by some scholars (Kannisto, 2001; Thatcher et
al., 2010), looking at trends in SD(M+) not only allow to figure out if vari-
ability of deaths above the modal age is increasing or declining but also to
get insights on a fascinating question: is there a limit to human lifespan?
Indeed, since the reduction of lifespan variability above the mode is associ-
ated with an increase in the rate of aging, observing compression of deaths
above the mode could be a sign of increasing resistance to further improve-
ments against senescence, and thus to further longevity extension, meaning
that human lifespan is approaching a biological limit. Although the ma-
jor goal of the analysis conducted in Chapter 6 was to monitor changes in
SD(M+) from 1980 to 2013 and to figure out which types causes of death and
in what manners are determining those changes, the theoretical implica-
tions behind the evolution over time of SD(M+) also permitted me to draw
some conclusions about the open question regarding the pre-determined
biological limit to human lifespan.
The debate over whether there is or not a boundary to how long people
can live has a long tradition and came to the fore again very recently. In
2016 Dong and his collaborators, showed that gains in survival appear to
decline after age 100, and that the age at death of the world’s oldest person
(the French woman Jeanne Calment who died at 122) has not augmented
since 1997 (Dong et al., 2016). Based on this results, the authors stated that
human length of life is likely subject to natural constraints, with a maxi-
mum fixed around age 115. In response to Dong’s article five groups of
researchers have published, in 2017, a series of rebuttals (Brown et al, 2017;
de Beer et al., 2017; Hughes and Hekimi, 2017; Lenart and Vaupel, 2017;
Rozing et al., 2017). According to the authors of these rebuttals, the data
are actually consistent with many different patterns and thus with many
different lifespan trajectories, including either a later plateau for maximum
lifespan or no plateau at all. Other criticism arose because Dongs and his
colleagues included in their analysis only the oldest to die in any year which
produced a small sample of deaths and thus a lot of randomnesses.
My results prove that, from 1980 to 2013, SD(M+) have been declining
for either Italian males or females. In particular, the compression of deaths
above the mode has been more pronounced for males, whose SD(M+) de-
creased of 1.21 years, than females, whose SD(M+) decreased of 0.68 years.
The roots of such trends have to be found in the increase of the rate of aging
registered by both sexes during the analyzed period and measured by the
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b parameter of the Kannisto model. Exploiting the cause-of-death decom-
position of b over time proposed by Horiuchi and his collaborators, I was
then able to assess, from a cause-of-death perspective, the reasons behind
the observed increase in the rate of aging. The result gives strong support
to the slope-effect hypothesis, i.e. all-cause b is increasing because cause-
specific b are increasing, and also suggests that the level-effect hypothesis
was actually a wrong prediction, i.e. the causes of death with higher b, thus
the causes of death more related with the senescence process and so less
preventable, are those reporting more conspicuous mortality decline. This
outcome indicates that longevity extension may be actually facing some re-
sistance since for all causes of death there is a slow down in the decline of
death rates with ages but also suggests that the maximum attainable lifes-
pan may further increase since old-age mortality is still considerably de-
clining and, moreover, the decline is more marked for senescence related
causes.
At the moment, data on the age pattern of mortality change at extremely
old ages seem to be readable in various way. Probably humans’ lifespan has
not reached its maximum yet, but likely further longevity extension will
occur more slowly than in the past.
Generally speaking, opinions among gerontologist, biologist and de-
mographer greatly differ about whether human lifespan will ever face bar-
riers or not and whether such hypothetical barriers are due mainly to bio-
logical causes (Comfort, 1979; Fries, 1980; Fries et al., 1989; Harman, 1991)
or to practical impediments (Olshansky et al., 1990). Moreover, if a limit
exists, we currently do not know if it can be relaxed by unforesseable break-
throughs in slowing the process of aging itself. However, it is not just im-
portant if we will continue to live longer, but also if longevity extension
would be accompanied by an extension of the period of healthy life.
7.4 Limitations and further study
In my dissertation I have benefited from having access to cause-of-death
data for Italy in the time interval 1980-2013. As already said, the statisti-
cal disruptions present in the database were fixed through the reconstruc-
tion of coherent cause-specific time series, exploting the cross-classification
of deaths between ICD-9 and ICD-10 performed by ISTAT. Bridge coding
data, however, were available only for 17 groups of causes of death and
thus only for these 17 causes it was possible to reconstruct the series. That
represents a considerable limitation to the epidemiological findings of my
analysis. Inside any of these 17 groups of causes of death, indeed, sev-
eral types of diseases, sometimes really diverse each other, are grouped
together. For instance, cerebrovascular diseases and ischaemic heart dis-
eases, both belonging to diseases of the circulatory system, result to be very
different either from a medical point of view or from an epidemiological
point of view. The same reasoning can be done for neoplasms which gather
together all type of cancer. Another important example of such diversity
inside the same group of causes regards external causes of death which, for
instance, gather together transport accident (a cause of death really typical
of young ages) and accidental falls (a cause of death really typical of old
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ages). Thus, in order to get a more accurate understanding of the epidemi-
ological changes which are leading to a greater certainty about the timing
of death, more detailed analysis at the cause-of-death level is needed. To
improve the knowledge in this field, therefore, researcher must take into ac-
count a larger and more comprehensive set of causes of death. In my thesis
a tried to overcome this problem conducting a few more detailed analysis
at the cause-of-death level for the time interval 2003-2013, in which causes
of death are classified according to ICD-10 all over the period and thus no
statistical disruption are reported. However, this time interval is too short
to get a complete epidemiological understanding of the observed mortality
compression.
With regard to data limitation, I must also evidenciate that my analysis
is restricted to Italian data. My reliance on the Italian cause-of-death series
does not allow to make broad inferences about the epidemiological nature
of changes in lifespan variability because it is not possible to assume that
the Italian case it is generalizable. Thus, it would be useful if further studies
would analyze additional countries in order to highlight differences and
similarity across nations.
With regard to limitations in terms of measures, my study of lifespan
variability relies on S10 and SD(M+). As already widely explained through-
out the dissertation, however, there are several indicators that can be used
to study variability in length of life, each of them evidencing a different as-
pect of this phenomenon. Even though I have chosen these two measures
because they fit well the aim of my work, it would have been useful to take
into account additional indicators of lifespan variability, since they would
have highlighted different pattern of the changes in the age-at-death distri-
bution over time.
Finally, with regard to limitations in terms of methods, I must point out
that in the cause-of-death decomposition of changes in variability of age at
death between 1980-2013 I don’t incorporate data from intermediate years.
Taking into account data for these intermediate years would have lead to a
more accurate and precise cause-of-death explanation of sex-specific trends
in variability in the length of life. Moreover, in my cause-of-death analy-
sis of old-age lifespan variability, I assume that Kannisto model holds for
cause-specific mortality rates. Since cause-specific mortality at old ages
generally do behave similarly respect to all-cause mortality, the assump-
tion is reasonable. However, for some causes of death the fit of the model
might be less accurate. Thus, cause-specific rate of aging estimates may re-
sult less accurate as well as the results of the cause-of-death decomposition
of b over time.
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Appendix A
A.1 Intermediate classification of causes of death
The intermediate classification of causes of death (104 causes), proposed
by the Human Cause-of-Death database has been used in Paragraph
4.2.2 and 5.1.3 for a more detailed analysis at the cause-of-death level
than those carried out using the 17 groups of causes classification.
Cause of death ICD-10 code
1 Other specified intestinal infections A00-A08
2 Diarrhoea and gastroenteritis of presumed A09
infectious origin
3 Tubercolosis A15-A19, B90
4 Septicemia A40-A41
5 Other bacterial diseases A20-A28, A30-A39
A42-A44, A46, A48-A49
6 HIV diseases B20-B24
7 Viral hepatitis B15-B19
8 Other viral diseases A80-A89, B00-B09,
B25-B34
9 Other and unspecified infectious diseases A50-A75, A77-A79,
A90-A99, B35-B60,
B64-B89, B91, B92,
B94-B97, B99
10 Malignant neoplasms of oral cavity C00-C14
11 Malignant neoplasms of oeshophagus C15
12 Malignant neoplasms of stomach C16
13 Malignant neoplasms of colon C18
14 Malignant neoplasms of rectum C19-C21
15 Malignant neoplasms of liver C22
16 Malignant neoplasms of pancreas C25
17 Other malignant neoplasms of the digestive C17,C23-C24,C26
system
18 Malignant neoplasms of larynx C32
19 Malignant neoplasms of lung C33-C34
20 Malignant neoplasms of skin C43-C44
21 Malignant neoplasms of breast C50
22 Malignant neoplasms of cervix uteri C53
23 Malignant neoplasms of uterus C54-C55
24 Malignant neoplasms of ovary C56
TABLE A.1: Cause-of-death intermediate classification.
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Cause of death ICD-10 code
25 Malignant neoplasms of prostate C61
26 Malignant neoplasms of other genital organs C51-C52,C57-C58,C60
27 Malignant neoplasms of kidney C67
28 Malignant neoplasms of bladder C64-C66, C68
29 Malignant neoplasms of nervous system C70-C72
30 Leucemia C91-C95
31 Other malignant neoplasms of lymphoid, C81-90,C96
hematopoietic and related tissue
32 Malignant neoplasms of indipendent multiple sites C97
33 Other neoplasms C30-C31, C37-C41,
C45-C49,C73-C80
34 Benign neoplasms and neoplasms of uncertain or D00-D48
unknown behavior
35 Diabetes mellitus E10-E14
36 Malnutrition E40-E46
37 Other endocrinologic and metabolic diseases E00-E07,E15-E16,
E20-E35,E50-E68
E70-E90
38 Blood diseases D50-D59
39 Dementia F01,F03
40 Alcohol abuse F10
41 Drug abuse F11-F19
42 Other mental disorders F04-F09,F20-F99
43 Systemic atrophies and demyelinating diseases of G10-G12, G35-G37
the central nervous system
44 Parkinson’s diseases G20-G25
45 Alzheimer G30-G31
46 Epilepsy G40-G41
47 Other diseases of the nervous system G00-G09,G43-G44,
G47-G83,G90-G99
H00-H95
48 Rheumatic heart diseases I00-I09
49 Essential hypertension I10
50 Hypertensive diseases I11-I15
51 Acute myocardial infarction I21-I23
52 Atherosclerotic cardiovascular and heart diseases I25.0,I25.1
53 Other IHD I20,I24,I25.2-I25.9
54 Pulmonary heart diseases I26-I28
55 Non rheumatic valve disorders I34-I38
56 Cardiac arrest I46
57 Heart failure I50
58 Other heart diseases I30-I33,I40-I45
I47-I49,I51
59 Intracranial haemorrhage I60-I62
60 Cerebral infarction, occlusion, and stenosis I63, I65-I66
61 Other cerebrovascular diseases G45,I64,I67
62 Sequelae of cerebrovascular disease I69
TABLE A.2: Cause-of-death intermediate classification.
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Cause of death ICD-10 code
63 Diseases of arteries, arterioles and capillaries I70-I78
64 Other circulatory diseases I80-I99
65 Influenza J09-J11
66 Pneumonia J12-J18
67 Other acute respiratory infection J00-J06, J20-J22,
U04
68 Asthma J45-J46
69 Other chronic obstructive pulmonary disease J40-J44, J47
70 Pneumonitis due to solids and liquids J69
71 Pneumoconioses and chemical effects J60-J68, J70
72 Other respiratory diseases, principally affecting the J80-J84
interstitium
73 Other diseases of the respiratory system J30-J39, J85-J98
74 Gastric and duodenal ulcer K25-K28
75 Hernia K40-K46
76 Enteritis, colitis and other intestinal diseases K35-K38, K50-K63
77 Alcoholic cirrhosis of liver K70
78 Other cirrhoses of liver K74
79 Other diseases of liver K71-K73, K75, K76
80 Cholelithiasis and other disorders of biliary tracts K80-K83
81 Diseases of pancreas K85-K86
82 Other digestive diseases K00-K22, K29-K31,
K65-K66, K90-K92
83 Diseases of skin and subcutaneous tissue L00-L98
84 Diseases of the musculoskeletal system M00-M99
85 Renal tubulo-interstitial diseases N00-N15
86 Renal failure N17-N19
87 Other diseases of urinary system N20-N36, N39
88 Diseases of genital organs N40-N99
89 Complications of pregnancy, childbirth, and O00-O99
puerperium
90 Certain conditions originating in the perinatal P00-P96
period
91 Congenital malformations, deformations, and Q00-Q99
chromosomal abnormalities
92 Sudden infant death syndrome R95
93 Transport accident V01-V99
94 Accidental falls W00-W19
95 Accidental drowning and submersion W65-W74
96 Accidental exposure to smoke, fire and flames X00-X09
97 Accidental poisoning by alcohol X45
98 Accidental poisoning by other substance X40-X44, X46-X49
99 Other accidental threats to breathing W75-W84
100 Suicide and self-inflicted injury X60-X84
101 Assault X85-Y09, Y35-Y36
102 Event of undetermined intent Y10-Y34
103 Complications of medical and surgical care Y40-Y84
104 Other accidents and late effects of accidents W20-W64, W85-W99
X10-X39, X50-X59
Y85-Y91, Y95-Y98
TABLE A.3: Cause-of-death intermediate classification.
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A.2 Correspondence table
Correspondence table contains the cross-classification of deaths between
ICD-9 and ICD-10 and represents the starting point for the reconstruc-
tion of coherent cause-specific time series. Two correspondence tables
have been used in this dissertation, one for deaths occurred in the first
year of life and one for deaths above age 1.
A.2.1 Correspondence table of deaths in the first year of life
Inf. Neo. Blood ENM Ment. Nerv. Circ. Resp Dig.
Infectious 23 0 0 0 0 0 0 0 0
Neoplasms 0 3 0 0 0 0 0 0 0
Blood 0 0 5 0 0 0 0 0 0
ENM 0 0 0 21 0 0 0 0 0
Mental 0 0 0 0 0 0 0 0 0
Nervous 0 0 0 0 0 33 0 0 0
Circolatory 0 0 0 0 0 0 31 0 0
Respiratory 0 0 0 0 0 0 2 16 0
Digestive 0 0 0 0 0 0 0 0 9
Skin 0 0 0 0 0 0 0 0 0
Muskoloskeletal 0 0 0 0 0 0 0 0 0
Genetourinary 0 0 0 0 0 0 0 0 0
Perinatal 7 0 1 1 0 4 13 5 8
Congenital 0 1 1 1 0 3 12 3 7
Ill-defined 0 0 0 0 0 0 6 3 0
External 0 0 0 0 0 0 0 0 0
Total-10 30 11 7 23 0 40 64 27 24
TABLE A.4: Cross-classification of deaths between ICD-9
and ICD-10 at age 0.
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Skin Mus. Gen. Per. Cong. Ill Ext. Tot-9
Infectious 0 0 0 6 1 0 0 30
Neoplasms 0 0 0 1 0 0 0 11
Blood 0 0 0 2 0 0 0 7
ENM 0 0 0 4 0 0 0 25
Mental 0 0 0 0 0 0 0 0
Nervous 0 0 0 2 3 0 0 38
Circolatory 0 0 0 8 1 0 0 40
Respiratory 0 0 0 11 1 0 0 30
Digestive 0 0 0 0 1 0 0 10
Skin 0 0 0 1 0 0 0 1
Muskoloskeletal 0 1 0 0 0 0 0 1
Genetourinary 0 4 0 5 1 0 0 10
Perinatal 0 0 0 1072 29 12 0 1152
Congenital 0 3 0 61 576 0 0 668
Ill-defined 0 0 0 12 0 40 0 61
External 0 0 0 0 0 0 40 40
Total-10 0 1 7 1185 613 52 40 2124
TABLE A.5: Cross-classification of deaths between ICD-9
and ICD-10 at age 0.
Continued
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A.2.2 Correspondence table of deaths above age 1
Inf. Neo. Blood ENM Ment. Nerv. Circ. Resp
Infectious 3192 101 47 24 16 30 76 49
Neoplasms 97 127626 55 63 12 53 234 101
Blood 41 335 1339 14 7 3 54 19
ENM 42 188 34 16850 55 43 306 201
Mental 26 79 15 225 5482 1058 1721 189
Nervous 42 67 9 79 56 12069 563 147
Circolatory 397 1643 92 1181 674 1217 190989 2077
Respiratory 182 560 35 143 510 421 1994 29988
Digestive 402 231 25 66 31 29 313 91
Skin 4 2 1 4 3 1 15 12
Muskoloskeletal 14 19 1 14 6 35 46 12
Genetourinary 66 53 11 42 10 27 231 58
Pregnancy 0 0 0 0 0 0 0 0
Congenital 5 13 3 9 0 9 99 4
Ill-defined 112 5 6 22 14 9 77 307
External 13 37 3 43 30 41 353 66
Total-10 4634 130982 1675 18780 6906 15049 197079 33339
TABLE A.6: Cross-classification of deaths between ICD-9
and ICD-10 for ages above 1.
A.2. Correspondence table 147
Dig Skin Mus. Gen Pre Cong. Ill Ext. Tot-9
Infectious 107 25 15 19 0 4 4 4 3712
Neoplasms 69 2 13 34 0 120 6 24 128510
Blood 59 0 28 7 1 142 1 3 2053
ENM 32 5 30 164 0 7 10 13 17980
Mental 54 25 60 37 0 3 46 16 9036
Nervous 56 13 58 27 0 13 40 17 13258
Circolatory 339 56 365 375 3 58 3396 232 203094
Respiratory 161 12 127 73 0 40 34 42 34322
Digestive 17478 5 18 30 0 8 14 27 18769
Skin 5 432 11 0 0 0 0 2 491
Muskoloskeletal 2 6 1328 5 0 2 5 36 1531
Genetourinary 28 10 9 6125 0 10 8 7 6695
Pregnancy 0 0 0 0 6 0 0 0 6
Congenital 10 1 2 6 0 274 2 2 529
Ill-defined 14 6 9 10 0 5 5942 20 6584
External 48 2 21 33 0 1 6 5466 6164
Total-10 18468 600 2095 6948 11 780 9513 5912 452773
TABLE A.7: Cross-classification of deaths between ICD-9
and ICD-10 for ages above 1.
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A.3 Transition matrix
Transition matrix contains coefficient of redistribution matrix that are
applied to cause-specific deaths count in order to avoid statistical disr-
pution and reconstruct cause-specific time series. Two transition matri-
ces have been used, one for deaths occurred in the first year of life and
one for deaths above age 1.
A.3.1 Transition matrix of deaths in the first year of life
Inf. Neo. Blood ENM Ment. Nerv. Circ. Resp
Infectious 0.767 0 0 0 0 0 0 0
Neoplasms 0 0.909 0 0 0 0 0 0
Blood 0 0 0.714 0 0 0 0 0
ENM 0 0 0 0.840 0 0 0 0
Mental 0 0 0 0 0 0 0 0
Nervous 0 0 0 0 0 0.868 0 0
Circolatory 0 0 0 0 0 0 0.775 0
Respiratory 0 0 0 0 0 0 0.067 0.533
Digestive 0 0 0 0 0 0 0 0
Skin 0 0 0 0 0 0 0 0
Muskoloskeletal 0 0 0 0 0 0 0 0
Genetourinary 0 0 0 0 0 0 0 0
Perinatal 0.006 0 0.001 0.001 0 0.003 0.011 0.004
Congenital 0 0.001 0.001 0.001 0 0.004 0.018 0.004
Ill-defined 0 0 0 0 0 0 0.098 0.050
External 0 0 0 0 0 0 0 0
TABLE A.8: Coefficient of redistributions for deaths at age
0.
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Dig. Skin Mus. Gen. Per. Cong. Ill Ext.
Infectious 0 0 0 0 0.200 0.033 0 0
Neoplasms 0 0 0 0 0.091 0 0 0
Blood 0 0 0 0 0.286 0 0 0
ENM 0 0 0 0 0.160 0 0 0
Mental 0 0 0 0 0 0 0 0
Nervous 0 0 0 0 0.053 0.079 0 0
Circolatory 0 0 0 0 0.200 0.250 0 0
Respiratory 0 0 0 0 0.367 0.033 0 0
Digestive 0.900 0 0 0 0 0.100 0 0
Skin 0 0 0 0 0 1 0 0
Muskoloskeletal 0 0 1 0 0 0 0 0
Genetourinary 0 0 0 0.400 0.500 0.100 0 0
Perinatal 0.007 0 0 0 0.931 0.025 0.010 0
Congenital 0.010 0 0 0.005 0.091 0.862 0 0
Ill-defined 0 0 0 0 0.197 0 0.656 0
External 0 0 0 0 0 0 0 1
TABLE A.9: Coefficient of redistributions for deaths at age
0.
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A.3.2 Transition matrix of deaths above age 1
Inf. Neo. Blood ENM Ment. Nerv. Circ. Resp
Infectious 0.860 0.027 0.013 0.006 0.004 0.008 0.020 0.013
Neoplasms 0.001 0.993 0.001 0.001 0.001 0.001 0.001 0.002
Blood 0.020 0.163 0.652 0.007 0.003 0.001 0.026 0.009
ENM 0.002 0.010 0.002 0.937 0.003 0.002 0.017 0.011
Mental 0.003 0.009 0.002 0.025 0.607 0.117 0.190 0.021
Nervous 0.003 0.005 0.001 0.006 0.004 0.910 0.042 0.011
Circolatory 0.002 0.008 0.001 0.006 0.003 0.006 0.904 0.010
Respiratory 0.005 0.016 0.001 0.004 0.015 0.012 0.058 0.874
Digestive 0.021 0.012 0.001 0.003 0.002 0.002 0.017 0.005
Skin 0.008 0.004 0.002 0.008 0.006 0.002 0.030 0.024
Muskoloskeletal 0.009 0.012 0.001 0.009 0.004 0.023 0.030 0.008
Genetourinary 0.010 0.008 0.002 0.006 0.001 0.004 0.034 0.009
Pregnancy 0 0 0 0 0 0 0 0
Congenital 0.011 0.030 0.007 0.021 0 0.0020 0.226 0.009
Ill-defined 0.017 0.001 0.001 0.003 0.002 0.001 0.012 0.047
External 0.002 0.006 0.001 0.007 0.005 0.007 0.057 0.011
TABLE A.10: Coefficient of redistributions for deaths above
age 1.
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Dig Skin Mus. Gen Pre Cong. Ill Ext.
Infectious 0.029 0.007 0.004 0.005 0 0.001 0.001 0.001
Neoplasms 0.001 0 0 0 0 0.001 0 0
Blood 0.029 0 0.014 0.003 0 0.069 0 0.001
ENM 0.002 0.001 0.002 0.009 0 0 0.001 0.001
Mental 0.006 0.003 0.007 0.004 0 0 0.005 0.002
Nervous 0.004 0.001 0.004 0.002 0 0.001 0.003 0.001
Circolatory 0.002 0 0.002 0.002 0 0 0.016 0.001
Respiratory 0.005 0.001 0.004 0.002 0 0.001 0.001 0.001
Digestive 0.931 0.001 0.001 0.002 0 0.001 0.001 0.001
Skin 0.010 0.878 0.022 0 0 0 0 0.004
Muskoloskeletal 0.001 0.003 0.867 0.003 0 0.001 0.003 0.023
Genetourinary 0.004 0.001 0.001 0.914 0 0.002 0.001 0.001
Pregnancy 0 0 0 0 1 0 0 0
Congenital 0.023 0.002 0.005 0.014 0 0.624 0.005 0.005
Ill-defined 0.002 0.001 0.001 0.001 0 0.001 0.906 0.003
External 0.008 0.001 0.003 0.005 0 0 0.001 0.887
TABLE A.11: Coefficient of redistributions for deaths above
age 1.
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A.4 Rates Of Mortality Improvement
Cause-specific ROMIs were analyzed in Paragraph 4.2.3. Here are re-
ported figures of all cause-specific ROMIs not shown in Paragraph 4.2.3.
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FIGURE A.1: Cause-specific surface of mortality improve-
ments based on smoothed death rates. Italy, 1980-2013.
